
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59E15A9264D3A33AE15A001E3D02F3.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="genes">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7464855/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Genes">
<meta name="citation_title" content="Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers">
<meta name="citation_author" content="Wejdan M Alenezi">
<meta name="citation_author_institution" content="Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada; wagdan.alenizy@mail.mcgill.ca (W.M.A.); caitlin.fierheller@mail.mcgill.ca (C.T.F.); neil.recio@mail.mcgill.ca (N.R.)">
<meta name="citation_author_institution" content="Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada">
<meta name="citation_author_institution" content="Department of Medical Laboratory Technology, Taibah University, Medina 42353, Saudi Arabia">
<meta name="citation_author" content="Caitlin T Fierheller">
<meta name="citation_author_institution" content="Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada; wagdan.alenizy@mail.mcgill.ca (W.M.A.); caitlin.fierheller@mail.mcgill.ca (C.T.F.); neil.recio@mail.mcgill.ca (N.R.)">
<meta name="citation_author_institution" content="Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada">
<meta name="citation_author" content="Neil Recio">
<meta name="citation_author_institution" content="Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada; wagdan.alenizy@mail.mcgill.ca (W.M.A.); caitlin.fierheller@mail.mcgill.ca (C.T.F.); neil.recio@mail.mcgill.ca (N.R.)">
<meta name="citation_author_institution" content="Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada">
<meta name="citation_author" content="Patricia N Tonin">
<meta name="citation_author_institution" content="Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada; wagdan.alenizy@mail.mcgill.ca (W.M.A.); caitlin.fierheller@mail.mcgill.ca (C.T.F.); neil.recio@mail.mcgill.ca (N.R.)">
<meta name="citation_author_institution" content="Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada">
<meta name="citation_author_institution" content="Department of Medicine, McGill University, Montreal, QC H3A 0G4, Canada">
<meta name="citation_publication_date" content="2020 Jul 27">
<meta name="citation_volume" content="11">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="856">
<meta name="citation_doi" content="10.3390/genes11080856">
<meta name="citation_pmid" content="32726901">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7464855/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7464855/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7464855/pdf/genes-11-00856.pdf">
<meta name="description" content="Soon after the discovery of BRCA1 and BRCA2 over 20 years ago, it became apparent that not all hereditary breast and/or ovarian cancer syndrome families were explained by germline variants in these cancer predisposing genes, suggesting that other ...">
<meta name="og:title" content="Literature Review of BARD1 as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Soon after the discovery of BRCA1 and BRCA2 over 20 years ago, it became apparent that not all hereditary breast and/or ovarian cancer syndrome families were explained by germline variants in these cancer predisposing genes, suggesting that other ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7464855/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="7464855">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/genes11080856"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/genes-11-00856.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7464855%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/7464855/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/7464855/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7464855/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-genes.png" alt="Genes logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Genes" title="Link to Genes" shape="default" href="http://www.mdpi.com/journal/genes" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Genes (Basel)</button></div>. 2020 Jul 27;11(8):856. doi: <a href="https://doi.org/10.3390/genes11080856" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/genes11080856</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Genes%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Genes%20(Basel)%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Genes%20(Basel)%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Genes%20(Basel)%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Literature Review of <em>BARD1</em> as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alenezi%20WM%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Wejdan M Alenezi</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Wejdan M Alenezi</span></h3>
<div class="p">
<sup>1</sup>Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada; wagdan.alenizy@mail.mcgill.ca (W.M.A.); caitlin.fierheller@mail.mcgill.ca (C.T.F.); neil.recio@mail.mcgill.ca (N.R.)</div>
<div class="p">
<sup>2</sup>Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada</div>
<div class="p">
<sup>3</sup>Department of Medical Laboratory Technology, Taibah University, Medina 42353, Saudi Arabia</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alenezi%20WM%22%5BAuthor%5D" class="usa-link"><span class="name western">Wejdan M Alenezi</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fierheller%20CT%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Caitlin T Fierheller</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Caitlin T Fierheller</span></h3>
<div class="p">
<sup>1</sup>Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada; wagdan.alenizy@mail.mcgill.ca (W.M.A.); caitlin.fierheller@mail.mcgill.ca (C.T.F.); neil.recio@mail.mcgill.ca (N.R.)</div>
<div class="p">
<sup>2</sup>Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fierheller%20CT%22%5BAuthor%5D" class="usa-link"><span class="name western">Caitlin T Fierheller</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Recio%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Neil Recio</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Neil Recio</span></h3>
<div class="p">
<sup>1</sup>Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada; wagdan.alenizy@mail.mcgill.ca (W.M.A.); caitlin.fierheller@mail.mcgill.ca (C.T.F.); neil.recio@mail.mcgill.ca (N.R.)</div>
<div class="p">
<sup>2</sup>Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Recio%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Neil Recio</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tonin%20PN%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Patricia N Tonin</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Patricia N Tonin</span></h3>
<div class="p">
<sup>1</sup>Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada; wagdan.alenizy@mail.mcgill.ca (W.M.A.); caitlin.fierheller@mail.mcgill.ca (C.T.F.); neil.recio@mail.mcgill.ca (N.R.)</div>
<div class="p">
<sup>2</sup>Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada</div>
<div class="p">
<sup>4</sup>Department of Medicine, McGill University, Montreal, QC H3A 0G4, Canada</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tonin%20PN%22%5BAuthor%5D" class="usa-link"><span class="name western">Patricia N Tonin</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>4,</sup><sup>*</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-genes-11-00856">
<sup>1</sup>Department of Human Genetics, McGill University, Montreal, QC H3A 0G4, Canada; wagdan.alenizy@mail.mcgill.ca (W.M.A.); caitlin.fierheller@mail.mcgill.ca (C.T.F.); neil.recio@mail.mcgill.ca (N.R.)</div>
<div id="af2-genes-11-00856">
<sup>2</sup>Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada</div>
<div id="af3-genes-11-00856">
<sup>3</sup>Department of Medical Laboratory Technology, Taibah University, Medina 42353, Saudi Arabia</div>
<div id="af4-genes-11-00856">
<sup>4</sup>Department of Medicine, McGill University, Montreal, QC H3A 0G4, Canada</div>
<div class="author-notes p">
<div class="fn" id="c1-genes-11-00856">
<sup>*</sup><p class="display-inline">Correspondence: <span>patricia.tonin@mcgill.ca</span>; Tel.: +1-514-934-1934 (ext. 44069)</p>
</div>
<div class="fn" id="fn1-genes-11-00856">
<sup>†</sup><p class="display-inline">Contributed equally to the work.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2020 Jun 30; Accepted 2020 Jul 23; Collection date 2020 Aug.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2020 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="http://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC7464855  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32726901/" class="usa-link">32726901</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Soon after the discovery of <em>BRCA1</em> and <em>BRCA2</em> over 20 years ago, it became apparent that not all hereditary breast and/or ovarian cancer syndrome families were explained by germline variants in these cancer predisposing genes, suggesting that other such genes have yet to be discovered. BRCA1-associated ring domain (<em>BARD1</em>), a direct interacting partner of BRCA1, was one of the earliest candidates investigated. Sequencing analyses revealed that potentially pathogenic <em>BARD1</em> variants likely conferred a low–moderate risk to hereditary breast cancer, but this association is inconsistent. Here, we review studies of <em>BARD1</em> as a cancer predisposing gene and illustrate the challenge of discovering additional cancer risk genes for hereditary breast and/or ovarian cancer. We selected peer reviewed research articles that focused on three themes: (i) sequence analyses of <em>BARD1</em> to identify potentially pathogenic germline variants in adult hereditary cancer syndromes; (ii) biological assays of <em>BARD1</em> variants to assess their effect on protein function; and (iii) association studies of <em>BARD1</em> variants in family-based and case-control study groups to assess cancer risk. In conclusion, <em>BARD1</em> is likely to be a low–moderate penetrance breast cancer risk gene.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> <em>BARD1</em>, cancer predisposing gene, hereditary cancer syndromes, breast cancer, ovarian cancer, next-generation sequencing, multi-gene panel testing</p></section></section><section id="sec1-genes-11-00856"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>After the discovery of <em>BRCA1</em> and <em>BRCA2</em>, the highly penetrant breast (BC) and ovarian cancer (OC) predisposing genes, it became evident that about 20% of hereditary BC and/or OC syndrome families did not carry pathogenic variants in these genes. Under the assumption that other genes contribute risk to these cancers, research focused on identifying an additional major risk gene, namely “<em>BRCAX</em>”. Since the discovery of <em>BRCA1</em> in 1994 [<a href="#B1-genes-11-00856" class="usa-link" aria-describedby="B1-genes-11-00856">1</a>], 27 cancer predisposing genes that confer significant lifetime risk to hereditary adult cancers have been discovered (reviewed in [<a href="#B2-genes-11-00856" class="usa-link" aria-describedby="B2-genes-11-00856">2</a>,<a href="#B3-genes-11-00856" class="usa-link" aria-describedby="B3-genes-11-00856">3</a>]). About half of these genes were discovered using genome-wide linkage analysis to identify candidate loci followed by sequencing candidate genes to identify pathogenic variants segregating in cancer families (reviewed in [<a href="#B2-genes-11-00856" class="usa-link" aria-describedby="B2-genes-11-00856">2</a>]). However, the rarity of large pedigrees of <em>BRCA1</em> and <em>BRCA2</em> mutation negative families and availability of family members suitable for linkage analyses posed considerable challenges for gene discovery projects. With knowledge about gene function, sequencing of candidate genes became a favoured strategy for gene discovery. Candidates can be selected based on having similar biological domains, involvement in the same biological pathway or biochemically interacting with known cancer predisposing gene(s). Using this candidate gene approach over 100 genes have been identified of which the majority have failed to be linked with hereditary cancer syndromes, including BC and/or OC, in independent studies (reviewed in [<a href="#B2-genes-11-00856" class="usa-link" aria-describedby="B2-genes-11-00856">2</a>,<a href="#B4-genes-11-00856" class="usa-link" aria-describedby="B4-genes-11-00856">4</a>]).</p>
<p>The BRCA1-associated RING domain 1 (<em>BARD1</em>) gene was discovered in 1996 in an effort to understand the biological function of BRCA1 protein as shown in the timeline of major discoveries of <em>BARD1</em> (<a href="#genes-11-00856-f001" class="usa-link">Figure 1</a>). BARD1 directly interacts with BRCA1 via its N-terminal RING (really interesting new gene) domain [<a href="#B5-genes-11-00856" class="usa-link" aria-describedby="B5-genes-11-00856">5</a>]. As pathogenic <em>BRCA1</em> variants located in the RING domain disrupt BARD1-BRCA1 interaction, it was hypothesized that variants in <em>BARD1</em> may also affect this interaction, thereby making <em>BARD1</em> an attractive candidate to pursue in <em>BRCA1</em> mutation negative cancer families. Although potentially pathogenic <em>BARD1</em> variants have been reported, the role of <em>BARD1</em> in cancer predisposition remains inconsistent. Here, we aim to review what is known about <em>BARD1</em> as a candidate cancer predisposing gene and discuss challenges facing researchers aiming to discover additional cancer predisposing genes. We focused on publications that: (i) described the analyses of potentially pathogenic germline <em>BARD1</em> variants in adult hereditary cancer syndromes; (ii) BARD1 <em>in vitro</em> and <em>in cellulo</em> assays that assessed the biological effect of potentially pathogenic variants on protein function; and (iii) analyzed cancer risk associated with potentially pathogenic <em>BARD1</em> variants in family-based and case-control study groups.</p>
<figure class="fig xbox font-sm" id="genes-11-00856-f001"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7464855_genes-11-00856-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae7e/7464855/38da91c3bebf/genes-11-00856-g001.jpg" loading="lazy" height="332" width="739" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/genes-11-00856-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Timeline of the major discoveries associated with <em>BARD1</em> function and risk to breast and ovarian cancer [<a href="#B1-genes-11-00856" class="usa-link" aria-describedby="B1-genes-11-00856">1</a>,<a href="#B5-genes-11-00856" class="usa-link" aria-describedby="B5-genes-11-00856">5</a>,<a href="#B6-genes-11-00856" class="usa-link" aria-describedby="B6-genes-11-00856">6</a>,<a href="#B7-genes-11-00856" class="usa-link" aria-describedby="B7-genes-11-00856">7</a>,<a href="#B8-genes-11-00856" class="usa-link" aria-describedby="B8-genes-11-00856">8</a>,<a href="#B9-genes-11-00856" class="usa-link" aria-describedby="B9-genes-11-00856">9</a>,<a href="#B10-genes-11-00856" class="usa-link" aria-describedby="B10-genes-11-00856">10</a>,<a href="#B11-genes-11-00856" class="usa-link" aria-describedby="B11-genes-11-00856">11</a>,<a href="#B12-genes-11-00856" class="usa-link" aria-describedby="B12-genes-11-00856">12</a>,<a href="#B13-genes-11-00856" class="usa-link" aria-describedby="B13-genes-11-00856">13</a>].</p></figcaption></figure></section><section id="sec2-genes-11-00856"><h2 class="pmc_sec_title">2. <em>BARD1</em> as a Candidate Cancer Predisposing Gene</h2>
<p>Little was known about the biological function of <em>BRCA1</em> when it was first reported as a cancer predisposing gene other than the predicted loss-of-function variants suggested that it may behave as tumour suppressor gene [<a href="#B1-genes-11-00856" class="usa-link" aria-describedby="B1-genes-11-00856">1</a>]. To learn about BRCA1 function, a yeast two-hybrid screening system was used to identify proteins that directly interact with BRCA1 and a protein was identified that interacts directly with its N-terminal RING domain [<a href="#B5-genes-11-00856" class="usa-link" aria-describedby="B5-genes-11-00856">5</a>]. Repeating the assay using a human cell line, a similar protein which contained a C-terminal motif with significant homology to the conserved C-terminal BRCA1 C terminus (BRCT) domains in BRCA1 and three tandem ankyrin (ANK) domains adjacent to the BRCT domains was identified. The BRCA1–BARD1 interaction was shown to be disrupted by <em>BRCA1</em> missense variants [<a href="#B5-genes-11-00856" class="usa-link" aria-describedby="B5-genes-11-00856">5</a>]. The formation of a stable BRCA1–BARD1 complex was considered to be critical for BRCA1 function and thus BARD1 may play a role as an effector or regulator of BRCA1 [<a href="#B5-genes-11-00856" class="usa-link" aria-describedby="B5-genes-11-00856">5</a>]. This led to the hypothesis that variants in <em>BARD1</em> could encode an aberrant protein affecting the interaction with BRCA1 and predispose to BC and/or OC, especially in hereditary cancer syndrome families not accounted for by <em>BRCA1</em> or <em>BRCA2</em> [<a href="#B6-genes-11-00856" class="usa-link" aria-describedby="B6-genes-11-00856">6</a>]. This study was the first report of molecular genetic analyses of <em>BARD1</em> in cancer samples in 1998 [<a href="#B6-genes-11-00856" class="usa-link" aria-describedby="B6-genes-11-00856">6</a>] (<a href="#genes-11-00856-f001" class="usa-link">Figure 1</a>). In a targeted sequencing analysis of 168 BC, OC, and uterine tumours, the first <em>BARD1</em> variant, c.1692G&gt;C; p.Gln564His, was identified in a woman diagnosed with a clear cell histopathological subtype of OC at the age of 73 years [<a href="#B6-genes-11-00856" class="usa-link" aria-describedby="B6-genes-11-00856">6</a>]. This variant is predicted to change an amino acid residue located near the BRCT domains in BARD1. This individual was also diagnosed with infiltrating lobular BC and six years later with a clear cell endometrial cancer. Sequencing of cloned <em>BARD1</em> mRNA transcripts from ovarian and uterine tumour tissues revealed only the variant allele. Sequencing of similarly generated cloned transcripts from non-cancerous uterine tissue revealed both the wild type and variant alleles, suggesting that the missense c.1692G&gt;C; p.Gln564His variant was of germline origin. No family history was available for the variant carrier; thus, it was not possible to determine if this rare variant (not identified in about 300 cancer-free individuals) could be associated with familial cancer. Regardless, the observation that a <em>BARD1</em> variant was found in an individual with three primary cancers suggests a strong possibility that it is associated with risk to cancer.</p>
<section id="sec3"><h3 class="pmc_sec_title">Subsequent Studies with Inconsistent Results </h3>
<p>The first statistical association was reported by analyzing the <em>BARD1</em> c.1670G&gt;C; p.Cys557Ser variant in cancer cases from Finnish [<a href="#B7-genes-11-00856" class="usa-link" aria-describedby="B7-genes-11-00856">7</a>], Nordic [<a href="#B14-genes-11-00856" class="usa-link" aria-describedby="B14-genes-11-00856">14</a>], and Icelandic [<a href="#B15-genes-11-00856" class="usa-link" aria-describedby="B15-genes-11-00856">15</a>] populations versus population-matched cancer-free controls. Collectively, these studies were in agreement with the possibility that carriers of this <em>BARD1</em> variant had an increased risk to BC and/or OC. However, a negative association was reported by three different research groups that analyzed case-control groups from Finnish [<a href="#B8-genes-11-00856" class="usa-link" aria-describedby="B8-genes-11-00856">8</a>], Australian [<a href="#B16-genes-11-00856" class="usa-link" aria-describedby="B16-genes-11-00856">16</a>], and Polish [<a href="#B17-genes-11-00856" class="usa-link" aria-describedby="B17-genes-11-00856">17</a>] populations. The inconsistency in results from the same Finnish population was explained by the possibility of a false positive association due to the small sample sizes [<a href="#B7-genes-11-00856" class="usa-link" aria-describedby="B7-genes-11-00856">7</a>,<a href="#B8-genes-11-00856" class="usa-link" aria-describedby="B8-genes-11-00856">8</a>]. Indeed, using publicly available population based genetic databases the minor allele frequency (MAF) of <em>BARD1</em> c.1670G&gt;C; p.Cys557Ser is 0.015 in the general cancer-free population overall, but it is highly variable among different populations (<a href="https://gnomad.broadinstitute.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://gnomad.broadinstitute.org</a> v2.1.1) [<a href="#B18-genes-11-00856" class="usa-link" aria-describedby="B18-genes-11-00856">18</a>]. It is the rarest (MAF = 5.2 × 10<sup>−5</sup>) in East Asians and the most common (MAF = 0.024) in the Ashkenazi Jewish population (<a href="#app1-genes-11-00856" class="usa-link">Supplementary Table S1</a>). In the Finnish population, this variant has a frequency of approximately 1%, which is relatively more common compared to known pathogenic variants in well-established BC and OC predisposing genes, <em>BRCA1</em> or <em>BRCA2</em> (0.001%). This suggests that the effect size of <em>BARD1</em> c.1670G&gt;C; p.Cys557Ser could be small, that is, it could confer a low–moderate risk to cancer relative to the high risk associated with <em>BRCA1/BRCA2</em> pathogenic variants.</p>
<p>Some subsequent studies reported no statistically significant association of <em>BARD1</em> variants with cancer risk, resulting in consideration of <em>BARD1</em> not being a strong candidate cancer predisposing gene [<a href="#B10-genes-11-00856" class="usa-link" aria-describedby="B10-genes-11-00856">10</a>,<a href="#B19-genes-11-00856" class="usa-link" aria-describedby="B19-genes-11-00856">19</a>,<a href="#B20-genes-11-00856" class="usa-link" aria-describedby="B20-genes-11-00856">20</a>,<a href="#B21-genes-11-00856" class="usa-link" aria-describedby="B21-genes-11-00856">21</a>]. In part, early studies lacked statistical power due to limited number of carriers identified in the small size of study groups. In 2017, a positive statistical association of <em>BARD1</em> variants with BC was reported in a large sample size of approximately 30,000 BC cases and 30,000 cancer-free controls [<a href="#B11-genes-11-00856" class="usa-link" aria-describedby="B11-genes-11-00856">11</a>] (<a href="#genes-11-00856-f001" class="usa-link">Figure 1</a>). Subsequent studies reported consistent positive results and proposed <em>BARD1</em> as a candidate cancer predisposing gene where variants confer low–moderate risk for BC, especially for triple-negative BC (TNBC) [<a href="#B13-genes-11-00856" class="usa-link" aria-describedby="B13-genes-11-00856">13</a>,<a href="#B22-genes-11-00856" class="usa-link" aria-describedby="B22-genes-11-00856">22</a>,<a href="#B23-genes-11-00856" class="usa-link" aria-describedby="B23-genes-11-00856">23</a>]. TNBC accounts for 10–20% of all BC cases and is defined by the absence of estrogen and progesterone receptors accompanied by overexpression of human epidermal growth factor receptor 2 (reviewed in [<a href="#B24-genes-11-00856" class="usa-link" aria-describedby="B24-genes-11-00856">24</a>,<a href="#B25-genes-11-00856" class="usa-link" aria-describedby="B25-genes-11-00856">25</a>]). These subsequent reports were enriched for TNBC cases, which should have reduced the genetic heterogeneity between BC subtypes [<a href="#B13-genes-11-00856" class="usa-link" aria-describedby="B13-genes-11-00856">13</a>,<a href="#B22-genes-11-00856" class="usa-link" aria-describedby="B22-genes-11-00856">22</a>,<a href="#B23-genes-11-00856" class="usa-link" aria-describedby="B23-genes-11-00856">23</a>,<a href="#B26-genes-11-00856" class="usa-link" aria-describedby="B26-genes-11-00856">26</a>].</p></section></section><section id="sec3-genes-11-00856"><h2 class="pmc_sec_title">3. Potentially Pathogenic Germline <em>BARD1</em> Variants Identified in Cancer Cases </h2>
<section id="sec3dot1-genes-11-00856"><h3 class="pmc_sec_title">3.1. Targeted BARD1 Studies of Breast and Ovarian Cancer</h3>
<p>A total of 100 unique germline variants have been reported in studies where targeted analysis of <em>BARD1</em> was performed (<a href="#app1-genes-11-00856" class="usa-link">Supplementary Table S1, File S1</a>) [<a href="#B6-genes-11-00856" class="usa-link" aria-describedby="B6-genes-11-00856">6</a>,<a href="#B7-genes-11-00856" class="usa-link" aria-describedby="B7-genes-11-00856">7</a>,<a href="#B8-genes-11-00856" class="usa-link" aria-describedby="B8-genes-11-00856">8</a>,<a href="#B9-genes-11-00856" class="usa-link" aria-describedby="B9-genes-11-00856">9</a>,<a href="#B10-genes-11-00856" class="usa-link" aria-describedby="B10-genes-11-00856">10</a>,<a href="#B11-genes-11-00856" class="usa-link" aria-describedby="B11-genes-11-00856">11</a>,<a href="#B12-genes-11-00856" class="usa-link" aria-describedby="B12-genes-11-00856">12</a>,<a href="#B14-genes-11-00856" class="usa-link" aria-describedby="B14-genes-11-00856">14</a>,<a href="#B15-genes-11-00856" class="usa-link" aria-describedby="B15-genes-11-00856">15</a>,<a href="#B17-genes-11-00856" class="usa-link" aria-describedby="B17-genes-11-00856">17</a>,<a href="#B24-genes-11-00856" class="usa-link" aria-describedby="B24-genes-11-00856">24</a>,<a href="#B25-genes-11-00856" class="usa-link" aria-describedby="B25-genes-11-00856">25</a>,<a href="#B26-genes-11-00856" class="usa-link" aria-describedby="B26-genes-11-00856">26</a>,<a href="#B27-genes-11-00856" class="usa-link" aria-describedby="B27-genes-11-00856">27</a>,<a href="#B28-genes-11-00856" class="usa-link" aria-describedby="B28-genes-11-00856">28</a>,<a href="#B29-genes-11-00856" class="usa-link" aria-describedby="B29-genes-11-00856">29</a>,<a href="#B30-genes-11-00856" class="usa-link" aria-describedby="B30-genes-11-00856">30</a>,<a href="#B31-genes-11-00856" class="usa-link" aria-describedby="B31-genes-11-00856">31</a>,<a href="#B32-genes-11-00856" class="usa-link" aria-describedby="B32-genes-11-00856">32</a>,<a href="#B33-genes-11-00856" class="usa-link" aria-describedby="B33-genes-11-00856">33</a>,<a href="#B34-genes-11-00856" class="usa-link" aria-describedby="B34-genes-11-00856">34</a>]. Variants identified in these BC and OC cases include: 12 frameshift; seven nonsense; five splice site; 67 missense; and nine synonymous variants. These variants are rare in the general population, with the MAFs ranging between 4.2 × 10<sup>−7</sup> and 8.12 × 10<sup>−1</sup> among cancer-free individuals, though some variants were not identified in this database (<a href="https://gnomad.broadinstitute.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://gnomad.broadinstitute.org</a> v2.1.1) [<a href="#B18-genes-11-00856" class="usa-link" aria-describedby="B18-genes-11-00856">18</a>]. In <em>BARD1</em> targeted sequencing studies that investigated ≥500 cancer cases, the allele frequencies ranged between 0.02%–49% [<a href="#B28-genes-11-00856" class="usa-link" aria-describedby="B28-genes-11-00856">28</a>,<a href="#B33-genes-11-00856" class="usa-link" aria-describedby="B33-genes-11-00856">33</a>] and 0.03%–48% [<a href="#B10-genes-11-00856" class="usa-link" aria-describedby="B10-genes-11-00856">10</a>] in BC and OC cases, respectively. Using the American College of Medical Genetics and Genomics (ACMG) guidelines for variant interpretation, only 19 potentially loss-of-function variants are classified as being pathogenic with a large portion of the remaining variants being classified as a variant of uncertain significance. As the pathogenicity of many of these variants is still unclear, we have re-evaluated all of the identified <em>BARD1</em> missense variants using in silico tools that predict the effect on protein function or conservation at that locus. We have found that 29 of the previously reported missense variants are potentially pathogenic based on being predicted to be damaging by at least five out of seven in silico tools and conserved by all three conservation prediction tools (<a href="#app1-genes-11-00856" class="usa-link">Supplementary Table S1, File S1</a>). Overall, the mutational spectrum of <em>BARD1</em> in BC and/or OC is diverse and there does not appear to be any hotspots in any particular domain (<a href="#genes-11-00856-f002" class="usa-link">Figure 2</a>A,B).</p>
<figure class="fig xbox font-sm" id="genes-11-00856-f002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7464855_genes-11-00856-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae7e/7464855/6823684f0c2b/genes-11-00856-g002.jpg" loading="lazy" height="732" width="762" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/genes-11-00856-f002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Potentially pathogenic germline variants reported in the literature mapped to full length BARD1 transcript including RING, ANK and BRCT encoding domains. (<strong>A</strong>) Predicted loss-of-function variants including nonsense, frameshift and canonical splice site variants. (<strong>B</strong>) Missense variants predicted to be damaging by in silico tools and conservation tools. (<strong>C</strong>) Variants discussed in the review. RING = Really Interesting New Gene domain; ANK = Ankyrin domain; BRCT = BRCA1 C Terminus domain. See <a href="#app1-genes-11-00856" class="usa-link">Supplementary Table S1</a> for more information.</p></figcaption></figure></section><section id="sec3dot2-genes-11-00856"><h3 class="pmc_sec_title">3.2. Multi-Gene Panel and Next-Generation Sequencing Studies Including BARD1 of Breast and Ovarian Cancers</h3>
<p>Multi-gene panels that usually contain known high-risk cancer predisposing genes, such as <em>BRCA1</em> and <em>BRCA2</em>, were used to determine the prevalence and spectrum of variants in the genes in defined study groups for comparative purposes. Germline whole gene sequencing panels included 10–219 genes [<a href="#B16-genes-11-00856" class="usa-link" aria-describedby="B16-genes-11-00856">16</a>,<a href="#B18-genes-11-00856" class="usa-link" aria-describedby="B18-genes-11-00856">18</a>,<a href="#B19-genes-11-00856" class="usa-link" aria-describedby="B19-genes-11-00856">19</a>,<a href="#B20-genes-11-00856" class="usa-link" aria-describedby="B20-genes-11-00856">20</a>,<a href="#B21-genes-11-00856" class="usa-link" aria-describedby="B21-genes-11-00856">21</a>,<a href="#B35-genes-11-00856" class="usa-link" aria-describedby="B35-genes-11-00856">35</a>,<a href="#B36-genes-11-00856" class="usa-link" aria-describedby="B36-genes-11-00856">36</a>,<a href="#B37-genes-11-00856" class="usa-link" aria-describedby="B37-genes-11-00856">37</a>,<a href="#B38-genes-11-00856" class="usa-link" aria-describedby="B38-genes-11-00856">38</a>,<a href="#B39-genes-11-00856" class="usa-link" aria-describedby="B39-genes-11-00856">39</a>,<a href="#B40-genes-11-00856" class="usa-link" aria-describedby="B40-genes-11-00856">40</a>,<a href="#B41-genes-11-00856" class="usa-link" aria-describedby="B41-genes-11-00856">41</a>,<a href="#B42-genes-11-00856" class="usa-link" aria-describedby="B42-genes-11-00856">42</a>,<a href="#B43-genes-11-00856" class="usa-link" aria-describedby="B43-genes-11-00856">43</a>,<a href="#B44-genes-11-00856" class="usa-link" aria-describedby="B44-genes-11-00856">44</a>,<a href="#B45-genes-11-00856" class="usa-link" aria-describedby="B45-genes-11-00856">45</a>,<a href="#B46-genes-11-00856" class="usa-link" aria-describedby="B46-genes-11-00856">46</a>,<a href="#B47-genes-11-00856" class="usa-link" aria-describedby="B47-genes-11-00856">47</a>,<a href="#B48-genes-11-00856" class="usa-link" aria-describedby="B48-genes-11-00856">48</a>,<a href="#B49-genes-11-00856" class="usa-link" aria-describedby="B49-genes-11-00856">49</a>,<a href="#B50-genes-11-00856" class="usa-link" aria-describedby="B50-genes-11-00856">50</a>,<a href="#B51-genes-11-00856" class="usa-link" aria-describedby="B51-genes-11-00856">51</a>,<a href="#B52-genes-11-00856" class="usa-link" aria-describedby="B52-genes-11-00856">52</a>,<a href="#B53-genes-11-00856" class="usa-link" aria-describedby="B53-genes-11-00856">53</a>,<a href="#B54-genes-11-00856" class="usa-link" aria-describedby="B54-genes-11-00856">54</a>,<a href="#B55-genes-11-00856" class="usa-link" aria-describedby="B55-genes-11-00856">55</a>,<a href="#B56-genes-11-00856" class="usa-link" aria-describedby="B56-genes-11-00856">56</a>,<a href="#B57-genes-11-00856" class="usa-link" aria-describedby="B57-genes-11-00856">57</a>,<a href="#B58-genes-11-00856" class="usa-link" aria-describedby="B58-genes-11-00856">58</a>,<a href="#B59-genes-11-00856" class="usa-link" aria-describedby="B59-genes-11-00856">59</a>,<a href="#B60-genes-11-00856" class="usa-link" aria-describedby="B60-genes-11-00856">60</a>,<a href="#B61-genes-11-00856" class="usa-link" aria-describedby="B61-genes-11-00856">61</a>,<a href="#B62-genes-11-00856" class="usa-link" aria-describedby="B62-genes-11-00856">62</a>] and whole exome sequencing strategies analyzed 10–832 genes [<a href="#B63-genes-11-00856" class="usa-link" aria-describedby="B63-genes-11-00856">63</a>,<a href="#B64-genes-11-00856" class="usa-link" aria-describedby="B64-genes-11-00856">64</a>,<a href="#B65-genes-11-00856" class="usa-link" aria-describedby="B65-genes-11-00856">65</a>,<a href="#B66-genes-11-00856" class="usa-link" aria-describedby="B66-genes-11-00856">66</a>,<a href="#B67-genes-11-00856" class="usa-link" aria-describedby="B67-genes-11-00856">67</a>]. These sequencing strategies were used in studies on BC and/or OC and male BC, the first being published in 2011 [<a href="#B61-genes-11-00856" class="usa-link" aria-describedby="B61-genes-11-00856">61</a>] (<a href="#genes-11-00856-f001" class="usa-link">Figure 1</a>). Collectively, 55 unique variants were reported in familial, high-risk or unselected BC and/or OC cases (<a href="#genes-11-00856-f002" class="usa-link">Figure 2</a>, <a href="#app1-genes-11-00856" class="usa-link">Supplementary Table S1</a>). Variants identified in these BC and OC cancer cases include: 15 frameshift; 13 nonsense; four splice site; 22 missense; and one synonymous variant. In silico tools revealed that six of the missense variants are predicted to be potentially pathogenic. A germline copy number deletion and deletion of exon 2 were identified in two BC cases [<a href="#B54-genes-11-00856" class="usa-link" aria-describedby="B54-genes-11-00856">54</a>,<a href="#B65-genes-11-00856" class="usa-link" aria-describedby="B65-genes-11-00856">65</a>]. A large (1258 bp) heterozygous germline deletion in intron three was identified by multiplex ligation-dependent probe amplification in <em>BARD1</em> in a BC case (diagnosed at age 36 years) [<a href="#B68-genes-11-00856" class="usa-link" aria-describedby="B68-genes-11-00856">68</a>]. This deletion was not detected to have an impact on RNA splicing and allelic imbalance could not be measured as there was no SNP to use. These findings are interesting because these variants may result in partial or complete loss of BARD1 protein. In studies of ≥500 cancer cases, the prevalence of potentially pathogenic <em>BARD1</em> variants ranged from 0.18–0.53% [<a href="#B11-genes-11-00856" class="usa-link" aria-describedby="B11-genes-11-00856">11</a>,<a href="#B47-genes-11-00856" class="usa-link" aria-describedby="B47-genes-11-00856">47</a>], 0.67–0.9% [<a href="#B13-genes-11-00856" class="usa-link" aria-describedby="B13-genes-11-00856">13</a>,<a href="#B22-genes-11-00856" class="usa-link" aria-describedby="B22-genes-11-00856">22</a>], and 0.07–0.23% [<a href="#B37-genes-11-00856" class="usa-link" aria-describedby="B37-genes-11-00856">37</a>,<a href="#B63-genes-11-00856" class="usa-link" aria-describedby="B63-genes-11-00856">63</a>] in BC, TNBC and OC cases, respectively. Clearly, in BC and OC cases carriers of <em>BARD1</em> variants are much less common than carriers of pathogenic <em>BRCA1/BRCA2</em> variants (5–10% each).</p></section><section id="sec3dot3-genes-11-00856"><h3 class="pmc_sec_title">3.3. BARD1 in Other Cancers</h3>
<p>The prevalence of potentially pathogenic germline <em>BARD1</em> variants has been investigated in colorectal [<a href="#B32-genes-11-00856" class="usa-link" aria-describedby="B32-genes-11-00856">32</a>,<a href="#B69-genes-11-00856" class="usa-link" aria-describedby="B69-genes-11-00856">69</a>], endometrial [<a href="#B70-genes-11-00856" class="usa-link" aria-describedby="B70-genes-11-00856">70</a>] and pancreatic [<a href="#B71-genes-11-00856" class="usa-link" aria-describedby="B71-genes-11-00856">71</a>,<a href="#B72-genes-11-00856" class="usa-link" aria-describedby="B72-genes-11-00856">72</a>] cancers (<a href="#genes-11-00856-f002" class="usa-link">Figure 2</a>A,B, <a href="#app1-genes-11-00856" class="usa-link">Supplementary Table S1</a>). The carrier frequency of <em>BARD1</em> in a familial colorectal cancer study was one in 29 (3.4%) [<a href="#B69-genes-11-00856" class="usa-link" aria-describedby="B69-genes-11-00856">69</a>]. The carrier frequency of <em>BARD1</em> in unselected endometrial cancer was one in 381 (0.26%) [<a href="#B70-genes-11-00856" class="usa-link" aria-describedby="B70-genes-11-00856">70</a>] and in two pancreatic cancer studies was one in 302 (0.33%) [<a href="#B71-genes-11-00856" class="usa-link" aria-describedby="B71-genes-11-00856">71</a>] and nine in 96 (9.4%) [<a href="#B72-genes-11-00856" class="usa-link" aria-describedby="B72-genes-11-00856">72</a>]. The presence of <em>BARD1</em> variants in other cancer types suggests that they may also play a role in risk in these diseases. Of the 15 variants that have been identified in these cancer cases, eight have been found in BC and OC cases and two in BC cases. </p></section><section id="sec3dot4-genes-11-00856"><h3 class="pmc_sec_title">3.4. Carriers of a BARD1 Variant and a Pathogenic Variant in a Known High-Risk Cancer Predisposing Gene</h3>
<p>The carriers of more than one pathogenic variant in different cancer predisposing genes, <em>BRCA1</em> and <em>BRCA2</em> as an example, has been described but reports are not common. One in 190,000 Europeans is estimated to carry a pathogenic variant in both <em>BRCA1</em> and <em>BRCA2</em> [<a href="#B73-genes-11-00856" class="usa-link" aria-describedby="B73-genes-11-00856">73</a>,<a href="#B74-genes-11-00856" class="usa-link" aria-describedby="B74-genes-11-00856">74</a>,<a href="#B75-genes-11-00856" class="usa-link" aria-describedby="B75-genes-11-00856">75</a>], and this may be higher in defined populations exhibiting founder effects due to common ancestors, such as in the Ashkenazi Jewish (one in 1800) [<a href="#B76-genes-11-00856" class="usa-link" aria-describedby="B76-genes-11-00856">76</a>,<a href="#B77-genes-11-00856" class="usa-link" aria-describedby="B77-genes-11-00856">77</a>] and French Canadian [<a href="#B78-genes-11-00856" class="usa-link" aria-describedby="B78-genes-11-00856">78</a>] populations. Carriers of a BARD1 variant and a pathogenic <em>BRCA1</em> or <em>BRCA2</em> variant, that is double heterozygosity, have been reported [<a href="#B14-genes-11-00856" class="usa-link" aria-describedby="B14-genes-11-00856">14</a>,<a href="#B15-genes-11-00856" class="usa-link" aria-describedby="B15-genes-11-00856">15</a>,<a href="#B45-genes-11-00856" class="usa-link" aria-describedby="B45-genes-11-00856">45</a>,<a href="#B48-genes-11-00856" class="usa-link" aria-describedby="B48-genes-11-00856">48</a>,<a href="#B79-genes-11-00856" class="usa-link" aria-describedby="B79-genes-11-00856">79</a>].</p>
<p>The contribution of <em>BARD1</em> variants to cancer risk or disease progression in carriers of pathogenic variants in known cancer predisposing genes is unknown. Four studies of BC cases have investigated the co-occurrence of carriers of the <em>BARD1</em> c.1670G&gt;C; p.Cys557Ser variant with pathogenic variants in <em>BRCA1</em> or <em>BRCA2</em> [<a href="#B14-genes-11-00856" class="usa-link" aria-describedby="B14-genes-11-00856">14</a>,<a href="#B15-genes-11-00856" class="usa-link" aria-describedby="B15-genes-11-00856">15</a>,<a href="#B17-genes-11-00856" class="usa-link" aria-describedby="B17-genes-11-00856">17</a>,<a href="#B80-genes-11-00856" class="usa-link" aria-describedby="B80-genes-11-00856">80</a>]. The prevalence of this <em>BARD1</em> variant was significantly higher in Icelandic BC cases who also carried the pathogenic <em>BRCA2</em> c.771_775del; p.Asn257LysfsTer17 variant known to be a founder pathogenic variant in this population [<a href="#B15-genes-11-00856" class="usa-link" aria-describedby="B15-genes-11-00856">15</a>]. The risk of BC associated with carrying both variants was estimated to be three-fold higher than carriers of <em>BRCA2</em> c.771_775del; p.Asn257LysfsTer17 alone and the lifetime probability of developing BC approaches 100% in carriers of both variants. Three other studies of BC cases from Nordic [<a href="#B14-genes-11-00856" class="usa-link" aria-describedby="B14-genes-11-00856">14</a>], Polish [<a href="#B17-genes-11-00856" class="usa-link" aria-describedby="B17-genes-11-00856">17</a>] and mixed populations [<a href="#B80-genes-11-00856" class="usa-link" aria-describedby="B80-genes-11-00856">80</a>] found that carriers of the <em>BARD1</em> c.1670G&gt;C; p.Cys557Ser variant and a <em>BRCA1</em> or <em>BRCA2</em> pathogenic variant did not confirm this finding. Thus, further studies are needed to clarify the interaction of BARD1 with BRCA1 or BRCA2. It is possible that specific BARD1 variants have additive effects by increasing or modifying risk in a linear or synergistic manner in carriers of other high risk variants (reviewed in [<a href="#B81-genes-11-00856" class="usa-link" aria-describedby="B81-genes-11-00856">81</a>,<a href="#B82-genes-11-00856" class="usa-link" aria-describedby="B82-genes-11-00856">82</a>,<a href="#B83-genes-11-00856" class="usa-link" aria-describedby="B83-genes-11-00856">83</a>]).</p>
<p>In our laboratory, whole exome sequencing of 40 BC cases with pathogenic <em>BRCA2</em> variants identified a carrier of <em>BARD1</em> c.1339C&gt;G; p.Leu447Val variant (unpublished data). These BC cases were selected by the following criteria: proband with a diagnosis of invasive BC &lt;66 years of age; a strong family history of BC defined by ≥3 BC cases in first-, second- or third-degree relatives in the same familial branch; and all four grandparents originating from Quebec, Canada (French Canadian origin). This rare <em>BARD1</em> variant, estimated to occur at an overall frequency of 0.006% in the general cancer-free population (<a href="https://gnomad.broadinstitute.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://gnomad.broadinstitute.org</a>) (<a href="#app1-genes-11-00856" class="usa-link">Supplementary Table S1</a>) [<a href="#B18-genes-11-00856" class="usa-link" aria-describedby="B18-genes-11-00856">18</a>]. It has been reported twice in the literature and was identified by multi-gene panel testing of 1297 BC cases diagnosed at ≤45 years old [<a href="#B56-genes-11-00856" class="usa-link" aria-describedby="B56-genes-11-00856">56</a>] and by targeted sequencing of <em>BARD1</em> in 4469 familial BC cases [<a href="#B33-genes-11-00856" class="usa-link" aria-describedby="B33-genes-11-00856">33</a>]. Further analysis of other members of our cancer family showed only one of five other carriers was affected by BC (unpublished data). This case is from the French Canadian population and carries a pathogenic variant in <em>BRCA2</em> c.8537_8538delAG; p.Glu2846GlyfsTer22 known to be a founder pathogenic variant as reported by our group and others [<a href="#B84-genes-11-00856" class="usa-link" aria-describedby="B84-genes-11-00856">84</a>,<a href="#B85-genes-11-00856" class="usa-link" aria-describedby="B85-genes-11-00856">85</a>,<a href="#B86-genes-11-00856" class="usa-link" aria-describedby="B86-genes-11-00856">86</a>,<a href="#B87-genes-11-00856" class="usa-link" aria-describedby="B87-genes-11-00856">87</a>,<a href="#B88-genes-11-00856" class="usa-link" aria-describedby="B88-genes-11-00856">88</a>,<a href="#B89-genes-11-00856" class="usa-link" aria-describedby="B89-genes-11-00856">89</a>,<a href="#B90-genes-11-00856" class="usa-link" aria-describedby="B90-genes-11-00856">90</a>,<a href="#B91-genes-11-00856" class="usa-link" aria-describedby="B91-genes-11-00856">91</a>,<a href="#B92-genes-11-00856" class="usa-link" aria-describedby="B92-genes-11-00856">92</a>,<a href="#B93-genes-11-00856" class="usa-link" aria-describedby="B93-genes-11-00856">93</a>].</p></section></section><section id="sec4-genes-11-00856"><h2 class="pmc_sec_title">4. The Biological Effect of Potentially Pathogenic <em>BARD1</em> Variants</h2>
<section id="sec4dot1-genes-11-00856"><h3 class="pmc_sec_title">4.1. BARD1 Expression in Mammalian Cells</h3>
<p>BARD1 is widely expressed in different types of mammalian cells. Early studies in human cell lines demonstrated a constant level of gene expression throughout the cell cycle, in contrast to BRCA1 expression, which has been shown to increase during late G1 phase and reaches a maximum during S phase [<a href="#B94-genes-11-00856" class="usa-link" aria-describedby="B94-genes-11-00856">94</a>]. Gene expression studies suggest a role of BARD1 in cell growth. Interestingly, partial repression of mouse Bard1 due to antisense RNAs resulted in development of phenotypes characteristic of the early stages of malignancy in murine mammary epithelial cell lines, suggesting a role of Bard1 in tumourigenesis [<a href="#B95-genes-11-00856" class="usa-link" aria-describedby="B95-genes-11-00856">95</a>]. Moreover, it has been shown that <em>BARD1</em> encodes multiple protein isoforms in human cells that affect cell growth, and the full length protein is able to suppress tumourigenic phenotypes while alternatively spliced transcripts encode proteins that behave as proto-oncogenes (<a href="http://www.genome.ucsc.edu" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.genome.ucsc.edu</a>) (reviewed in [<a href="#B96-genes-11-00856" class="usa-link" aria-describedby="B96-genes-11-00856">96</a>]). Genetic abnormalities affecting chromosome 2q34–q35 region that harbours the <em>BARD1</em> locus are not common in BC and OC cases [<a href="#B97-genes-11-00856" class="usa-link" aria-describedby="B97-genes-11-00856">97</a>,<a href="#B98-genes-11-00856" class="usa-link" aria-describedby="B98-genes-11-00856">98</a>,<a href="#B99-genes-11-00856" class="usa-link" aria-describedby="B99-genes-11-00856">99</a>,<a href="#B100-genes-11-00856" class="usa-link" aria-describedby="B100-genes-11-00856">100</a>]. BARD1 is expressed in breast and ovarian normal tissues as well as in BC and OC tissues (<a href="http://www.proteinatlas.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.proteinatlas.org</a>) and is therefore a plausible candidate cancer predisposing gene.</p></section><section id="sec4dot2-genes-11-00856"><h3 class="pmc_sec_title">4.2. BARD1 in Animal and Cell Line Models</h3>
<p>Genetically engineered mouse models [<a href="#B101-genes-11-00856" class="usa-link" aria-describedby="B101-genes-11-00856">101</a>,<a href="#B102-genes-11-00856" class="usa-link" aria-describedby="B102-genes-11-00856">102</a>] suggest that the mouse orthologue of BARD1 plays a role in tumourigenesis. Human BARD1 and mouse Bard1 orthologues have been shown to share about 70% sequence identity [<a href="#B103-genes-11-00856" class="usa-link" aria-describedby="B103-genes-11-00856">103</a>]. Bard1<sup>−/−</sup> knockout mice resulted in embryos that died between days E7.5 and E8.5 due to severe impairment of cell proliferation [<a href="#B101-genes-11-00856" class="usa-link" aria-describedby="B101-genes-11-00856">101</a>]. Bard1 and p53 double knockout embryos displayed increased chromosomal aneuploidy in comparison to p53<sup>−/−</sup> mice, suggesting a role in maintaining genomic stability [<a href="#B101-genes-11-00856" class="usa-link" aria-describedby="B101-genes-11-00856">101</a>]. Bard1<sup>+/−</sup> heterozygous mice were indistinguishable from their wild-type littermates in terms of viability and fertility and did not develop detectable tumours by 21 months of age. Interestingly, conditional knockouts resulting in the inactivation of Bard1 and/or Brca1 resulted in mice that developed BC with histopathologies strikingly similarity to human TNBC, indicating that this is tumourigenic [<a href="#B102-genes-11-00856" class="usa-link" aria-describedby="B102-genes-11-00856">102</a>]. The authors suggested that this tumourigenic phenotype could be mediated through the BARD1–BRCA1 heterodimer complex.</p></section><section id="sec4dot3-genes-11-00856"><h3 class="pmc_sec_title">4.3. The Biological Impact of Potentially Pathogenic Variants in Different BARD1 Domains</h3>
<p>BARD1 protein (777 amino acids; GenBank Accession number <a href="https://www.ncbi.nlm.nih.gov/protein/CAE48237.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">CAE48237.1</a>) is structurally similar to BRCA1 (1,863 amino acids; GenBank Accesstion Number <a href="https://www.ncbi.nlm.nih.gov/protein/AAC37594.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">AAC37594.1</a>) by having a single N-terminal RING and two C-terminal BRCT domains. However, BARD1 has four tandem ANK domains adjacent to the BRCT domains, which are absent in BRCA1 [<a href="#B5-genes-11-00856" class="usa-link" aria-describedby="B5-genes-11-00856">5</a>,<a href="#B6-genes-11-00856" class="usa-link" aria-describedby="B6-genes-11-00856">6</a>,<a href="#B104-genes-11-00856" class="usa-link" aria-describedby="B104-genes-11-00856">104</a>]. BARD1 maintains genomic stability by functioning in DNA repair, ubiqutination, and transcriptional regulation (reviewed in [<a href="#B105-genes-11-00856" class="usa-link" aria-describedby="B105-genes-11-00856">105</a>]). The BRCA1–BARD1 complex functions in the homologous recombination DNA repair pathway that repairs DNA double-strand breaks by assisting in the recruitment of RAD51 to the single stranded DNA as a template for repair and downstream pathway function (reviewed in [<a href="#B105-genes-11-00856" class="usa-link" aria-describedby="B105-genes-11-00856">105</a>]). Aberrant homologous recombination leaves cells prone to genetic alterations and genome instability.</p>
<p>The RING domain is highly conserved and enriched for cysteine residues that are crucial for binding to zinc cations to ensure proper RING domain folding. The RING domain is crucial for direct BRCA1 interaction and stabilization in a cell cycle-dependent manner and subsequently affects DNA repair [<a href="#B5-genes-11-00856" class="usa-link" aria-describedby="B5-genes-11-00856">5</a>,<a href="#B94-genes-11-00856" class="usa-link" aria-describedby="B94-genes-11-00856">94</a>,<a href="#B103-genes-11-00856" class="usa-link" aria-describedby="B103-genes-11-00856">103</a>,<a href="#B106-genes-11-00856" class="usa-link" aria-describedby="B106-genes-11-00856">106</a>,<a href="#B107-genes-11-00856" class="usa-link" aria-describedby="B107-genes-11-00856">107</a>,<a href="#B108-genes-11-00856" class="usa-link" aria-describedby="B108-genes-11-00856">108</a>,<a href="#B109-genes-11-00856" class="usa-link" aria-describedby="B109-genes-11-00856">109</a>,<a href="#B110-genes-11-00856" class="usa-link" aria-describedby="B110-genes-11-00856">110</a>]. RING domains are not only found in proteins that exhibit tumour suppressor or proto-oncogenic function but also in proteins that exhibit E3 ubiquitin ligase activity (reviewed in [<a href="#B111-genes-11-00856" class="usa-link" aria-describedby="B111-genes-11-00856">111</a>,<a href="#B112-genes-11-00856" class="usa-link" aria-describedby="B112-genes-11-00856">112</a>]). Studies have shown that ubiquitin ligase activity reaches its maximum when BRCA1 is complexed with the RING domain of BARD1 [<a href="#B110-genes-11-00856" class="usa-link" aria-describedby="B110-genes-11-00856">110</a>,<a href="#B113-genes-11-00856" class="usa-link" aria-describedby="B113-genes-11-00856">113</a>]. Studies of germline pathogenic <em>BRCA1</em> variants located in the RING domain disrupted the BRCA1–BARD1 interaction [<a href="#B5-genes-11-00856" class="usa-link" aria-describedby="B5-genes-11-00856">5</a>]. Other <em>BRCA1</em> missense variants located in the RING domain impaired E3 ubiquitin ligase activity of the BRCA1–BARD1 heterodimer and affected tumourigenesis [<a href="#B113-genes-11-00856" class="usa-link" aria-describedby="B113-genes-11-00856">113</a>,<a href="#B114-genes-11-00856" class="usa-link" aria-describedby="B114-genes-11-00856">114</a>,<a href="#B115-genes-11-00856" class="usa-link" aria-describedby="B115-genes-11-00856">115</a>]. These findings suggest that having a germline variant in the RING domain of BARD1 could increase risk to BC or OC [<a href="#B6-genes-11-00856" class="usa-link" aria-describedby="B6-genes-11-00856">6</a>,<a href="#B116-genes-11-00856" class="usa-link" aria-describedby="B116-genes-11-00856">116</a>]. One frameshift <em>BARD1</em> variant was identified in a young age of onset BC case (29 years old at diagnosis) by multi-gene panel testing; this variant is predicted to result in premature termination of the protein and partial loss of the RING domain [<a href="#B46-genes-11-00856" class="usa-link" aria-describedby="B46-genes-11-00856">46</a>]. The BARD1 c.247A&gt;G; p.Cys83Arg protein isoform retained the ability to interact with BRCA1 and retained E3 ubiquitin ligase activity, but the BARD1–BRCA1 complex was less efficient in binding to the nucleosomes and ubiquitylating histone H2A [<a href="#B117-genes-11-00856" class="usa-link" aria-describedby="B117-genes-11-00856">117</a>]. In contrast, the BARD1 c.253G&gt;T; p.Val85Leu variant had no effect on the BARD1–BRCA1 interaction and homologous recombination DNA repair activity [<a href="#B118-genes-11-00856" class="usa-link" aria-describedby="B118-genes-11-00856">118</a>]. We classified both variants as potentially pathogenic based on in silico prediction tools (<a href="#genes-11-00856-f002" class="usa-link">Figure 2</a>B,C, <a href="#app1-genes-11-00856" class="usa-link">Supplementary Table S1</a>).</p>
<p>Based on amino acid composition BARD1 was thought to contain three ANK repeats but crystallization studies revealed an additional repeat adjacent to the BRCT domain [<a href="#B104-genes-11-00856" class="usa-link" aria-describedby="B104-genes-11-00856">104</a>]. This newly identified domain may have been missed in earlier studies as it is less conserved than the other ANK domains. These domains are found in a broad spectrum of functionally diverse proteins and have been implicated as sites of highly specific protein-protein interactions (reviewed in [<a href="#B105-genes-11-00856" class="usa-link" aria-describedby="B105-genes-11-00856">105</a>]). It has been proposed that BARD1 plays a role in apoptosis via its ANK domains in a p53-dependent manner (reviewed in [<a href="#B96-genes-11-00856" class="usa-link" aria-describedby="B96-genes-11-00856">96</a>,<a href="#B105-genes-11-00856" class="usa-link" aria-describedby="B105-genes-11-00856">105</a>,<a href="#B119-genes-11-00856" class="usa-link" aria-describedby="B119-genes-11-00856">119</a>]). Most recently, ANK domains have been shown to be important for recognition of the epigenetic methylation site H4K20me0 on histone H4, for BARD1–BRCA1 recruitment to sites of DNA damage via the homologous recombination DNA repair pathway [<a href="#B120-genes-11-00856" class="usa-link" aria-describedby="B120-genes-11-00856">120</a>]. Variants in the ANK domains may hinder H4K20me0 recognition which abrogates accumulation of BRCA1 to sites of double-strand breaks, resulting in the activation of alternative DNA repair pathways and genome instability. A deletion of exons 2–6 in <em>BARD1</em> results in the loss of most of the RING and ANK domains, and consequently its capacity to interact with BRCA1 [<a href="#B121-genes-11-00856" class="usa-link" aria-describedby="B121-genes-11-00856">121</a>]. Carriers of 14 frameshift and nine nonsense variants located upstream or within the ANK repeats, which could have the effect of encoding a protein lacking ANK domains, have been reported in BC and OC cases (<a href="#app1-genes-11-00856" class="usa-link">Supplementary Table S1</a>). Interestingly, it was shown that the exonic c.1361C&gt;T; p.Pro454Leu affects the splicing enhancing site, resulting in skipping of exon 5 (<a href="#genes-11-00856-f002" class="usa-link">Figure 2</a>C) [<a href="#B122-genes-11-00856" class="usa-link" aria-describedby="B122-genes-11-00856">122</a>], which would result in the loss of a segment of the ANK domains. Studies of <em>BARD1</em> missense variants, c.1482A&gt;G; p.Asn470Ser and c.1519G&gt;A; p.Val507Met, suggest that these amino acid substitutions did not significantly affect the secondary structure of BARD1 [<a href="#B104-genes-11-00856" class="usa-link" aria-describedby="B104-genes-11-00856">104</a>]. Indeed, studies have shown that the <em>BARD1</em> c.1519G&gt;A; p.Val507Met protein isoform has no effect on homologous recombination DNA repair pathway activity [<a href="#B118-genes-11-00856" class="usa-link" aria-describedby="B118-genes-11-00856">118</a>] (<a href="#genes-11-00856-f002" class="usa-link">Figure 2</a>C, <a href="#app1-genes-11-00856" class="usa-link">Supplementary Table S1</a>).</p>
<p>Both C-terminal BRCT domains are well conserved and are often found in proteins that play a role in cell cycle checkpoint and DNA damage response (reviewed in [<a href="#B105-genes-11-00856" class="usa-link" aria-describedby="B105-genes-11-00856">105</a>]). BRCT domains in BARD1 are recognized by poly (ADP-ribose) polymerase (PARP) as well as other binding proteins [<a href="#B123-genes-11-00856" class="usa-link" aria-describedby="B123-genes-11-00856">123</a>,<a href="#B124-genes-11-00856" class="usa-link" aria-describedby="B124-genes-11-00856">124</a>]. Twenty-four frameshift and 15 nonsense variants in <em>BARD1</em> have been reported upstream or within BRCT domains, which could result in losing these domains fully or partially and could affect function (<a href="#genes-11-00856-f002" class="usa-link">Figure 2</a>, <a href="#app1-genes-11-00856" class="usa-link">Supplementary Table S1</a>). It has been shown that the <em>BARD1</em> c. 1793C&gt;T; p.Thr598Ile protein isoform exhibits significantly lower homologous recombination DNA repair activity [<a href="#B118-genes-11-00856" class="usa-link" aria-describedby="B118-genes-11-00856">118</a>]. This isoform might affect binding to PARP1, as the amino acid change is predicted to alter the protein’s surface and not any of the known binding sites involved in DNA repair [<a href="#B118-genes-11-00856" class="usa-link" aria-describedby="B118-genes-11-00856">118</a>].</p>
<p>The biological function of <em>BARD1</em> variants that lie outside the RING, ANK or BRCT domains have been studied [<a href="#B29-genes-11-00856" class="usa-link" aria-describedby="B29-genes-11-00856">29</a>,<a href="#B32-genes-11-00856" class="usa-link" aria-describedby="B32-genes-11-00856">32</a>,<a href="#B125-genes-11-00856" class="usa-link" aria-describedby="B125-genes-11-00856">125</a>,<a href="#B126-genes-11-00856" class="usa-link" aria-describedby="B126-genes-11-00856">126</a>,<a href="#B127-genes-11-00856" class="usa-link" aria-describedby="B127-genes-11-00856">127</a>,<a href="#B128-genes-11-00856" class="usa-link" aria-describedby="B128-genes-11-00856">128</a>,<a href="#B129-genes-11-00856" class="usa-link" aria-describedby="B129-genes-11-00856">129</a>,<a href="#B130-genes-11-00856" class="usa-link" aria-describedby="B130-genes-11-00856">130</a>,<a href="#B131-genes-11-00856" class="usa-link" aria-describedby="B131-genes-11-00856">131</a>]. The first identified <em>BARD1</em> c.1692G&gt;C; p.Gln564His variant and the most prevalent c.1670G&gt;C; p.Cys557Ser variant are located in the linker motif between the ANK and BRCT domains (<a href="#genes-11-00856-f002" class="usa-link">Figure 2</a>C). The <em>BARD1</em> c.1692G&gt;C; p.Gln564His isoform was shown to disrupt the interaction with the Cleavage stimulating factor 50 (CstF50) protein resulting in impairment of RNA processing. Although both of these isoforms showed no effect on the homologous recombination activity [<a href="#B126-genes-11-00856" class="usa-link" aria-describedby="B126-genes-11-00856">126</a>], they were found to negatively affect the interaction with p53, resulting in impaired p53-dependent apoptosis [<a href="#B29-genes-11-00856" class="usa-link" aria-describedby="B29-genes-11-00856">29</a>]. These results suggest that the risk to cancer of these variants is unlikely to be a consequence of defects in homologous recombination DNA repair function but may involve cell cycle or RNA processing pathways.</p></section></section><section id="sec5-genes-11-00856"><h2 class="pmc_sec_title">5. Risk Assessments for Cancer in Carriers of <em>BARD1</em> Variants </h2>
<p>Risk estimates for cancer predisposing genes can be presented as odds ratios (OR) and the risk is interpreted as low (1–1.5), moderate (1.5–5), or high (≥5) [<a href="#B132-genes-11-00856" class="usa-link" aria-describedby="B132-genes-11-00856">132</a>]. For example, ORs for known BC and OC predisposing genes such as <em>BRCA1</em> and <em>BRCA2</em> are high, and variants in these genes have been shown to confer high risk to cancer in carriers. Estimates of the lifetime risk for cancer that are associated with carriers of a potentially pathogenic <em>BARD1</em> variant have been reported for BC and OC in case-control studies, although most involved familial BC cases. Risk estimates have been determined for individual variants or all variants found in the gene (gene-based risk) (<a href="#genes-11-00856-t001" class="usa-link">Table 1</a> and <a href="#genes-11-00856-t002" class="usa-link">Table 2</a>).</p>
<section class="tw xbox font-sm" id="genes-11-00856-t001"><h3 class="obj_head">Table 1.</h3>
<div class="caption p"><p>Risk of breast or ovarian cancer associated with <em>BARD1</em>.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cancer Type</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Selection of Cancer Cases</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Cases</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Controls</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Population</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of Variants Included</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OR (95% CI)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<em>p</em>-Value</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B11-genes-11-00856" class="usa-link" aria-describedby="B11-genes-11-00856">11</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">28,536</td>
<td align="center" valign="middle" rowspan="1" colspan="1">26,078 <sup>b</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Mixed <sup>e</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LoF or missense <sup>f</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2.16 (1.31–3.63)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2.26 × 10<sup>−3</sup>
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B52-genes-11-00856" class="usa-link" aria-describedby="B52-genes-11-00856">52</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Familial</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2134</td>
<td align="center" valign="middle" rowspan="1" colspan="1">26,375 <sup>b</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Mixed <sup>e</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LoF or missense <sup>g</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3.18 (1.34–7.36)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.22 × 10<sup>−2</sup>
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B13-genes-11-00856" class="usa-link" aria-describedby="B13-genes-11-00856">13</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">TNBC</td>
<td align="center" valign="middle" rowspan="1" colspan="1">High risk</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4090</td>
<td align="center" valign="middle" rowspan="1" colspan="1">26,079 <sup>b</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">White</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LoF or missense <sup>f</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">5.92 (3.36–10.27)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2.20 × 10<sup>−9</sup>
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">TNBC</td>
<td align="center" valign="middle" rowspan="1" colspan="1">High risk</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2003</td>
<td align="center" valign="middle" rowspan="1" colspan="1">26,079 <sup>b</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">White</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LoF or missense <sup>f</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4.35 (2.02–9.30)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7.6 × 10<sup>−4</sup>
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B23-genes-11-00856" class="usa-link" aria-describedby="B23-genes-11-00856">23</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Familial</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3667</td>
<td align="center" valign="middle" rowspan="1" colspan="1">– <sup>b</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">French</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LoF or missense <sup>g</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2.00 (0.74–4.10)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">TNBC</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Familial</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3667</td>
<td align="center" valign="middle" rowspan="1" colspan="1">– <sup>b</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">French</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LoF or missense <sup>g</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">11.27 (3.37–25.01)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B33-genes-11-00856" class="usa-link" aria-describedby="B33-genes-11-00856">33</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Familial</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4469</td>
<td align="center" valign="middle" rowspan="1" colspan="1">37,265 <sup>c</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unknown</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LoF or missense <sup>f</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">5.35 (3.17–9.04)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">&lt;10<sup>−5</sup>
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B22-genes-11-00856" class="usa-link" aria-describedby="B22-genes-11-00856">22</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">TNBC</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4824</td>
<td align="center" valign="middle" rowspan="1" colspan="1">123,136 <sup>d</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Mixed <sup>e</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">LoF or missense <sup>f</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">9.76 (6.77–13.87)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">[<a href="#B60-genes-11-00856" class="usa-link" aria-describedby="B60-genes-11-00856">60</a>]</td>
<td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Ovarian <sup>a</sup>
</td>
<td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1915</td>
<td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">36,276 <sup>b</sup>
</td>
<td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Mixed <sup>e</sup>
</td>
<td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">LoF or missense <sup>g</sup>
</td>
<td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">4.2 (1.4–12.5)</td>
<td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.02</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B63-genes-11-00856" class="usa-link" aria-describedby="B63-genes-11-00856">63</a>]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ovarian <sup>a</sup>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High risk</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4122</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4688</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">White</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LoF</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.59 (0.31–9.56) <sup>h</sup>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.57</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/genes-11-00856-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn2"><p>TNBC = triple-negative breast cancer; LoF = loss-of-function variant (nonsense, frameshift or canonical splice site); OR = odds ratio; 95% CI = 95% confidence interval; ExAC = Exome Aggregation Consortium; FLOSSIES = Fabulous Ladies Over Seventy; gnomAD = Genome Aggregation Database; ACMG = American College of Medical Genetics and Genomics [<a href="#B136-genes-11-00856" class="usa-link" aria-describedby="B136-genes-11-00856">136</a>,<a href="#B137-genes-11-00856" class="usa-link" aria-describedby="B137-genes-11-00856">137</a>]; – = not stated; <sup>a</sup> Mixed histopathological subtypes; <sup>b</sup> ExAC; <sup>c</sup> ExAC, FLOSSIES, and geographically matched female controls; <sup>d</sup> gnomAD; <sup>e</sup> Majority of cases are white; <sup>f</sup> ACMG; <sup>g</sup> Missense variants were classified using different bioinformatic tools in each study; <sup>h</sup> Adjusted OR was calculated as 6.3 (95%CI 0.55–74.25, <em>p</em> = 0.19).</p></div></div></section><section class="tw xbox font-sm" id="genes-11-00856-t002"><h3 class="obj_head">Table 2.</h3>
<div class="caption p"><p>Risk of breast or ovarian cancer associated with potentially pathogenic <em>BARD1</em> variants.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Coding DNA Reference Sequence <sup>a</sup>
</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Predicted Amino Acid Change</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cancer Type</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Selection of Cancer Cases</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Cases</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Controls</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Population</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OR (95% CI)</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<em>p</em>-Value</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B28-genes-11-00856" class="usa-link" aria-describedby="B28-genes-11-00856">28</a>]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.70C&gt;T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Pro24Ser</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">507</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">539</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.68 (0.52–0.9)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B34-genes-11-00856" class="usa-link" aria-describedby="B34-genes-11-00856">34</a>]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.722C&gt;G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Ser241Cys</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">143</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">155</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Japan</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.57 (0.61–4.05) <sup>b</sup>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B34-genes-11-00856" class="usa-link" aria-describedby="B34-genes-11-00856">34</a>]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1139_1159del</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Asn380_Phe387delinsIle</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">143</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">155</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Japan</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.96 (0.49–1.86) <sup>c</sup>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B34-genes-11-00856" class="usa-link" aria-describedby="B34-genes-11-00856">34</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1134G&gt;C</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Arg378Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">143</td>
<td align="center" valign="middle" rowspan="1" colspan="1">155</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Japan</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.35 (0.7–2.61) <sup>d</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B28-genes-11-00856" class="usa-link" aria-describedby="B28-genes-11-00856">28</a>]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1134G&gt;C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Arg378Ser</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">507</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">539</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.94 (0.72–1.24)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B26-genes-11-00856" class="usa-link" aria-describedby="B26-genes-11-00856">26</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1972C&gt;T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Arg658Cys</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12,476</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4707</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Poland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.16 (0.75–1.81)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.51</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B26-genes-11-00856" class="usa-link" aria-describedby="B26-genes-11-00856">26</a>]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1972C&gt;T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Arg658Cys</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNBC</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1120</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4707</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poland</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.97 (0.40–2.36)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.95</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B26-genes-11-00856" class="usa-link" aria-describedby="B26-genes-11-00856">26</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1977A&gt;G</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Arg659= </td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">12,476</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4707</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Poland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.32 (0.73–2.40)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.36</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B26-genes-11-00856" class="usa-link" aria-describedby="B26-genes-11-00856">26</a>]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1977A&gt;G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Arg659=</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNBC</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1120</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4707</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poland</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.60 (0.14–2.64)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B34-genes-11-00856" class="usa-link" aria-describedby="B34-genes-11-00856">34</a>]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1518C&gt;T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.His506=</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">143</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">155</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Japan</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.71 (0.36–1.42) <sup>e</sup>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B34-genes-11-00856" class="usa-link" aria-describedby="B34-genes-11-00856">34</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1519G&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Val507Met</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">143</td>
<td align="center" valign="middle" rowspan="1" colspan="1">155</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Japan</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.28 (0.8–2.04) <sup>f</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B8-genes-11-00856" class="usa-link" aria-describedby="B8-genes-11-00856">8</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1519G&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Val507Met</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Familial</td>
<td align="center" valign="middle" rowspan="1" colspan="1">663</td>
<td align="center" valign="middle" rowspan="1" colspan="1">718</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Finland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.04 (0.8–1.34)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.79</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B8-genes-11-00856" class="usa-link" aria-describedby="B8-genes-11-00856">8</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1519G&gt;A</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Val507Met</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">867</td>
<td align="center" valign="middle" rowspan="1" colspan="1">718</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Finland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.27 (0.99–1.63)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.06</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B28-genes-11-00856" class="usa-link" aria-describedby="B28-genes-11-00856">28</a>]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1519G&gt;A</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Val507Met</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">507</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">539</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">China</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.98 (0.75–1.29)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">–</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B7-genes-11-00856" class="usa-link" aria-describedby="B7-genes-11-00856">7</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1670G&gt;C </td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Cys557Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast or ovarian</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Familial</td>
<td align="center" valign="middle" rowspan="1" colspan="1">126</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1018</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Finland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4.2 (1.7–10.7)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">5 × 10<sup>−3</sup>
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B8-genes-11-00856" class="usa-link" aria-describedby="B8-genes-11-00856">8</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1670G&gt;C </td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Cys557Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Familial</td>
<td align="center" valign="middle" rowspan="1" colspan="1">926</td>
<td align="center" valign="middle" rowspan="1" colspan="1">725</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Finland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.49 (0.24–1.01)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.05</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B8-genes-11-00856" class="usa-link" aria-describedby="B8-genes-11-00856">8</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1670G&gt;C </td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Cys557Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Familial</td>
<td align="center" valign="middle" rowspan="1" colspan="1">255</td>
<td align="center" valign="middle" rowspan="1" colspan="1">358</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Finland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.70 (0.21–2.34)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.56</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B8-genes-11-00856" class="usa-link" aria-describedby="B8-genes-11-00856">8</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1670G&gt;C </td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Cys557Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">868</td>
<td align="center" valign="middle" rowspan="1" colspan="1">725</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Finland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.74 (0.38–1.44)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.38</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B8-genes-11-00856" class="usa-link" aria-describedby="B8-genes-11-00856">8</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1670G&gt;C </td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Cys557Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">697</td>
<td align="center" valign="middle" rowspan="1" colspan="1">358</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Finland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.09 (0.47–2.56)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.84</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B14-genes-11-00856" class="usa-link" aria-describedby="B14-genes-11-00856">14</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1670G&gt;C </td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Cys557Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast or ovarian</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Familial</td>
<td align="center" valign="middle" rowspan="1" colspan="1">757</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3591</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Nordic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.9 (1.32–2.83)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">10<sup>−3</sup>
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B14-genes-11-00856" class="usa-link" aria-describedby="B14-genes-11-00856">14</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1670G&gt;C </td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Cys557Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1984</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3591</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Nordic</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.7 (1.23–2.22)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">10<sup>−3</sup>
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B15-genes-11-00856" class="usa-link" aria-describedby="B15-genes-11-00856">15</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1670G&gt;C </td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Cys557Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">992</td>
<td align="center" valign="middle" rowspan="1" colspan="1">703</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Iceland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.82 (1.11–3.01)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.014</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B17-genes-11-00856" class="usa-link" aria-describedby="B17-genes-11-00856">17</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1670G&gt;C </td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Cys557Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">High risk</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3188</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1038</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Poland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.2 (0.9–1.7)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.3</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B16-genes-11-00856" class="usa-link" aria-describedby="B16-genes-11-00856">16</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1670G&gt;C </td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Cys557Ser</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1136</td>
<td align="center" valign="middle" rowspan="1" colspan="1">623</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Australia</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.80 (0.50–1.27) <sup>g</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.3</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B35-genes-11-00856" class="usa-link" aria-describedby="B35-genes-11-00856">35</a>]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1670G&gt;C </td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Cys557Ser</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">High risk</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">322</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">570</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chile</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.4 (0.6–3.7)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.47</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B64-genes-11-00856" class="usa-link" aria-describedby="B64-genes-11-00856">64</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1690C&gt;T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Gln564Ter</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Familial</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1018</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2036</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Poland</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1.0 (0.1–8.6)</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B26-genes-11-00856" class="usa-link" aria-describedby="B26-genes-11-00856">26</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">c.1690C&gt;T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">p.Gln564Ter</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" rowspan="1" colspan="1">13,935</td>
<td align="center" valign="middle" rowspan="1" colspan="1">5896</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Poland, Belarus</td>
<td align="center" valign="middle" rowspan="1" colspan="1">2.30 (1.03–5.15) <sup>h</sup>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.04</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<a href="#B26-genes-11-00856" class="usa-link" aria-describedby="B26-genes-11-00856">26</a>]</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">c.1690C&gt;T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">p.Gln564Ter</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">TNBC</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unselected</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1120</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4707</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poland</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.62 (1.21–10.78)</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.02</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/genes-11-00856-t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn3"><p>TNBC = triple-negative breast cancer; OR = odds ratio; 95% CI = 95% confidence interval; – = not stated; <sup>a</sup> Human GRCh37/hg19 transcript <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000465.4" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000465.4</a>; OR adjusted for age, first-degree family history of breast cancer, age at first live birth and body mass index was calculated as <sup>b</sup> 1.65 (95%CI 0.61–4.43), <sup>c</sup> 0.94 (95%CI 0.46–1.90), <sup>d</sup> 1.38 (95%CI 0.69–2.76), <sup>e</sup> 0.67 (95%CI 0.32–1.41), <sup>f</sup> 1.32 (95%CI 0.81–2.16); <sup>g</sup> Adjusted OR is shown as the crude OR was not reported; <sup>h</sup> OR adjusted for study origin was 2.24 (95%CI 0.99–5.03, <em>p</em> = 0.05) and using the Mantel-Haenszel method was 2.12 (95%CI 0.97–4.62, <em>p</em> = 0.06).</p></div></div></section><p>In our literature review, we found three studies that had reported risk estimates for BC, where they were derived from BC cases not selected for family history of cancer [<a href="#B11-genes-11-00856" class="usa-link" aria-describedby="B11-genes-11-00856">11</a>,<a href="#B22-genes-11-00856" class="usa-link" aria-describedby="B22-genes-11-00856">22</a>,<a href="#B60-genes-11-00856" class="usa-link" aria-describedby="B60-genes-11-00856">60</a>] (<a href="#genes-11-00856-t001" class="usa-link">Table 1</a>). In these studies the ORs for the association of potentially pathogenic <em>BARD1</em> variants and risk for BC (any subtype), TNBC or OC were estimated as 2.16 (95% confidence interval (CI) 1.31–3.63, <em>p</em> = 2.26 × 10<sup>−3</sup>), 9.76 (95% CI 6.77–13.87, <em>p</em> &lt;0.05) and 4.2 (95% CI 1.4–12.5, <em>p</em> = 0.02), respectively. The narrow CI for any subtype of BC reported by Couch et al. [<a href="#B11-genes-11-00856" class="usa-link" aria-describedby="B11-genes-11-00856">11</a>], is a reflection of the large sample size of BC cases (<em>N</em> = 28,536) compared with the other studies. In one study the estimated risk was higher for BC to be diagnosed before 40 years of age in familial cases (OR 12.04, 95% CI 5.78–25.08, <em>p</em> &lt;0.001) [<a href="#B33-genes-11-00856" class="usa-link" aria-describedby="B33-genes-11-00856">33</a>], which is consistent with younger age of diagnosis being associated with carriers of pathogenic variants in known cancer predisposing genes, such as <em>BRCA1</em> [<a href="#B133-genes-11-00856" class="usa-link" aria-describedby="B133-genes-11-00856">133</a>]. A meta-analysis of risk estimates for 37 known or proposed genetic risk factors estimated that the OR for <em>BARD1</em> was 2.33 for BC and &lt;2 for OC [<a href="#B134-genes-11-00856" class="usa-link" aria-describedby="B134-genes-11-00856">134</a>].</p>
<p>A number of studies estimated the cancer risk associated with specific variants in <em>BARD1</em> in BC and hereditary BC and/or OC syndrome families (<a href="#genes-11-00856-t002" class="usa-link">Table 2</a>). We found reports describing the risk for nine different <em>BARD1</em> variants: one nonsense, one frameshift, six missense and two synonymous variants. Risk estimates are variable across these studies, where the highest risk was observed for c.1690C&gt;T; p.Gln564Ter in association with TNBC cases not selected for family history of cancer (OR 3.62, 95% CI 1.21–10.78, <em>p</em> = 0.02). This is consistent with the previous report suggesting that <em>BARD1</em> variants may be associated with a higher risk for TNBC [<a href="#B22-genes-11-00856" class="usa-link" aria-describedby="B22-genes-11-00856">22</a>]. A meta-analysis of the c.1670G&gt;C; p.Cys557Ser variant in 11,870 BC cases and 7687 controls, from Nordic, Australian, Canadian, Russian, English, and Polish populations, concluded that carriers of this <em>BARD1</em> variant have a low risk for BC (OR 1.14, 95%CI 0.94–1.34, <em>p</em> = 0.13) [<a href="#B135-genes-11-00856" class="usa-link" aria-describedby="B135-genes-11-00856">135</a>]. While studies estimating the familial risk of <em>BARD1</em> variants to OC are still lacking, evidence is emerging that <em>BARD1</em> is a potential moderate risk gene for TNBC. </p></section><section id="sec6-genes-11-00856"><h2 class="pmc_sec_title">6. <em>BARD1</em> in Medical Genetics Settings </h2>
<p>Although risk estimates for developing cancer in carriers of <em>BARD1</em> variants remains to be validated for clinical settings, <em>BARD1</em> has been included in multi-gene testing panels in hereditary cancer medical genetic settings. Indeed, <em>BARD1</em> was added to gene testing panels not long after it was proposed as a cancer predisposing gene. Given that risk for cancer in carriers of <em>BARD1</em> variants is equivocal, we questioned if there are recommendations should potentially pathogenic variants be identified by panel testing. We reviewed publicly available resources for statements akin to those providing guidance for the genetic counselling of carriers of known high risk cancer predisposing genes (<a href="#genes-11-00856-t003" class="usa-link">Table 3</a>). Recommendations for the known high risk genes, <em>BRCA1</em> and <em>BRCA2</em>, include increased breast awareness and screening, discussion of risk-reducing mastectomy and/or bilateral-salpingo oophorectomy, education about cancer signs and symptoms and genetic counselling (see The National Comprehensive Cancer Network (NCCN) Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Cancer, Version 1.2020). The NCCN guidelines for moderate risk BC genes state that there is an increased risk of female BC with management options for increased screening (mammography), but not risk-reducing mastectomy as there is insufficient evidence. American Society of Clinical Oncology (ASCO) guidelines [<a href="#B138-genes-11-00856" class="usa-link" aria-describedby="B138-genes-11-00856">138</a>] and the ACMG statement [<a href="#B139-genes-11-00856" class="usa-link" aria-describedby="B139-genes-11-00856">139</a>] for BC recommend that for moderate-penetrance genes the mutation status should not directly alter treatment, mastectomy or systemic therapy options as data is lacking for these genes. The NCCN Guidelines added <em>BARD1</em> to their 2020 version stating that though there is a potential for increased risk for BC in female heterozygous carriers of <em>BARD1</em> variants (risk not defined), though there is insufficient evidence to make recommendations (<a href="http://www.nccn.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.nccn.org</a>). The risk for other cancers, including OC, is insufficient to impact risk management. The other resources (ASCO, ACMG, and Institut national d’excellence en santé et en services sociaux (INESSS), a Quebec, Canada resource) did not mention <em>BARD1</em>. Nonetheless, <em>BARD1</em> continues to be included in multi-gene testing panels for clinical purposes, including commercially available resources. It has been argued that the continued testing of <em>BARD1</em> would allow for ready access to carrier status if and when risk estimates and recommendations become available in the future. </p>
<section class="tw xbox font-sm" id="genes-11-00856-t003"><h3 class="obj_head">Table 3.</h3>
<div class="caption p"><p>Publicly available resources reviewed for recommendations for management of carriers of a potentially pathogenic <em>BARD1</em> variant.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Resource Name</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Acronym</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Resource Type</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<em>BARD1</em> Included in Resource</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">
<a href="http://www.nccn.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.nccn.org</a>
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">National Comprehensive Cancer Network</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NCCN</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Guideline</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Yes</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B138-genes-11-00856" class="usa-link" aria-describedby="B138-genes-11-00856">138</a>,<a href="#B140-genes-11-00856" class="usa-link" aria-describedby="B140-genes-11-00856">140</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">American Society of Clinical Oncology</td>
<td align="center" valign="middle" rowspan="1" colspan="1">ASCO</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Guideline</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">[<a href="#B139-genes-11-00856" class="usa-link" aria-describedby="B139-genes-11-00856">139</a>]</td>
<td align="center" valign="middle" rowspan="1" colspan="1">American College of Medical Genetics and Genomics</td>
<td align="center" valign="middle" rowspan="1" colspan="1">ACMG</td>
<td align="center" valign="middle" rowspan="1" colspan="1">Statement</td>
<td align="center" valign="middle" rowspan="1" colspan="1">No</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<a href="http://www.inesss.qc.ca" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.inesss.qc.ca</a>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Institut national d’excellence en santé et en services sociaux</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">INESSS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Statement</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/genes-11-00856-t003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Clinical diagnostic laboratories as well as researchers have used the ClinVar database [<a href="#B141-genes-11-00856" class="usa-link" aria-describedby="B141-genes-11-00856">141</a>] (<a href="http://www.ncbi.nlm.nih.gov/clinvar" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.ncbi.nlm.nih.gov/clinvar</a>) to access reports of variants identified in human diseases, including those for <em>BARD1</em>. Submissions to ClinVar are accepted from a number of different groups but the majority come from clinical testing laboratories and very few variants have been assessed for their biological effect on protein function. Each variant is interpreted and assigned a clinical significance: benign, likely benign, uncertain significance, likely pathogenic or pathogenic. There have been a number of reports of <em>BARD1</em> variants in the context of hereditary cancer syndromes: 160 pathogenic, 19 pathogenic or likely pathogenic, 56 likely pathogenic, and 1131 variants of uncertain significance (reviewed in [<a href="#B96-genes-11-00856" class="usa-link" aria-describedby="B96-genes-11-00856">96</a>]). We suggest that ClinVar should be used with caution as a resource to determine if a <em>BARD1</em> variant may play a role in hereditary cancer risk, as few of these variants have been vetted by expert review panels akin to those available for variants in <em>BRCA1</em> and <em>BRCA2</em> (<a href="http://www.brcaexchange.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.brcaexchange.org</a>) [<a href="#B142-genes-11-00856" class="usa-link" aria-describedby="B142-genes-11-00856">142</a>]. </p>
<p>The prevalence of variants in high risk cancer predisposing genes in clinical genetic testing settings has been difficult to estimate due to lack of access to data. Recently, Ambry Genetics<sup>®</sup> (which offers commercially available and clinically approved multi-gene panel tests) developed an open access web-based tool to query prevalence of pathogenic variants in 49 genes, including <em>BARD1</em>, found in nine cancer types (<a href="http://www.ambrygen.com/clinician/resources/prevalence-tool" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.ambrygen.com/clinician/resources/prevalence-tool</a>) [<a href="#B143-genes-11-00856" class="usa-link" aria-describedby="B143-genes-11-00856">143</a>]. Pathogenic variants in <em>BARD1</em> were identified in 0.27% of BC cases and 0.15% of OC cases (<a href="#genes-11-00856-f003" class="usa-link">Figure 3</a>, <a href="#genes-11-00856-t004" class="usa-link">Table 4</a>). Although there is a higher prevalence of carriers in BC cases with a family history of BC and/or OC than those with no family history of cancer, findings are not statistically significant. The prevalence of carriers was also higher in OC cases with a family history of BC than those not selected for family history of cancer, though this difference is not statistically significant. The highest prevalence of carriers was found in TNBC cases (0.85%)—a subtype of BC aforementioned to be most likely to be associated with moderate risk in carriers of <em>BARD1</em> variants—which is significantly higher than BC cases unselected for subtype (<em>p</em> &lt; 0.001) (<a href="#genes-11-00856-f003" class="usa-link">Figure 3</a>, <a href="#genes-11-00856-t004" class="usa-link">Table 4</a>). </p>
<figure class="fig xbox font-sm" id="genes-11-00856-f003"><h3 class="obj_head">Figure 3.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7464855_genes-11-00856-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae7e/7464855/061282f704bd/genes-11-00856-g003.jpg" loading="lazy" height="411" width="783" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/genes-11-00856-f003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Proportion of carriers of pathogenic <em>BARD1</em> variants in breast cancer and ovarian cancer cases relative to carriers of variants in known cancer predisposing genes, <em>BRCA1</em> and <em>BRCA2</em>. Source: Interactive Prevalence Tables From Multi-Gene Panel Testing: A collaboration between investigators from Mayo Clinic and Ambry Genetics<sup>®</sup> [<a href="#B143-genes-11-00856" class="usa-link" aria-describedby="B143-genes-11-00856">143</a>] (<a href="http://www.ambrygen.com/clinician/resources/prevalence-tool" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.ambrygen.com/clinician/resources/prevalence-tool</a>).</p></figcaption></figure><section class="tw xbox font-sm" id="genes-11-00856-t004"><h3 class="obj_head">Table 4.</h3>
<div class="caption p"><p>Prevalence of <em>BARD1</em> variants in breast and ovarian cancer cases <sup>a</sup>.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Context</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Cases Tested</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Number of Carriers</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">%</th>
</tr></thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Personal history of breast cancer</td>
<td align="center" valign="middle" rowspan="1" colspan="1">59,375</td>
<td align="center" valign="middle" rowspan="1" colspan="1">158</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.27</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">ER+</td>
<td align="center" valign="middle" rowspan="1" colspan="1">30,950</td>
<td align="center" valign="middle" rowspan="1" colspan="1">51</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.16</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">PR+</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">HER2+</td>
<td align="center" valign="middle" rowspan="1" colspan="1">1670</td>
<td align="center" valign="middle" rowspan="1" colspan="1">4</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.24</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">TNBC</td>
<td align="center" valign="middle" rowspan="1" colspan="1">6745</td>
<td align="center" valign="middle" rowspan="1" colspan="1">56</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.83</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Family history of cancer</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">37,372</td>
<td align="center" valign="middle" rowspan="1" colspan="1">107</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.29</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Ovarian</td>
<td align="center" valign="middle" rowspan="1" colspan="1">7990</td>
<td align="center" valign="middle" rowspan="1" colspan="1">20</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.25</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast and ovarian</td>
<td align="center" valign="middle" rowspan="1" colspan="1">5138</td>
<td align="center" valign="middle" rowspan="1" colspan="1">18</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.35</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No cancer</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3491</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.23</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Personal history of ovarian cancer</td>
<td align="center" valign="middle" rowspan="1" colspan="1">9149</td>
<td align="center" valign="middle" rowspan="1" colspan="1">14</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.15</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Family history of cancer</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
<td align="center" valign="middle" rowspan="1" colspan="1">
</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast</td>
<td align="center" valign="middle" rowspan="1" colspan="1">3867</td>
<td align="center" valign="middle" rowspan="1" colspan="1">9</td>
<td align="center" valign="middle" rowspan="1" colspan="1">0.23</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Ovarian</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">Breast and ovarian</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No cancer</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/genes-11-00856-t004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="fn4"><p>ER = estrogen receptor; PR = progesterone receptor; HER2 = human epidermal growth factor receptor 2; TNBC = triple-negative breast cancer. <sup>a</sup> Source: Interactive Prevalence Tables From Multi-Gene Panel Testing: A collaboration between investigators from Mayo Clinic and Ambry Genetics<sup>®</sup> [<a href="#B143-genes-11-00856" class="usa-link" aria-describedby="B143-genes-11-00856">143</a>] (<a href="http://www.ambrygen.com/clinician/resources/prevalence-tool" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.ambrygen.com/clinician/resources/prevalence-tool</a>).</p></div></div></section></section><section id="sec7-genes-11-00856"><h2 class="pmc_sec_title">7. Our Perspective of <em>BARD1</em> as a Cancer Predisposing Gene</h2>
<p>Since the discovery over 20 years ago that BARD1 interacts with BRCA1, numerous studies have investigated the possibility that <em>BARD1</em> variants may affect risk to the heritable form of BC and OC, and perhaps account for the missing heritability not attributed to <em>BRCA1/BRCA2</em>, historically denoted as “<em>BRCAX</em>”. However, genetic studies involving family-based cancer cases and case-control study groups have consistently shown that potentially pathogenic variants in <em>BARD1</em> are unlikely to: i) confer a high lifetime risk (OR ≥ 5) to BC and OC in heterozygous carriers akin to pathogenic variants described for <em>BRCA1</em> and <em>BRCA2</em>; and ii) account for the remaining or a significant proportion of heritability of BC and OC attributable to known cancer predisposing genes, especially in cancer syndromes involving these cancer types. Indeed, such studies investigating diverse populations worldwide support the hypothesis that potentially pathogenic variants in <em>BARD1</em> confer a low–moderate risk to cancer, with perhaps a moderate risk to TNBC. Molecular biology studies of BARD1 support a role in neoplasia in modifying cell growth and tumour suppressor activity leading to tumourigenesis, particularly in the context of modelling variants found associated with heritable disease. Although collectively the research literature supports a role for <em>BARD1</em> variants in the etiology of cancer, there is insufficient evidence to translate findings to clinical settings for the purposes of providing cancer risk in variant carriers or managing cancer care as is currently available for carriers of variants in known high risk genes, such as <em>BRCA1</em> and <em>BRCA2</em> [<a href="#B144-genes-11-00856" class="usa-link" aria-describedby="B144-genes-11-00856">144</a>].</p>
<p>There are barriers to estimating risk for <em>BARD1</em> variants: i) the rarity of carriers of potentially pathogenic <em>BARD1</em> variants; ii) the posited low–moderate risk of cancer associated with <em>BARD1</em> variants; and iii) the heterogeneity within and between populations, cancer cases of the same primary tissue site and cancer subtypes (based on histopathology or biomarkers). A family-based study estimated that the relative risk associated with <em>BARD1</em> carriers was 2.27 (95%CI 0.47–18.91) for BC [<a href="#B47-genes-11-00856" class="usa-link" aria-describedby="B47-genes-11-00856">47</a>], suggesting that women with a family history of BC have at least a two-fold increased risk for this disease as compared with those who do not. However, the wide confidence interval, reflecting small sample groups in this study, suggest that this information should be viewed with caution. It will be difficult to identify a sufficiently large sample size to improve risk estimates as the numbers of carriers of <em>BARD1</em> variants are rare, as has been observed for carriers of potentially pathogenic <em>PALB2</em>, <em>BRIP1</em>, <em>RAD51C</em> or <em>RAD51D</em> variants in hereditary BC and/or OC cancer syndrome families (<a href="#genes-11-00856-f003" class="usa-link">Figure 3</a>) [<a href="#B145-genes-11-00856" class="usa-link" aria-describedby="B145-genes-11-00856">145</a>,<a href="#B146-genes-11-00856" class="usa-link" aria-describedby="B146-genes-11-00856">146</a>]. For <em>PALB2</em> the risk of a pathogenic variant was estimated with high confidence in an international study of 524 families [<a href="#B146-genes-11-00856" class="usa-link" aria-describedby="B146-genes-11-00856">146</a>]. It has been estimated that approximately 40,000 OC cases and 40,000 controls would be required to estimate risk for <em>BARD1</em> variant carriers, should this risk be in the low-moderate range [<a href="#B10-genes-11-00856" class="usa-link" aria-describedby="B10-genes-11-00856">10</a>]. Ideally, the appropriate control population should be matched with the cases on age and sex and have no family history of cancer. Cancer cases should have clearly defined histopathology to more precisely characterize associations with TNBC (<a href="#genes-11-00856-t001" class="usa-link">Table 1</a>). The design of future studies to assess the risk of <em>BARD1</em> pathogenic variants in different cancers will be crucial to determine if translation to patient care in the clinic is appropriate.</p>
<p>A number of <em>BARD1</em> missense variants have been characterized and shown to directly alter BARD1 function or its interaction with BRCA1 (<a href="#genes-11-00856-f002" class="usa-link">Figure 2</a>). It will be important to continue to functionally characterize variants, especially missense variants identified through hereditary cancer studies and clinics, to assess risk. Evaluating new nonsense variants in the C-terminus of the protein will also be important, as previous studies have shown with <em>BRCA2</em> c.9976A&gt;T; p.Lys3326Ter that truncation of the end of protein may not significantly increase risk to BC [<a href="#B141-genes-11-00856" class="usa-link" aria-describedby="B141-genes-11-00856">141</a>,<a href="#B147-genes-11-00856" class="usa-link" aria-describedby="B147-genes-11-00856">147</a>]. Moreover, <em>in cellulo</em> functional assays have demonstrated that the impact of some nonsense variants are not necessarily associated with nonsense-mediated decay [<a href="#B148-genes-11-00856" class="usa-link" aria-describedby="B148-genes-11-00856">148</a>]. Canonical splicing variants will also be important to assess as aberrant splicing is known to affect the expression of <em>BARD1</em> and may lead to mis-localization of the protein (reviewed in [<a href="#B96-genes-11-00856" class="usa-link" aria-describedby="B96-genes-11-00856">96</a>]). Furthermore, studies are lacking that specifically address genotype-phenotype correlations, variable expressivity, epigenetic modification(s), somatic mosaicism, large genomic rearrangements or de novo germline variants. As <em>BARD1</em> variants have also been identified in carriers of known cancer predisposing genes, <em>BRCA1</em> and <em>BRCA2</em>, it will be important to explore if <em>BARD1</em> variants modify risk in an epistatic or additive manner in this context. </p>
<p>Genetic epidemiology studies have identified a number of host factors that modify cancer risk regardless of variant carrier status (reviewed in [<a href="#B149-genes-11-00856" class="usa-link" aria-describedby="B149-genes-11-00856">149</a>]). For example, it has been shown that carriers of pathogenic <em>BRCA1</em> or <em>BRCA2</em> variants have reduced risk for OC due to oral contraceptive pill use or parity or surgical intervention (i.e., tubal ligation or oophorectomy) [<a href="#B150-genes-11-00856" class="usa-link" aria-describedby="B150-genes-11-00856">150</a>,<a href="#B151-genes-11-00856" class="usa-link" aria-describedby="B151-genes-11-00856">151</a>,<a href="#B152-genes-11-00856" class="usa-link" aria-describedby="B152-genes-11-00856">152</a>,<a href="#B153-genes-11-00856" class="usa-link" aria-describedby="B153-genes-11-00856">153</a>,<a href="#B154-genes-11-00856" class="usa-link" aria-describedby="B154-genes-11-00856">154</a>]. As the risk attributed to potentially pathogenic <em>BARD1</em> variants is expected to be low–moderate, interactions with these host factors should be investigated; results could inform the development of guidelines for patient management and genetic counselling. </p>
<p>The clinical impact of BARD1 dysfunction in cancer cells is currently unknown. Carriers of pathogenic <em>BRCA1</em> or <em>BRCA2</em> variants respond well to platinum chemotherapies [<a href="#B155-genes-11-00856" class="usa-link" aria-describedby="B155-genes-11-00856">155</a>,<a href="#B156-genes-11-00856" class="usa-link" aria-describedby="B156-genes-11-00856">156</a>] and to new therapies such as PARP inhibitors that take advantage of DNA repair pathways affected by pathogenic variants in these genes [<a href="#B157-genes-11-00856" class="usa-link" aria-describedby="B157-genes-11-00856">157</a>,<a href="#B158-genes-11-00856" class="usa-link" aria-describedby="B158-genes-11-00856">158</a>,<a href="#B159-genes-11-00856" class="usa-link" aria-describedby="B159-genes-11-00856">159</a>,<a href="#B160-genes-11-00856" class="usa-link" aria-describedby="B160-genes-11-00856">160</a>,<a href="#B161-genes-11-00856" class="usa-link" aria-describedby="B161-genes-11-00856">161</a>,<a href="#B162-genes-11-00856" class="usa-link" aria-describedby="B162-genes-11-00856">162</a>]. Assaying <em>BARD1</em> variants in women with BC and OC as biomarkers for guiding therapeutic use has not been fully explored.</p>
<p>Evidence from the literature presented in this review is sufficient to conclude that variants in <em>BARD1</em> can confer low–moderate risk to BC, especially TNBC, or modify risk to BC in carriers of pathogenic <em>BRCA1</em> or <em>BRCA2</em> variants (so-called double heterozygous carriers). However, much work remains, and continued research with larger well-defined study subjects with associated clinical correlates, with additionally discovered variants that have been characterized in biological assays, will elucidate the role of BARD1 in the etiology of cancer and help develop guidelines for care in carriers and new therapies. </p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors acknowledge Corinne Serruya and Mary Fujiwara for assistance in editing drafts and conceptualization. The authors acknowledge the National Comprehensive Cancer Network guidelines for information regarding clinical management of carriers of variants in cancer predisposing genes. The authors acknowledge Evan Weber, Zaki El Haffaf for discussions about clinical guidelines and recommendations, and Karine Bédard for assistance with statements.</p></section><section id="app1-genes-11-00856" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>The following are available online at <a href="https://www.mdpi.com/2073-4425/11/8/856/s1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdpi.com/2073-4425/11/8/856/s1</a>, Supplementary Table S1: All <em>BARD1</em> genetic variants identified from a literature review; Supplementary file S1: Methodology.</p>
<section class="sm xbox font-sm" id="genes-11-00856-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/7464855/bin/genes-11-00856-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (81.5KB, zip) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceptualization, W.M.A., C.T.F., and P.N.T.; writing—original draft preparation, W.M.A., C.T.F. and N.R.; writing—review and editing, P.N.T.; supervision, P.N.T.; All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research was funded by: The Canadian Institute for Health Research (CIHR) operating grants [PCC-156736 to P.N.T., Celia M.T. Greenwood, Jiannis Ragoussis; PJT-156124 to P.N.T., Jiannis Raggousis]; The RI-MUHC and CRCHUM receive support from the FRQS. W.M.A. is supported by a Taibah University Scholarship Award and The Ministry of Higher Education, Saudi Arabia.</p></section><section id="notes3"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflict of interest.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-genes-11-00856">
<span class="label">1.</span><cite>Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W., et al.  Strong Candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71. doi: 10.1126/science.7545954.</cite> [<a href="https://doi.org/10.1126/science.7545954" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7545954/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Strong%20Candidate%20for%20the%20breast%20and%20ovarian%20cancer%20susceptibility%20gene%20BRCA1&amp;author=Y.%20Miki&amp;author=J.%20Swensen&amp;author=D.%20Shattuck-Eidens&amp;author=P.A.%20Futreal&amp;author=K.%20Harshman&amp;volume=266&amp;publication_year=1994&amp;pages=66-71&amp;pmid=7545954&amp;doi=10.1126/science.7545954&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-genes-11-00856">
<span class="label">2.</span><cite>Rahman N. Realizing the promise of cancer predisposition genes. Nature. 2014;505:302–308. doi: 10.1038/nature12981.</cite> [<a href="https://doi.org/10.1038/nature12981" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4975511/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24429628/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Realizing%20the%20promise%20of%20cancer%20predisposition%20genes&amp;author=N.%20Rahman&amp;volume=505&amp;publication_year=2014&amp;pages=302-308&amp;pmid=24429628&amp;doi=10.1038/nature12981&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-genes-11-00856">
<span class="label">3.</span><cite>Fearon E.R. Human cancer syndromes: Clues to the origin and nature of cancer. Science. 1997;278:1043–1050. doi: 10.1126/science.278.5340.1043.</cite> [<a href="https://doi.org/10.1126/science.278.5340.1043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9353177/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Human%20cancer%20syndromes:%20Clues%20to%20the%20origin%20and%20nature%20of%20cancer&amp;author=E.R.%20Fearon&amp;volume=278&amp;publication_year=1997&amp;pages=1043-1050&amp;pmid=9353177&amp;doi=10.1126/science.278.5340.1043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-genes-11-00856">
<span class="label">4.</span><cite>Nielsen F.C., van Overeem Hansen T., Sørensen C.S. Hereditary breast and ovarian cancer: New genes in confined pathways. Nat. Rev. Cancer. 2016;16:599–612. doi: 10.1038/nrc.2016.72.</cite> [<a href="https://doi.org/10.1038/nrc.2016.72" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27515922/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Cancer&amp;title=Hereditary%20breast%20and%20ovarian%20cancer:%20New%20genes%20in%20confined%20pathways&amp;author=F.C.%20Nielsen&amp;author=T.%20van%20Overeem%20Hansen&amp;author=C.S.%20S%C3%B8rensen&amp;volume=16&amp;publication_year=2016&amp;pages=599-612&amp;pmid=27515922&amp;doi=10.1038/nrc.2016.72&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-genes-11-00856">
<span class="label">5.</span><cite>Wu L.C., Wang Z.W., Tsan J.T., Spillman M.A., Phung A., Xu X.L., Yang M.C., Hwang L.Y., Bowcock A.M., Baer R. Identification of a RING protein that can interact in vivo with the BRCA1 gene product. Nat. Genet. 1996;14:430–440. doi: 10.1038/ng1296-430.</cite> [<a href="https://doi.org/10.1038/ng1296-430" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8944023/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Genet.&amp;title=Identification%20of%20a%20RING%20protein%20that%20can%20interact%20in%20vivo%20with%20the%20BRCA1%20gene%20product&amp;author=L.C.%20Wu&amp;author=Z.W.%20Wang&amp;author=J.T.%20Tsan&amp;author=M.A.%20Spillman&amp;author=A.%20Phung&amp;volume=14&amp;publication_year=1996&amp;pages=430-440&amp;pmid=8944023&amp;doi=10.1038/ng1296-430&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-genes-11-00856">
<span class="label">6.</span><cite>Thai T.H., Du F., Tsan J.T., Jin Y., Phung A., Spillman M.A., Massa H.F., Muller C.Y., Ashfaq R., Mathis J.M., et al.  Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum. Mol. Genet. 1998;7:195–202. doi: 10.1093/hmg/7.2.195.</cite> [<a href="https://doi.org/10.1093/hmg/7.2.195" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9425226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mol.%20Genet.&amp;title=Mutations%20in%20the%20BRCA1-associated%20RING%20domain%20(BARD1)%20gene%20in%20primary%20breast,%20ovarian%20and%20uterine%20cancers&amp;author=T.H.%20Thai&amp;author=F.%20Du&amp;author=J.T.%20Tsan&amp;author=Y.%20Jin&amp;author=A.%20Phung&amp;volume=7&amp;publication_year=1998&amp;pages=195-202&amp;pmid=9425226&amp;doi=10.1093/hmg/7.2.195&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-genes-11-00856">
<span class="label">7.</span><cite>Karppinen S.-M., Heikkinen K., Rapakko K., Winqvist R. Mutation screening of the BARD1 gene: Evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer. J. Med. Genet. 2004;41:e114. doi: 10.1136/jmg.2004.020669.</cite> [<a href="https://doi.org/10.1136/jmg.2004.020669" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1735890/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15342711/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Mutation%20screening%20of%20the%20BARD1%20gene:%20Evidence%20for%20involvement%20of%20the%20Cys557Ser%20allele%20in%20hereditary%20susceptibility%20to%20breast%20cancer&amp;author=S.-M.%20Karppinen&amp;author=K.%20Heikkinen&amp;author=K.%20Rapakko&amp;author=R.%20Winqvist&amp;volume=41&amp;publication_year=2004&amp;pages=e114&amp;pmid=15342711&amp;doi=10.1136/jmg.2004.020669&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-genes-11-00856">
<span class="label">8.</span><cite>Karppinen S.-M., Barkardottir R.B., Backenhorn K., Sydenham T., Syrjäkoski K., Schleutker J., Ikonen T., Pylkäs K., Rapakko K., Erkko H., et al.  Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: Enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies. J. Med. Genet. 2006;43:856–862. doi: 10.1136/jmg.2006.041731.</cite> [<a href="https://doi.org/10.1136/jmg.2006.041731" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2563183/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16825437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Nordic%20collaborative%20study%20of%20the%20BARD1%20Cys557Ser%20allele%20in%203956%20patients%20with%20cancer:%20Enrichment%20in%20familial%20BRCA1/BRCA2%20mutation-negative%20breast%20cancer%20but%20not%20in%20other%20malignancies&amp;author=S.-M.%20Karppinen&amp;author=R.B.%20Barkardottir&amp;author=K.%20Backenhorn&amp;author=T.%20Sydenham&amp;author=K.%20Syrj%C3%A4koski&amp;volume=43&amp;publication_year=2006&amp;pages=856-862&amp;pmid=16825437&amp;doi=10.1136/jmg.2006.041731&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-genes-11-00856">
<span class="label">9.</span><cite>Stacey S.N., Sulem P., Johannsson O.T., Helgason A., Gudmundsson J., Kostic J.P., Kristjansson K., Jonsdottir T., Sigurdsson H., Hrafnkelsson J., et al.  The BARD1 Cys557Ser variant and breast cancer risk in Iceland. PLoS Med. 2006;3:e217.  doi: 10.1371/journal.pmed.0030217.</cite> [<a href="https://doi.org/10.1371/journal.pmed.0030217" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1479388/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16768547/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Med.&amp;title=The%20BARD1%20Cys557Ser%20variant%20and%20breast%20cancer%20risk%20in%20Iceland&amp;author=S.N.%20Stacey&amp;author=P.%20Sulem&amp;author=O.T.%20Johannsson&amp;author=A.%20Helgason&amp;author=J.%20Gudmundsson&amp;volume=3&amp;publication_year=2006&amp;pages=e217&amp;pmid=16768547&amp;doi=10.1371/journal.pmed.0030217&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-genes-11-00856">
<span class="label">10.</span><cite>Vahteristo P., Syrjäkoski K., Heikkinen T., Eerola H., Aittomäki K., von Smitten K., Holli K., Blomqvist C., Kallioniemi O.-P., Nevanlinna H. BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition. Eur. J. Hum. Genet. 2006;14:167–172. doi: 10.1038/sj.ejhg.5201542.</cite> [<a href="https://doi.org/10.1038/sj.ejhg.5201542" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16333312/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Hum.%20Genet.&amp;title=BARD1%20variants%20Cys557Ser%20and%20Val507Met%20in%20breast%20cancer%20predisposition&amp;author=P.%20Vahteristo&amp;author=K.%20Syrj%C3%A4koski&amp;author=T.%20Heikkinen&amp;author=H.%20Eerola&amp;author=K.%20Aittom%C3%A4ki&amp;volume=14&amp;publication_year=2006&amp;pages=167-172&amp;pmid=16333312&amp;doi=10.1038/sj.ejhg.5201542&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-genes-11-00856">
<span class="label">11.</span><cite>Johnatty S.E., Beesley J., Chen X., Hopper J.L., Southey M.C., Giles G.G., Goldgar D.E., Chenevix-Trench G., Spurdle A.B. The BARD1 Cys557Ser polymorphism and breast cancer risk: An Australian case-control and family analysis. Breast Cancer Res. Treat. 2009;115:145–150. doi: 10.1007/s10549-008-0045-y.</cite> [<a href="https://doi.org/10.1007/s10549-008-0045-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18481171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=The%20BARD1%20Cys557Ser%20polymorphism%20and%20breast%20cancer%20risk:%20An%20Australian%20case-control%20and%20family%20analysis&amp;author=S.E.%20Johnatty&amp;author=J.%20Beesley&amp;author=X.%20Chen&amp;author=J.L.%20Hopper&amp;author=M.C.%20Southey&amp;volume=115&amp;publication_year=2009&amp;pages=145-150&amp;pmid=18481171&amp;doi=10.1007/s10549-008-0045-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-genes-11-00856">
<span class="label">12.</span><cite>Jakubowska A., Cybulski C., Szymańska A., Huzarski T., Byrski T., Gronwald J., Debniak T., Górski B., Kowalska E., Narod S.A., et al.  BARD1 and breast cancer in Poland. Breast Cancer Res. Treat. 2008;107:119–122. doi: 10.1007/s10549-007-9537-4.</cite> [<a href="https://doi.org/10.1007/s10549-007-9537-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17333333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=BARD1%20and%20breast%20cancer%20in%20Poland&amp;author=A.%20Jakubowska&amp;author=C.%20Cybulski&amp;author=A.%20Szyma%C5%84ska&amp;author=T.%20Huzarski&amp;author=T.%20Byrski&amp;volume=107&amp;publication_year=2008&amp;pages=119-122&amp;pmid=17333333&amp;doi=10.1007/s10549-007-9537-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-genes-11-00856">
<span class="label">13.</span><cite>Karczewski K.J., Francioli L.C., Tiao G., Cummings B.B., Alföldi J., Wang Q., Collins R.L., Laricchia K.M., Ganna A., Birnbaum D.P., et al.  The mutational constraint spectrum quantified from variation in 141, 456 humans. Nature. 2020;581:434–443. doi: 10.1038/s41586-020-2308-7.</cite> [<a href="https://doi.org/10.1038/s41586-020-2308-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7334197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32461654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The%20mutational%20constraint%20spectrum%20quantified%20from%20variation%20in%20141,%20456%20humans&amp;author=K.J.%20Karczewski&amp;author=L.C.%20Francioli&amp;author=G.%20Tiao&amp;author=B.B.%20Cummings&amp;author=J.%20Alf%C3%B6ldi&amp;volume=581&amp;publication_year=2020&amp;pages=434-443&amp;pmid=32461654&amp;doi=10.1038/s41586-020-2308-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-genes-11-00856">
<span class="label">14.</span><cite>Guénard F., Labrie Y., Ouellette G., Beauparlant C.J., Durocher F. Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer. J. Hum. Genet. 2009;54:152–161. doi: 10.1038/jhg.2009.6.</cite> [<a href="https://doi.org/10.1038/jhg.2009.6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19197335/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Hum.%20Genet.&amp;title=Genetic%20sequence%20variations%20of%20BRCA1-interacting%20genes%20AURKA,%20BAP1,%20BARD1%20and%20DHX9%20in%20French%20Canadian%20families%20with%20high%20risk%20of%20breast%20cancer&amp;author=F.%20Gu%C3%A9nard&amp;author=Y.%20Labrie&amp;author=G.%20Ouellette&amp;author=C.J.%20Beauparlant&amp;author=F.%20Durocher&amp;volume=54&amp;publication_year=2009&amp;pages=152-161&amp;pmid=19197335&amp;doi=10.1038/jhg.2009.6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-genes-11-00856">
<span class="label">15.</span><cite>Ramus S.J., Song H., Dicks E., Tyrer J.P., Rosenthal A.N., Intermaggio M.P., Fraser L., Gentry-Maharaj A., Hayward J., Philpott S., et al.  Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer. J. Natl. Cancer Inst. 2015;107 doi: 10.1093/jnci/djv214.</cite> [<a href="https://doi.org/10.1093/jnci/djv214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4643629/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26315354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=Germline%20mutations%20in%20the%20BRIP1,%20BARD1,%20PALB2,%20and%20NBN%20genes%20in%20women%20with%20ovarian%20cancer&amp;author=S.J.%20Ramus&amp;author=H.%20Song&amp;author=E.%20Dicks&amp;author=J.P.%20Tyrer&amp;author=A.N.%20Rosenthal&amp;volume=107&amp;publication_year=2015&amp;pmid=26315354&amp;doi=10.1093/jnci/djv214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-genes-11-00856">
<span class="label">16.</span><cite>Couch F.J., Hart S.N., Sharma P., Toland A.E., Wang X., Miron P., Olson J.E., Godwin A.K., Pankratz V.S., Olswold C., et al.  Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer. J. Clin. Oncol. 2015;33:304–311. doi: 10.1200/JCO.2014.57.1414.</cite> [<a href="https://doi.org/10.1200/JCO.2014.57.1414" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4302212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25452441/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=Inherited%20mutations%20in%2017%20breast%20cancer%20susceptibility%20genes%20among%20a%20large%20triple-negative%20breast%20cancer%20cohort%20unselected%20for%20family%20history%20of%20breast%20cancer&amp;author=F.J.%20Couch&amp;author=S.N.%20Hart&amp;author=P.%20Sharma&amp;author=A.E.%20Toland&amp;author=X.%20Wang&amp;volume=33&amp;publication_year=2015&amp;pages=304-311&amp;pmid=25452441&amp;doi=10.1200/JCO.2014.57.1414&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-genes-11-00856">
<span class="label">17.</span><cite>Gorringe K.L., Choong D.Y.H., Visvader J.E., Lindeman G.J., Campbell I.G. BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer. Breast Cancer Res. Treat. 2008;111:505–509. doi: 10.1007/s10549-007-9799-x.</cite> [<a href="https://doi.org/10.1007/s10549-007-9799-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17972171/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=BARD1%20variants%20are%20not%20associated%20with%20breast%20cancer%20risk%20in%20Australian%20familial%20breast%20cancer&amp;author=K.L.%20Gorringe&amp;author=D.Y.H.%20Choong&amp;author=J.E.%20Visvader&amp;author=G.J.%20Lindeman&amp;author=I.G.%20Campbell&amp;volume=111&amp;publication_year=2008&amp;pages=505-509&amp;pmid=17972171&amp;doi=10.1007/s10549-007-9799-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-genes-11-00856">
<span class="label">18.</span><cite>Couch F.J., Shimelis H., Hu C., Hart S.N., Polley E.C., Na J., Hallberg E., Moore R., Thomas A., Lilyquist J., et al.  Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol. 2017;3:1190–1196. doi: 10.1001/jamaoncol.2017.0424.</cite> [<a href="https://doi.org/10.1001/jamaoncol.2017.0424" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5599323/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28418444/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol.&amp;title=Associations%20between%20cancer%20predisposition%20testing%20panel%20genes%20and%20breast%20cancer&amp;author=F.J.%20Couch&amp;author=H.%20Shimelis&amp;author=C.%20Hu&amp;author=S.N.%20Hart&amp;author=E.C.%20Polley&amp;volume=3&amp;publication_year=2017&amp;pages=1190-1196&amp;pmid=28418444&amp;doi=10.1001/jamaoncol.2017.0424&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-genes-11-00856">
<span class="label">19.</span><cite>Hu C., Polley E.C., Yadav S., Lilyquist J., Shimelis H., Na J., Hart S.N., Goldgar D.E., Shah S., Pesaran T., et al.  The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort. J. Natl. Cancer Inst. 2020 doi: 10.1093/jnci/djaa023.</cite> [<a href="https://doi.org/10.1093/jnci/djaa023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7735776/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32091585/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=The%20contribution%20of%20germline%20predisposition%20gene%20mutations%20to%20clinical%20subtypes%20of%20invasive%20breast%20cancer%20from%20a%20clinical%20genetic%20testing%20cohort&amp;author=C.%20Hu&amp;author=E.C.%20Polley&amp;author=S.%20Yadav&amp;author=J.%20Lilyquist&amp;author=H.%20Shimelis&amp;publication_year=2020&amp;pmid=32091585&amp;doi=10.1093/jnci/djaa023&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-genes-11-00856">
<span class="label">20.</span><cite>Shimelis H., LaDuca H., Hu C., Hart S.N., Na J., Thomas A., Akinhanmi M., Moore R.M., Brauch H., Cox A., et al.  Triple-Negative breast cancer risk genes identified by multigene hereditary cancer panel testing. J. Natl. Cancer Inst. 2018;110:855–862. doi: 10.1093/jnci/djy106.</cite> [<a href="https://doi.org/10.1093/jnci/djy106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6093350/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30099541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=Triple-Negative%20breast%20cancer%20risk%20genes%20identified%20by%20multigene%20hereditary%20cancer%20panel%20testing&amp;author=H.%20Shimelis&amp;author=H.%20LaDuca&amp;author=C.%20Hu&amp;author=S.N.%20Hart&amp;author=J.%20Na&amp;volume=110&amp;publication_year=2018&amp;pages=855-862&amp;pmid=30099541&amp;doi=10.1093/jnci/djy106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-genes-11-00856">
<span class="label">21.</span><cite>Castéra L., Harter V., Muller E., Krieger S., Goardon N., Ricou A., Rousselin A., Paimparay G., Legros A., Bruet O., et al.  Landscape of pathogenic variations in a panel of 34 genes and cancer risk estimation from 5131 HBOC families. Genet. Med. 2018;20:1677–1686. doi: 10.1038/s41436-018-0005-9.</cite> [<a href="https://doi.org/10.1038/s41436-018-0005-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29988077/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Landscape%20of%20pathogenic%20variations%20in%20a%20panel%20of%2034%20genes%20and%20cancer%20risk%20estimation%20from%205131%20HBOC%20families&amp;author=L.%20Cast%C3%A9ra&amp;author=V.%20Harter&amp;author=E.%20Muller&amp;author=S.%20Krieger&amp;author=N.%20Goardon&amp;volume=20&amp;publication_year=2018&amp;pages=1677-1686&amp;pmid=29988077&amp;doi=10.1038/s41436-018-0005-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-genes-11-00856">
<span class="label">22.</span><cite>Kumar P., Aggarwal R. An overview of triple-negative breast cancer. Arch. Gynecol. Obstet. 2016;293:247–269. doi: 10.1007/s00404-015-3859-y.</cite> [<a href="https://doi.org/10.1007/s00404-015-3859-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26341644/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Arch.%20Gynecol.%20Obstet.&amp;title=An%20overview%20of%20triple-negative%20breast%20cancer&amp;author=P.%20Kumar&amp;author=R.%20Aggarwal&amp;volume=293&amp;publication_year=2016&amp;pages=247-269&amp;pmid=26341644&amp;doi=10.1007/s00404-015-3859-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-genes-11-00856">
<span class="label">23.</span><cite>Ryu D.W., Jung M.J., Choi W.S., Lee C.H. Clinical significance of morphologic characteristics in triple negative breast cancer. J. Korean Surg. Soc. 2011;80:301. doi: 10.4174/jkss.2011.80.5.301.</cite> [<a href="https://doi.org/10.4174/jkss.2011.80.5.301" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3204700/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22066052/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Korean%20Surg.%20Soc.&amp;title=Clinical%20significance%20of%20morphologic%20characteristics%20in%20triple%20negative%20breast%20cancer&amp;author=D.W.%20Ryu&amp;author=M.J.%20Jung&amp;author=W.S.%20Choi&amp;author=C.H.%20Lee&amp;volume=80&amp;publication_year=2011&amp;pages=301&amp;pmid=22066052&amp;doi=10.4174/jkss.2011.80.5.301&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-genes-11-00856">
<span class="label">24.</span><cite>Suszynska M., Kluzniak W., Wokolorczyk D., Jakubowska A., Huzarski T., Gronwald J., Debniak T., Szwiec M., Ratajska M., Klonowska K., et al.  BARD1 is a low/moderate breast cancer risk gene: Evidence Based on an association study of the central European p.Q564X Recurrent mutation. Cancers (Basel) 2019;11:740.  doi: 10.3390/cancers11060740.</cite> [<a href="https://doi.org/10.3390/cancers11060740" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6627038/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31142030/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=BARD1%20is%20a%20low/moderate%20breast%20cancer%20risk%20gene:%20Evidence%20Based%20on%20an%20association%20study%20of%20the%20central%20European%20p.Q564X%20Recurrent%20mutation&amp;author=M.%20Suszynska&amp;author=W.%20Kluzniak&amp;author=D.%20Wokolorczyk&amp;author=A.%20Jakubowska&amp;author=T.%20Huzarski&amp;volume=11&amp;publication_year=2019&amp;pages=740&amp;pmid=31142030&amp;doi=10.3390/cancers11060740&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-genes-11-00856">
<span class="label">25.</span><cite>Ratajska M., Antoszewska E., Piskorz A., Brozek I., Borg Å., Kusmierek H., Biernat W., Limon J. Cancer predisposing BARD1 mutations in breast-ovarian cancer families. Breast Cancer Res. Treat. 2012;131:89–97. doi: 10.1007/s10549-011-1403-8.</cite> [<a href="https://doi.org/10.1007/s10549-011-1403-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21344236/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Cancer%20predisposing%20BARD1%20mutations%20in%20breast-ovarian%20cancer%20families&amp;author=M.%20Ratajska&amp;author=E.%20Antoszewska&amp;author=A.%20Piskorz&amp;author=I.%20Brozek&amp;author=%C3%85.%20Borg&amp;volume=131&amp;publication_year=2012&amp;pages=89-97&amp;pmid=21344236&amp;doi=10.1007/s10549-011-1403-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-genes-11-00856">
<span class="label">26.</span><cite>Huo X., Hu Z., Zhai X., Wang Y., Wang S., Wang X., Qin J., Chen W., Jin G., Liu J., et al.  Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: A case-control analysis. Breast Cancer Res. Treat. 2007;102:329–337. doi: 10.1007/s10549-006-9332-7.</cite> [<a href="https://doi.org/10.1007/s10549-006-9332-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17028982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Common%20non-synonymous%20polymorphisms%20in%20the%20BRCA1%20Associated%20RING%20Domain%20(BARD1)%20gene%20are%20associated%20with%20breast%20cancer%20susceptibility:%20A%20case-control%20analysis&amp;author=X.%20Huo&amp;author=Z.%20Hu&amp;author=X.%20Zhai&amp;author=Y.%20Wang&amp;author=S.%20Wang&amp;volume=102&amp;publication_year=2007&amp;pages=329-337&amp;pmid=17028982&amp;doi=10.1007/s10549-006-9332-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-genes-11-00856">
<span class="label">27.</span><cite>Sauer M.K., Andrulis I.L. Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer. J. Med. Genet. 2005;42:633–638. doi: 10.1136/jmg.2004.030049.</cite> [<a href="https://doi.org/10.1136/jmg.2004.030049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1736120/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16061562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Identification%20and%20characterization%20of%20missense%20alterations%20in%20the%20BRCA1%20associated%20RING%20domain%20(BARD1)%20gene%20in%20breast%20and%20ovarian%20cancer&amp;author=M.K.%20Sauer&amp;author=I.L.%20Andrulis&amp;volume=42&amp;publication_year=2005&amp;pages=633-638&amp;pmid=16061562&amp;doi=10.1136/jmg.2004.030049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-genes-11-00856">
<span class="label">28.</span><cite>De Brakeleer S., De Grève J., Loris R., Janin N., Lissens W., Sermijn E., Teugels E. Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families. Hum. Mutat. 2010;31:E1175-85. doi: 10.1002/humu.21200.</cite> [<a href="https://doi.org/10.1002/humu.21200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20077502/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Cancer%20predisposing%20missense%20and%20protein%20truncating%20BARD1%20mutations%20in%20non-BRCA1%20or%20BRCA2%20breast%20cancer%20families&amp;author=S.%20De%20Brakeleer&amp;author=J.%20De%20Gr%C3%A8ve&amp;author=R.%20Loris&amp;author=N.%20Janin&amp;author=W.%20Lissens&amp;volume=31&amp;publication_year=2010&amp;pages=E1175-85&amp;pmid=20077502&amp;doi=10.1002/humu.21200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-genes-11-00856">
<span class="label">29.</span><cite>De Brakeleer S., De Grève J., Desmedt C., Joris S., Sotiriou C., Piccart M., Pauwels I., Teugels E. Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients. Clin. Genet. 2016;89:336–340. doi: 10.1111/cge.12620.</cite> [<a href="https://doi.org/10.1111/cge.12620" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26010302/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Genet.&amp;title=Frequent%20incidence%20of%20BARD1-truncating%20mutations%20in%20germline%20DNA%20from%20triple-negative%20breast%20cancer%20patients&amp;author=S.%20De%20Brakeleer&amp;author=J.%20De%20Gr%C3%A8ve&amp;author=C.%20Desmedt&amp;author=S.%20Joris&amp;author=C.%20Sotiriou&amp;volume=89&amp;publication_year=2016&amp;pages=336-340&amp;pmid=26010302&amp;doi=10.1111/cge.12620&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-genes-11-00856">
<span class="label">30.</span><cite>Toh M.R., Chong S.T., Chan S.H., Low C.E., Ishak N.D.B., Lim J.Q., Courtney E., Ngeow J. Functional analysis of clinical BARD1 germline variants. Cold Spring Harb. Mol. Case Stud. 2019;5 doi: 10.1101/mcs.a004093.</cite> [<a href="https://doi.org/10.1101/mcs.a004093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6672023/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31371347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cold%20Spring%20Harb.%20Mol.%20Case%20Stud.&amp;title=Functional%20analysis%20of%20clinical%20BARD1%20germline%20variants&amp;author=M.R.%20Toh&amp;author=S.T.%20Chong&amp;author=S.H.%20Chan&amp;author=C.E.%20Low&amp;author=N.D.B.%20Ishak&amp;volume=5&amp;publication_year=2019&amp;pmid=31371347&amp;doi=10.1101/mcs.a004093&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31-genes-11-00856">
<span class="label">31.</span><cite>Weber-Lassalle N., Borde J., Weber-Lassalle K., Horváth J., Niederacher D., Arnold N., Kaulfuß S., Ernst C., Paul V.G., Honisch E., et al.  Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer. Breast Cancer Res. 2019;21:55. doi: 10.1186/s13058-019-1137-9.</cite> [<a href="https://doi.org/10.1186/s13058-019-1137-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6489184/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31036035/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.&amp;title=Germline%20loss-of-function%20variants%20in%20the%20BARD1%20gene%20are%20associated%20with%20early-onset%20familial%20breast%20cancer%20but%20not%20ovarian%20cancer&amp;author=N.%20Weber-Lassalle&amp;author=J.%20Borde&amp;author=K.%20Weber-Lassalle&amp;author=J.%20Horv%C3%A1th&amp;author=D.%20Niederacher&amp;volume=21&amp;publication_year=2019&amp;pages=55&amp;pmid=31036035&amp;doi=10.1186/s13058-019-1137-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-genes-11-00856">
<span class="label">32.</span><cite>Ishitobi M., Miyoshi Y., Hasegawa S., Egawa C., Tamaki Y., Monden M., Noguchi S. Mutational analysis of BARD1 in familial breast cancer patients in Japan. Cancer Lett. 2003;200:1–7. doi: 10.1016/S0304-3835(03)00387-2.</cite> [<a href="https://doi.org/10.1016/S0304-3835(03)00387-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14550946/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett.&amp;title=Mutational%20analysis%20of%20BARD1%20in%20familial%20breast%20cancer%20patients%20in%20Japan&amp;author=M.%20Ishitobi&amp;author=Y.%20Miyoshi&amp;author=S.%20Hasegawa&amp;author=C.%20Egawa&amp;author=Y.%20Tamaki&amp;volume=200&amp;publication_year=2003&amp;pages=1-7&amp;pmid=14550946&amp;doi=10.1016/S0304-3835(03)00387-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33-genes-11-00856">
<span class="label">33.</span><cite>Gonzalez-Hormazabal P., Reyes J.M., Blanco R., Bravo T., Carrera I., Peralta O., Gomez F., Waugh E., Margarit S., Ibañez G., et al.  The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population. Mol. Biol. Rep. 2012;39:8091–8098. doi: 10.1007/s11033-012-1656-2.</cite> [<a href="https://doi.org/10.1007/s11033-012-1656-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22544576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Biol.%20Rep.&amp;title=The%20BARD1%20Cys557Ser%20variant%20and%20risk%20of%20familial%20breast%20cancer%20in%20a%20South-American%20population&amp;author=P.%20Gonzalez-Hormazabal&amp;author=J.M.%20Reyes&amp;author=R.%20Blanco&amp;author=T.%20Bravo&amp;author=I.%20Carrera&amp;volume=39&amp;publication_year=2012&amp;pages=8091-8098&amp;pmid=22544576&amp;doi=10.1007/s11033-012-1656-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34-genes-11-00856">
<span class="label">34.</span><cite>Gass J., Tatro M., Blackburn P., Hines S., Atwal P.S. BARD1 nonsense variant c.1921C&gt;T in a patient with recurrent breast cancer. Clin. Case Rep. 2017;5:104–107. doi: 10.1002/ccr3.793.</cite> [<a href="https://doi.org/10.1002/ccr3.793" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5290515/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28174632/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Case%20Rep.&amp;title=BARD1%20nonsense%20variant%20c.1921C&gt;T%20in%20a%20patient%20with%20recurrent%20breast%20cancer&amp;author=J.%20Gass&amp;author=M.%20Tatro&amp;author=P.%20Blackburn&amp;author=S.%20Hines&amp;author=P.S.%20Atwal&amp;volume=5&amp;publication_year=2017&amp;pages=104-107&amp;pmid=28174632&amp;doi=10.1002/ccr3.793&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35-genes-11-00856">
<span class="label">35.</span><cite>Rana H.Q., Sacca R., Drogan C., Gutierrez S., Schlosnagle E., Regan M.M., Speare V., LaDuca H., Dolinsky J., Garber J.E., et al.  Prevalence of germline variants in inflammatory breast cancer. Cancer. 2019;125:2194–2202. doi: 10.1002/cncr.32062.</cite> [<a href="https://doi.org/10.1002/cncr.32062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30933323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=Prevalence%20of%20germline%20variants%20in%20inflammatory%20breast%20cancer&amp;author=H.Q.%20Rana&amp;author=R.%20Sacca&amp;author=C.%20Drogan&amp;author=S.%20Gutierrez&amp;author=E.%20Schlosnagle&amp;volume=125&amp;publication_year=2019&amp;pages=2194-2202&amp;pmid=30933323&amp;doi=10.1002/cncr.32062&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36-genes-11-00856">
<span class="label">36.</span><cite>Churpek J.E., Walsh T., Zheng Y., Moton Z., Thornton A.M., Lee M.K., Casadei S., Watts A., Neistadt B., Churpek M.M., et al.  Inherited predisposition to breast cancer among African American women. Breast Cancer Res. Treat. 2015;149:31–39. doi: 10.1007/s10549-014-3195-0.</cite> [<a href="https://doi.org/10.1007/s10549-014-3195-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4298662/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25428789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Inherited%20predisposition%20to%20breast%20cancer%20among%20African%20American%20women&amp;author=J.E.%20Churpek&amp;author=T.%20Walsh&amp;author=Y.%20Zheng&amp;author=Z.%20Moton&amp;author=A.M.%20Thornton&amp;volume=149&amp;publication_year=2015&amp;pages=31-39&amp;pmid=25428789&amp;doi=10.1007/s10549-014-3195-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37-genes-11-00856">
<span class="label">37.</span><cite>Norquist B.M., Harrell M.I., Brady M.F., Walsh T., Lee M.K., Gulsuner S., Bernards S.S., Casadei S., Yi Q., Burger R.A., et al.  Inherited mutations in women with ovarian carcinoma. JAMA Oncol. 2016;2:482–490. doi: 10.1001/jamaoncol.2015.5495.</cite> [<a href="https://doi.org/10.1001/jamaoncol.2015.5495" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4845939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26720728/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA%20Oncol.&amp;title=Inherited%20mutations%20in%20women%20with%20ovarian%20carcinoma&amp;author=B.M.%20Norquist&amp;author=M.I.%20Harrell&amp;author=M.F.%20Brady&amp;author=T.%20Walsh&amp;author=M.K.%20Lee&amp;volume=2&amp;publication_year=2016&amp;pages=482-490&amp;pmid=26720728&amp;doi=10.1001/jamaoncol.2015.5495&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38-genes-11-00856">
<span class="label">38.</span><cite>Walsh T., Casadei S., Lee M.K., Pennil C.C., Nord A.S., Thornton A.M., Roeb W., Agnew K.J., Stray S.M., Wickramanayake A., et al.  Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing. Proc. Natl. Acad. Sci. USA. 2011;108:18032–18037. doi: 10.1073/pnas.1115052108.</cite> [<a href="https://doi.org/10.1073/pnas.1115052108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3207658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22006311/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=Mutations%20in%2012%20genes%20for%20inherited%20ovarian,%20fallopian%20tube,%20and%20peritoneal%20carcinoma%20identified%20by%20massively%20parallel%20sequencing&amp;author=T.%20Walsh&amp;author=S.%20Casadei&amp;author=M.K.%20Lee&amp;author=C.C.%20Pennil&amp;author=A.S.%20Nord&amp;volume=108&amp;publication_year=2011&amp;pages=18032-18037&amp;pmid=22006311&amp;doi=10.1073/pnas.1115052108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39-genes-11-00856">
<span class="label">39.</span><cite>Caminsky N.G., Mucaki E.J., Perri A.M., Lu R., Knoll J.H.M., Rogan P.K. Prioritizing variants in complete hereditary breast and ovarian cancer genes in patients lacking known BRCA mutations. Hum. Mutat. 2016;37:640–652. doi: 10.1002/humu.22972.</cite> [<a href="https://doi.org/10.1002/humu.22972" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26898890/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Prioritizing%20variants%20in%20complete%20hereditary%20breast%20and%20ovarian%20cancer%20genes%20in%20patients%20lacking%20known%20BRCA%20mutations&amp;author=N.G.%20Caminsky&amp;author=E.J.%20Mucaki&amp;author=A.M.%20Perri&amp;author=R.%20Lu&amp;author=J.H.M.%20Knoll&amp;volume=37&amp;publication_year=2016&amp;pages=640-652&amp;pmid=26898890&amp;doi=10.1002/humu.22972&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40-genes-11-00856">
<span class="label">40.</span><cite>Lhotova K., Stolarova L., Zemankova P., Vocka M., Janatova M., Borecka M., Cerna M., Jelinkova S., Kral J., Volkova Z., et al.  Multigene panel germline testing of 1333 czech patients with ovarian cancer. Cancers (Basel) 2020;12:956.  doi: 10.3390/cancers12040956.</cite> [<a href="https://doi.org/10.3390/cancers12040956" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7226062/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32295079/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Multigene%20panel%20germline%20testing%20of%201333%20czech%20patients%20with%20ovarian%20cancer&amp;author=K.%20Lhotova&amp;author=L.%20Stolarova&amp;author=P.%20Zemankova&amp;author=M.%20Vocka&amp;author=M.%20Janatova&amp;volume=12&amp;publication_year=2020&amp;pages=956&amp;pmid=32295079&amp;doi=10.3390/cancers12040956&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41-genes-11-00856">
<span class="label">41.</span><cite>Buys S.S., Sandbach J.F., Gammon A., Patel G., Kidd J., Brown K.L., Sharma L., Saam J., Lancaster J., Daly M.B. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes. Cancer. 2017;123:1721–1730. doi: 10.1002/cncr.30498.</cite> [<a href="https://doi.org/10.1002/cncr.30498" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28085182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer&amp;title=A%20study%20of%20over%2035,000%20women%20with%20breast%20cancer%20tested%20with%20a%2025-gene%20panel%20of%20hereditary%20cancer%20genes&amp;author=S.S.%20Buys&amp;author=J.F.%20Sandbach&amp;author=A.%20Gammon&amp;author=G.%20Patel&amp;author=J.%20Kidd&amp;volume=123&amp;publication_year=2017&amp;pages=1721-1730&amp;pmid=28085182&amp;doi=10.1002/cncr.30498&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42-genes-11-00856">
<span class="label">42.</span><cite>Koczkowska M., Krawczynska N., Stukan M., Kuzniacka A., Brozek I., Sniadecki M., Debniak J., Wydra D., Biernat W., Kozlowski P., et al.  Spectrum and prevalence of pathogenic variants in ovarian cancer susceptibility genes in a group of 333 patients. Cancers (Basel) 2018;10:442.  doi: 10.3390/cancers10110442.</cite> [<a href="https://doi.org/10.3390/cancers10110442" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6266089/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30441849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Spectrum%20and%20prevalence%20of%20pathogenic%20variants%20in%20ovarian%20cancer%20susceptibility%20genes%20in%20a%20group%20of%20333%20patients&amp;author=M.%20Koczkowska&amp;author=N.%20Krawczynska&amp;author=M.%20Stukan&amp;author=A.%20Kuzniacka&amp;author=I.%20Brozek&amp;volume=10&amp;publication_year=2018&amp;pages=442&amp;pmid=30441849&amp;doi=10.3390/cancers10110442&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43-genes-11-00856">
<span class="label">43.</span><cite>Jian W., Shao K., Qin Q., Wang X., Song S., Wang X. Clinical and genetic characterization of hereditary breast cancer in a Chinese population. Hered. Cancer Clin. Pract. 2017;15:19. doi: 10.1186/s13053-017-0079-4.</cite> [<a href="https://doi.org/10.1186/s13053-017-0079-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5663067/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29093764/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hered.%20Cancer%20Clin.%20Pract.&amp;title=Clinical%20and%20genetic%20characterization%20of%20hereditary%20breast%20cancer%20in%20a%20Chinese%20population&amp;author=W.%20Jian&amp;author=K.%20Shao&amp;author=Q.%20Qin&amp;author=X.%20Wang&amp;author=S.%20Song&amp;volume=15&amp;publication_year=2017&amp;pages=19&amp;pmid=29093764&amp;doi=10.1186/s13053-017-0079-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44-genes-11-00856">
<span class="label">44.</span><cite>Pennington K.P., Walsh T., Harrell M.I., Lee M.K., Pennil C.C., Rendi M.H., Thornton A., Norquist B.M., Casadei S., Nord A.S., et al.  Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas. Clin. Cancer Res. 2014;20:764–775. doi: 10.1158/1078-0432.CCR-13-2287.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-13-2287" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3944197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24240112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&amp;title=Germline%20and%20somatic%20mutations%20in%20homologous%20recombination%20genes%20predict%20platinum%20response%20and%20survival%20in%20ovarian,%20fallopian%20tube,%20and%20peritoneal%20carcinomas&amp;author=K.P.%20Pennington&amp;author=T.%20Walsh&amp;author=M.I.%20Harrell&amp;author=M.K.%20Lee&amp;author=C.C.%20Pennil&amp;volume=20&amp;publication_year=2014&amp;pages=764-775&amp;pmid=24240112&amp;doi=10.1158/1078-0432.CCR-13-2287&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45-genes-11-00856">
<span class="label">45.</span><cite>Park J.S., Lee S.-T., Nam E.J., Han J.W., Lee J.-Y., Kim J., Kim T.I., Park H.S. Variants of cancer susceptibility genes in Korean BRCA1/2 mutation-negative patients with high risk for hereditary breast cancer. BMC Cancer. 2018;18:83.  doi: 10.1186/s12885-017-3940-y.</cite> [<a href="https://doi.org/10.1186/s12885-017-3940-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5769462/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29338689/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Variants%20of%20cancer%20susceptibility%20genes%20in%20Korean%20BRCA1/2%20mutation-negative%20patients%20with%20high%20risk%20for%20hereditary%20breast%20cancer&amp;author=J.S.%20Park&amp;author=S.-T.%20Lee&amp;author=E.J.%20Nam&amp;author=J.W.%20Han&amp;author=J.-Y.%20Lee&amp;volume=18&amp;publication_year=2018&amp;pages=83&amp;pmid=29338689&amp;doi=10.1186/s12885-017-3940-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46-genes-11-00856">
<span class="label">46.</span><cite>González-Rivera M., Lobo M., López-Tarruella S., Jerez Y., Del Monte-Millán M., Massarrah T., Ramos-Medina R., Ocaña I., Picornell A., Santillán Garzón S., et al.  Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial. Breast Cancer Res. Treat. 2016;156:507–515. doi: 10.1007/s10549-016-3792-1.</cite> [<a href="https://doi.org/10.1007/s10549-016-3792-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27083178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Frequency%20of%20germline%20DNA%20genetic%20findings%20in%20an%20unselected%20prospective%20cohort%20of%20triple-negative%20breast%20cancer%20patients%20participating%20in%20a%20platinum-based%20neoadjuvant%20chemotherapy%20trial&amp;author=M.%20Gonz%C3%A1lez-Rivera&amp;author=M.%20Lobo&amp;author=S.%20L%C3%B3pez-Tarruella&amp;author=Y.%20Jerez&amp;author=M.%20Del%20Monte-Mill%C3%A1n&amp;volume=156&amp;publication_year=2016&amp;pages=507-515&amp;pmid=27083178&amp;doi=10.1007/s10549-016-3792-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47-genes-11-00856">
<span class="label">47.</span><cite>Corredor J., Woodson A.H., Gutierrez Barrera A., Arun B. Multigene panel testing results in patients with multiple breast cancer primaries. Breast J. 2020;26:1337–1342. doi: 10.1111/tbj.13762.</cite> [<a href="https://doi.org/10.1111/tbj.13762" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31999039/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20J.&amp;title=Multigene%20panel%20testing%20results%20in%20patients%20with%20multiple%20breast%20cancer%20primaries&amp;author=J.%20Corredor&amp;author=A.H.%20Woodson&amp;author=A.%20Gutierrez%20Barrera&amp;author=B.%20Arun&amp;volume=26&amp;publication_year=2020&amp;pages=1337-1342&amp;pmid=31999039&amp;doi=10.1111/tbj.13762&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48-genes-11-00856">
<span class="label">48.</span><cite>Ng P.S., Wen W.X., Fadlullah M.Z.H., Yoon S.Y., Lee S.Y., Thong M.K., Yip C.H., Mohd Taib N.A., Teo S.H. Identification of germline alterations in breast cancer predisposition genes among Malaysian breast cancer patients using panel testing. Clin. Genet. 2016;90:315–323. doi: 10.1111/cge.12735.</cite> [<a href="https://doi.org/10.1111/cge.12735" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26757417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Genet.&amp;title=Identification%20of%20germline%20alterations%20in%20breast%20cancer%20predisposition%20genes%20among%20Malaysian%20breast%20cancer%20patients%20using%20panel%20testing&amp;author=P.S.%20Ng&amp;author=W.X.%20Wen&amp;author=M.Z.H.%20Fadlullah&amp;author=S.Y.%20Yoon&amp;author=S.Y.%20Lee&amp;volume=90&amp;publication_year=2016&amp;pages=315-323&amp;pmid=26757417&amp;doi=10.1111/cge.12735&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49-genes-11-00856">
<span class="label">49.</span><cite>Lolas Hamameh S., Renbaum P., Kamal L., Dweik D., Salahat M., Jaraysa T., Abu Rayyan A., Casadei S., Mandell J.B., Gulsuner S., et al.  Genomic analysis of inherited breast cancer among Palestinian women: Genetic heterogeneity and a founder mutation in TP53. Int. J. Cancer. 2017;141:750–756. doi: 10.1002/ijc.30771.</cite> [<a href="https://doi.org/10.1002/ijc.30771" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5526459/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28486781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cancer&amp;title=Genomic%20analysis%20of%20inherited%20breast%20cancer%20among%20Palestinian%20women:%20Genetic%20heterogeneity%20and%20a%20founder%20mutation%20in%20TP53&amp;author=S.%20Lolas%20Hamameh&amp;author=P.%20Renbaum&amp;author=L.%20Kamal&amp;author=D.%20Dweik&amp;author=M.%20Salahat&amp;volume=141&amp;publication_year=2017&amp;pages=750-756&amp;pmid=28486781&amp;doi=10.1002/ijc.30771&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50-genes-11-00856">
<span class="label">50.</span><cite>Li J., Meeks H., Feng B.-J., Healey S., Thorne H., Makunin I., Ellis J., Campbell I., Southey M., Mitchell G., et al.  Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families. J. Med. Genet. 2016;53:34–42. doi: 10.1136/jmedgenet-2015-103452.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2015-103452" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4915734/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26534844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Targeted%20massively%20parallel%20sequencing%20of%20a%20panel%20of%20putative%20breast%20cancer%20susceptibility%20genes%20in%20a%20large%20cohort%20of%20multiple-case%20breast%20and%20ovarian%20cancer%20families&amp;author=J.%20Li&amp;author=H.%20Meeks&amp;author=B.-J.%20Feng&amp;author=S.%20Healey&amp;author=H.%20Thorne&amp;volume=53&amp;publication_year=2016&amp;pages=34-42&amp;pmid=26534844&amp;doi=10.1136/jmedgenet-2015-103452&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51-genes-11-00856">
<span class="label">51.</span><cite>Crawford B., Adams S.B., Sittler T., van den Akker J., Chan S., Leitner O., Ryan L., Gil E., van ’t Veer L. Multi-Gene panel testing for hereditary cancer predisposition in unsolved high-risk breast and ovarian cancer patients. Breast Cancer Res. Treat. 2017;163:383–390. doi: 10.1007/s10549-017-4181-0.</cite> [<a href="https://doi.org/10.1007/s10549-017-4181-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5410210/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28281021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Multi-Gene%20panel%20testing%20for%20hereditary%20cancer%20predisposition%20in%20unsolved%20high-risk%20breast%20and%20ovarian%20cancer%20patients&amp;author=B.%20Crawford&amp;author=S.B.%20Adams&amp;author=T.%20Sittler&amp;author=J.%20van%20den%20Akker&amp;author=S.%20Chan&amp;volume=163&amp;publication_year=2017&amp;pages=383-390&amp;pmid=28281021&amp;doi=10.1007/s10549-017-4181-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B52-genes-11-00856">
<span class="label">52.</span><cite>Silva Carvalho S.D.C.E., Cury N.M., Brotto D.B., de Araujo L.F., Rosa R.C.A., Texeira L.A., Plaça J.R., Marques A.A., Peronni K.C., de Cássia Ruy P., et al.  Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: Analysis of a 21 gene panel in the Brazilian population. BMC Med. Genom. 2020;13:21.  doi: 10.1186/s12920-019-0652-y.</cite> [<a href="https://doi.org/10.1186/s12920-019-0652-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7011249/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32039725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med.%20Genom.&amp;title=Germline%20variants%20in%20DNA%20repair%20genes%20associated%20with%20hereditary%20breast%20and%20ovarian%20cancer%20syndrome:%20Analysis%20of%20a%2021%20gene%20panel%20in%20the%20Brazilian%20population&amp;author=S.D.C.E.%20Silva%20Carvalho&amp;author=N.M.%20Cury&amp;author=D.B.%20Brotto&amp;author=L.F.%20de%20Araujo&amp;author=R.C.A.%20Rosa&amp;volume=13&amp;publication_year=2020&amp;pages=21&amp;pmid=32039725&amp;doi=10.1186/s12920-019-0652-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B53-genes-11-00856">
<span class="label">53.</span><cite>Amemiya Y., Bacopulos S., Al-Shawarby M., Al-Tamimi D., Naser W., Ahmed A., Khalifa M., Slodkowska E., Seth A. A comparative analysis of breast and ovarian cancer-related gene mutations in canadian and saudi arabian patients with breast cancer. Anticancer Res. 2015;35:2601–2610.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/25964535/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer%20Res.&amp;title=A%20comparative%20analysis%20of%20breast%20and%20ovarian%20cancer-related%20gene%20mutations%20in%20canadian%20and%20saudi%20arabian%20patients%20with%20breast%20cancer&amp;author=Y.%20Amemiya&amp;author=S.%20Bacopulos&amp;author=M.%20Al-Shawarby&amp;author=D.%20Al-Tamimi&amp;author=W.%20Naser&amp;volume=35&amp;publication_year=2015&amp;pages=2601-2610&amp;pmid=25964535&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B54-genes-11-00856">
<span class="label">54.</span><cite>Rodríguez-Balada M., Roig B., Melé M., Albacar C., Serrano S., Salvat M., Querol M., Borràs J., Martorell L., Gumà J. Identification of germline pathogenic variants in DNA damage repair genes by a next-generation sequencing multigene panel in BRCAX patients. Clin. Biochem. 2020;76:17–23. doi: 10.1016/j.clinbiochem.2019.11.014.</cite> [<a href="https://doi.org/10.1016/j.clinbiochem.2019.11.014" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31786208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Biochem.&amp;title=Identification%20of%20germline%20pathogenic%20variants%20in%20DNA%20damage%20repair%20genes%20by%20a%20next-generation%20sequencing%20multigene%20panel%20in%20BRCAX%20patients&amp;author=M.%20Rodr%C3%ADguez-Balada&amp;author=B.%20Roig&amp;author=M.%20Mel%C3%A9&amp;author=C.%20Albacar&amp;author=S.%20Serrano&amp;volume=76&amp;publication_year=2020&amp;pages=17-23&amp;pmid=31786208&amp;doi=10.1016/j.clinbiochem.2019.11.014&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B55-genes-11-00856">
<span class="label">55.</span><cite>Slavin T.P., Maxwell K.N., Lilyquist J., Vijai J., Neuhausen S.L., Hart S.N., Ravichandran V., Thomas T., Maria A., Villano D., et al.  The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk. NPJ Breast Cancer. 2017;3:22. doi: 10.1038/s41523-017-0024-8.</cite> [<a href="https://doi.org/10.1038/s41523-017-0024-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5466608/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28649662/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NPJ%20Breast%20Cancer&amp;title=The%20contribution%20of%20pathogenic%20variants%20in%20breast%20cancer%20susceptibility%20genes%20to%20familial%20breast%20cancer%20risk&amp;author=T.P.%20Slavin&amp;author=K.N.%20Maxwell&amp;author=J.%20Lilyquist&amp;author=J.%20Vijai&amp;author=S.L.%20Neuhausen&amp;volume=3&amp;publication_year=2017&amp;pages=22&amp;pmid=28649662&amp;doi=10.1038/s41523-017-0024-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B56-genes-11-00856">
<span class="label">56.</span><cite>Castéra L., Krieger S., Rousselin A., Legros A., Baumann J.-J., Bruet O., Brault B., Fouillet R., Goardon N., Letac O., et al.  Next-Generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes. Eur. J. Hum. Genet. 2014;22:1305–1313. doi: 10.1038/ejhg.2014.16.</cite> [<a href="https://doi.org/10.1038/ejhg.2014.16" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4200427/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24549055/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur.%20J.%20Hum.%20Genet.&amp;title=Next-Generation%20sequencing%20for%20the%20diagnosis%20of%20hereditary%20breast%20and%20ovarian%20cancer%20using%20genomic%20capture%20targeting%20multiple%20candidate%20genes&amp;author=L.%20Cast%C3%A9ra&amp;author=S.%20Krieger&amp;author=A.%20Rousselin&amp;author=A.%20Legros&amp;author=J.-J.%20Baumann&amp;volume=22&amp;publication_year=2014&amp;pages=1305-1313&amp;pmid=24549055&amp;doi=10.1038/ejhg.2014.16&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B57-genes-11-00856">
<span class="label">57.</span><cite>Adedokun B., Zheng Y., Ndom P., Gakwaya A., Makumbi T., Zhou A.Y., Yoshimatsu T.F., Rodriguez A., Madduri R.K., Foster I.T., et al.  Prevalence of inherited mutations in breast cancer predisposition genes among women in uganda and cameroon. Cancer Epidemiol. Biomark. Prev. 2020;29:359–367. doi: 10.1158/1055-9965.EPI-19-0506.</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-19-0506" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7007381/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31871109/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol.%20Biomark.%20Prev.&amp;title=Prevalence%20of%20inherited%20mutations%20in%20breast%20cancer%20predisposition%20genes%20among%20women%20in%20uganda%20and%20cameroon&amp;author=B.%20Adedokun&amp;author=Y.%20Zheng&amp;author=P.%20Ndom&amp;author=A.%20Gakwaya&amp;author=T.%20Makumbi&amp;volume=29&amp;publication_year=2020&amp;pages=359-367&amp;pmid=31871109&amp;doi=10.1158/1055-9965.EPI-19-0506&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B58-genes-11-00856">
<span class="label">58.</span><cite>Li J.-Y., Jing R., Wei H., Wang M., Xiaowei Q., Liu H., Jian L., Ou J.-H., Jiang W.-H., Tian F.-G., et al.  Germline mutations in 40 cancer susceptibility genes among Chinese patients with high hereditary risk breast cancer. Int. J. Cancer. 2019;144:281–289. doi: 10.1002/ijc.31601.</cite> [<a href="https://doi.org/10.1002/ijc.31601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29752822/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cancer&amp;title=Germline%20mutations%20in%2040%20cancer%20susceptibility%20genes%20among%20Chinese%20patients%20with%20high%20hereditary%20risk%20breast%20cancer&amp;author=J.-Y.%20Li&amp;author=R.%20Jing&amp;author=H.%20Wei&amp;author=M.%20Wang&amp;author=Q.%20Xiaowei&amp;volume=144&amp;publication_year=2019&amp;pages=281-289&amp;pmid=29752822&amp;doi=10.1002/ijc.31601&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B59-genes-11-00856">
<span class="label">59.</span><cite>Young E.L., Feng B.J., Stark A.W., Damiola F., Durand G., Forey N., Francy T.C., Gammon A., Kohlmann W.K., Kaphingst K.A., et al.  Multigene testing of moderate-risk genes: Be mindful of the missense. J. Med. Genet. 2016;53:366–376. doi: 10.1136/jmedgenet-2015-103398.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2015-103398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4893078/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26787654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Multigene%20testing%20of%20moderate-risk%20genes:%20Be%20mindful%20of%20the%20missense&amp;author=E.L.%20Young&amp;author=B.J.%20Feng&amp;author=A.W.%20Stark&amp;author=F.%20Damiola&amp;author=G.%20Durand&amp;volume=53&amp;publication_year=2016&amp;pages=366-376&amp;pmid=26787654&amp;doi=10.1136/jmedgenet-2015-103398&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B60-genes-11-00856">
<span class="label">60.</span><cite>Bonache S., Esteban I., Moles-Fernández A., Tenés A., Duran-Lozano L., Montalban G., Bach V., Carrasco E., Gadea N., López-Fernández A., et al.  Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings. J. Cancer Res. Clin. Oncol. 2018;144:2495–2513. doi: 10.1007/s00432-018-2763-9.</cite> [<a href="https://doi.org/10.1007/s00432-018-2763-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11813382/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30306255/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cancer%20Res.%20Clin.%20Oncol.&amp;title=Multigene%20panel%20testing%20beyond%20BRCA1/2%20in%20breast/ovarian%20cancer%20Spanish%20families%20and%20clinical%20actionability%20of%20findings&amp;author=S.%20Bonache&amp;author=I.%20Esteban&amp;author=A.%20Moles-Fern%C3%A1ndez&amp;author=A.%20Ten%C3%A9s&amp;author=L.%20Duran-Lozano&amp;volume=144&amp;publication_year=2018&amp;pages=2495-2513&amp;pmid=30306255&amp;doi=10.1007/s00432-018-2763-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B61-genes-11-00856">
<span class="label">61.</span><cite>Scarpitta R., Zanna I., Aretini P., Gambino G., Scatena C., Mei B., Ghilli M., Rossetti E., Roncella M., Congregati C., et al.  Germline investigation in male breast cancer of DNA repair genes by next-generation sequencing. Breast Cancer Res. Treat. 2019;178:557–564. doi: 10.1007/s10549-019-05429-z.</cite> [<a href="https://doi.org/10.1007/s10549-019-05429-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31512090/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Germline%20investigation%20in%20male%20breast%20cancer%20of%20DNA%20repair%20genes%20by%20next-generation%20sequencing&amp;author=R.%20Scarpitta&amp;author=I.%20Zanna&amp;author=P.%20Aretini&amp;author=G.%20Gambino&amp;author=C.%20Scatena&amp;volume=178&amp;publication_year=2019&amp;pages=557-564&amp;pmid=31512090&amp;doi=10.1007/s10549-019-05429-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B62-genes-11-00856">
<span class="label">62.</span><cite>Kaur R.P., Kumar V., Shafi G., Vashistha R., Kulharia M., Munshi A. A study of mechanistic mapping of novel SNPs to male breast cancer. Med. Oncol. 2019;36:70. doi: 10.1007/s12032-019-1290-0.</cite> [<a href="https://doi.org/10.1007/s12032-019-1290-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31203460/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Med.%20Oncol.&amp;title=A%20study%20of%20mechanistic%20mapping%20of%20novel%20SNPs%20to%20male%20breast%20cancer&amp;author=R.P.%20Kaur&amp;author=V.%20Kumar&amp;author=G.%20Shafi&amp;author=R.%20Vashistha&amp;author=M.%20Kulharia&amp;volume=36&amp;publication_year=2019&amp;pages=70&amp;pmid=31203460&amp;doi=10.1007/s12032-019-1290-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B63-genes-11-00856">
<span class="label">63.</span><cite>Arvai K.J., Roberts M.E., Torene R.I., Susswein L.R., Marshall M.L., Zhang Z., Carter N.J., Yackowski L., Rinella E.S., Klein R.T., et al.  Age-Adjusted association of homologous recombination genes with ovarian cancer using clinical exomes as controls. Hered. Cancer Clin. Pract. 2019;17:19. doi: 10.1186/s13053-019-0119-3.</cite> [<a href="https://doi.org/10.1186/s13053-019-0119-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6631909/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31341520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hered.%20Cancer%20Clin.%20Pract.&amp;title=Age-Adjusted%20association%20of%20homologous%20recombination%20genes%20with%20ovarian%20cancer%20using%20clinical%20exomes%20as%20controls&amp;author=K.J.%20Arvai&amp;author=M.E.%20Roberts&amp;author=R.I.%20Torene&amp;author=L.R.%20Susswein&amp;author=M.L.%20Marshall&amp;volume=17&amp;publication_year=2019&amp;pages=19&amp;pmid=31341520&amp;doi=10.1186/s13053-019-0119-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B64-genes-11-00856">
<span class="label">64.</span><cite>Cybulski C., Kluźniak W., Huzarski T., Wokołorczyk D., Kashyap A., Rusak B., Stempa K., Gronwald J., Szymiczek A., Bagherzadeh M., et al.  The spectrum of mutations predisposing to familial breast cancer in Poland. Int. J. Cancer. 2019;145:3311–3320. doi: 10.1002/ijc.32492.</cite> [<a href="https://doi.org/10.1002/ijc.32492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31173646/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cancer&amp;title=The%20spectrum%20of%20mutations%20predisposing%20to%20familial%20breast%20cancer%20in%20Poland&amp;author=C.%20Cybulski&amp;author=W.%20Klu%C5%BAniak&amp;author=T.%20Huzarski&amp;author=D.%20Woko%C5%82orczyk&amp;author=A.%20Kashyap&amp;volume=145&amp;publication_year=2019&amp;pages=3311-3320&amp;pmid=31173646&amp;doi=10.1002/ijc.32492&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B65-genes-11-00856">
<span class="label">65.</span><cite>Zeng C., Guo X., Wen W., Shi J., Long J., Cai Q., Shu X.-O., Xiang Y., Zheng W. Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women. Breast Cancer Res. Treat. 2020;181:465–473. doi: 10.1007/s10549-020-05643-0.</cite> [<a href="https://doi.org/10.1007/s10549-020-05643-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7188717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32318955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Evaluation%20of%20pathogenetic%20mutations%20in%20breast%20cancer%20predisposition%20genes%20in%20population-based%20studies%20conducted%20among%20Chinese%20women&amp;author=C.%20Zeng&amp;author=X.%20Guo&amp;author=W.%20Wen&amp;author=J.%20Shi&amp;author=J.%20Long&amp;volume=181&amp;publication_year=2020&amp;pages=465-473&amp;pmid=32318955&amp;doi=10.1007/s10549-020-05643-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B66-genes-11-00856">
<span class="label">66.</span><cite>Shahi R.B., De Brakeleer S., Caljon B., Pauwels I., Bonduelle M., Joris S., Fontaine C., Vanhoeij M., Van Dooren S., Teugels E., et al.  Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families. BMC Cancer. 2019;19:313.  doi: 10.1186/s12885-019-5494-7.</cite> [<a href="https://doi.org/10.1186/s12885-019-5494-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6449945/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30947698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Identification%20of%20candidate%20cancer%20predisposing%20variants%20by%20performing%20whole-exome%20sequencing%20on%20index%20patients%20from%20BRCA1%20and%20BRCA2-negative%20breast%20cancer%20families&amp;author=R.B.%20Shahi&amp;author=S.%20De%20Brakeleer&amp;author=B.%20Caljon&amp;author=I.%20Pauwels&amp;author=M.%20Bonduelle&amp;volume=19&amp;publication_year=2019&amp;pages=313&amp;pmid=30947698&amp;doi=10.1186/s12885-019-5494-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B67-genes-11-00856">
<span class="label">67.</span><cite>Torrezan G.T., de Almeida F.G.D.S.R., Figueiredo M.C.P., de Figueiredo Barros B.D., de Paula C.A.A., Valieris R., de Souza J.E.S., Ramalho R.F., da Silva F.C.C., Ferreira E.N., et al.  Complex landscape of germline variants in brazilian patients with hereditary and early onset breast cancer. Front. Genet. 2018;9:161. doi: 10.3389/fgene.2018.00161.</cite> [<a href="https://doi.org/10.3389/fgene.2018.00161" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5949367/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29868112/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Genet.&amp;title=Complex%20landscape%20of%20germline%20variants%20in%20brazilian%20patients%20with%20hereditary%20and%20early%20onset%20breast%20cancer&amp;author=G.T.%20Torrezan&amp;author=F.G.D.S.R.%20de%20Almeida&amp;author=M.C.P.%20Figueiredo&amp;author=B.D.%20de%20Figueiredo%20Barros&amp;author=C.A.A.%20de%20Paula&amp;volume=9&amp;publication_year=2018&amp;pages=161&amp;pmid=29868112&amp;doi=10.3389/fgene.2018.00161&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B68-genes-11-00856">
<span class="label">68.</span><cite>Rouleau E., Jesson B., Briaux A., Nogues C., Chabaud V., Demange L., Sokolowska J., Coulet F., Barouk-Simonet E., Bignon Y.J., et al.  Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition. Breast Cancer Res. Treat. 2012;133:1179–1190. doi: 10.1007/s10549-012-2009-5.</cite> [<a href="https://doi.org/10.1007/s10549-012-2009-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22476849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Rare%20germline%20large%20rearrangements%20in%20the%20BRCA1/2%20genes%20and%20eight%20candidate%20genes%20in%20472%20patients%20with%20breast%20cancer%20predisposition&amp;author=E.%20Rouleau&amp;author=B.%20Jesson&amp;author=A.%20Briaux&amp;author=C.%20Nogues&amp;author=V.%20Chabaud&amp;volume=133&amp;publication_year=2012&amp;pages=1179-1190&amp;pmid=22476849&amp;doi=10.1007/s10549-012-2009-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B69-genes-11-00856">
<span class="label">69.</span><cite>Esteban-Jurado C., Vila-Casadesús M., Garre P., Lozano J.J., Pristoupilova A., Beltran S., Muñoz J., Ocaña T., Balaguer F., López-Cerón M., et al.  Whole-Exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer. Genet. Med. 2015;17:131–142. doi: 10.1038/gim.2014.89.</cite> [<a href="https://doi.org/10.1038/gim.2014.89" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4318970/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25058500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Whole-Exome%20sequencing%20identifies%20rare%20pathogenic%20variants%20in%20new%20predisposition%20genes%20for%20familial%20colorectal%20cancer&amp;author=C.%20Esteban-Jurado&amp;author=M.%20Vila-Casades%C3%BAs&amp;author=P.%20Garre&amp;author=J.J.%20Lozano&amp;author=A.%20Pristoupilova&amp;volume=17&amp;publication_year=2015&amp;pages=131-142&amp;pmid=25058500&amp;doi=10.1038/gim.2014.89&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B70-genes-11-00856">
<span class="label">70.</span><cite>Ring K.L., Bruegl A.S., Allen B.A., Elkin E.P., Singh N., Hartman A.-R., Daniels M.S., Broaddus R.R. Germline multi-gene hereditary cancer panel testing in an unselected endometrial cancer cohort. Mod. Pathol. 2016;29:1381–1389. doi: 10.1038/modpathol.2016.135.</cite> [<a href="https://doi.org/10.1038/modpathol.2016.135" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5541389/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27443514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mod.%20Pathol.&amp;title=Germline%20multi-gene%20hereditary%20cancer%20panel%20testing%20in%20an%20unselected%20endometrial%20cancer%20cohort&amp;author=K.L.%20Ring&amp;author=A.S.%20Bruegl&amp;author=B.A.%20Allen&amp;author=E.P.%20Elkin&amp;author=N.%20Singh&amp;volume=29&amp;publication_year=2016&amp;pages=1381-1389&amp;pmid=27443514&amp;doi=10.1038/modpathol.2016.135&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B71-genes-11-00856">
<span class="label">71.</span><cite>Chaffee K.G., Oberg A.L., McWilliams R.R., Majithia N., Allen B.A., Kidd J., Singh N., Hartman A.-R., Wenstrup R.J., Petersen G.M. Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history. Genet. Med. 2018;20:119–127. doi: 10.1038/gim.2017.85.</cite> [<a href="https://doi.org/10.1038/gim.2017.85" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5760284/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28726808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Prevalence%20of%20germ-line%20mutations%20in%20cancer%20genes%20among%20pancreatic%20cancer%20patients%20with%20a%20positive%20family%20history&amp;author=K.G.%20Chaffee&amp;author=A.L.%20Oberg&amp;author=R.R.%20McWilliams&amp;author=N.%20Majithia&amp;author=B.A.%20Allen&amp;volume=20&amp;publication_year=2018&amp;pages=119-127&amp;pmid=28726808&amp;doi=10.1038/gim.2017.85&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B72-genes-11-00856">
<span class="label">72.</span><cite>Hu C., Hart S.N., Bamlet W.R., Moore R.M., Nandakumar K., Eckloff B.W., Lee Y.K., Petersen G.M., McWilliams R.R., Couch F.J. Prevalence of pathogenic mutations in cancer predisposition genes among pancreatic cancer patients. Cancer Epidemiol. Biomark. Prev. 2016;25:207–211. doi: 10.1158/1055-9965.EPI-15-0455.</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-15-0455" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4754121/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26483394/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol.%20Biomark.%20Prev.&amp;title=Prevalence%20of%20pathogenic%20mutations%20in%20cancer%20predisposition%20genes%20among%20pancreatic%20cancer%20patients&amp;author=C.%20Hu&amp;author=S.N.%20Hart&amp;author=W.R.%20Bamlet&amp;author=R.M.%20Moore&amp;author=K.%20Nandakumar&amp;volume=25&amp;publication_year=2016&amp;pages=207-211&amp;pmid=26483394&amp;doi=10.1158/1055-9965.EPI-15-0455&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B73-genes-11-00856">
<span class="label">73.</span><cite>Meynard G., Mansi L., Lebahar P., Villanueva C., Klajer E., Calcagno F., Vivalta A., Chaix M., Collonge-Rame M.-A., Populaire C., et al.  First description of a double heterozygosity for BRCA1 and BRCA2 pathogenic variants in a French metastatic breast cancer patient: A case report. Oncol. Rep. 2017;37:1573–1578. doi: 10.3892/or.2017.5422.</cite> [<a href="https://doi.org/10.3892/or.2017.5422" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28184945/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol.%20Rep.&amp;title=First%20description%20of%20a%20double%20heterozygosity%20for%20BRCA1%20and%20BRCA2%20pathogenic%20variants%20in%20a%20French%20metastatic%20breast%20cancer%20patient:%20A%20case%20report&amp;author=G.%20Meynard&amp;author=L.%20Mansi&amp;author=P.%20Lebahar&amp;author=C.%20Villanueva&amp;author=E.%20Klajer&amp;volume=37&amp;publication_year=2017&amp;pages=1573-1578&amp;pmid=28184945&amp;doi=10.3892/or.2017.5422&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B74-genes-11-00856">
<span class="label">74.</span><cite>Palmirotta R., Lovero D., Stucci L.S., Silvestris E., Quaresmini D., Cardascia A., Silvestris F. Double heterozygosity for BRCA1 pathogenic variant and BRCA2 polymorphic stop codon K3326X: A case report in a Southern Italian family. Int. J. Mol. Sci. 2018;19:285.  doi: 10.3390/ijms19010285.</cite> [<a href="https://doi.org/10.3390/ijms19010285" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5796231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29346284/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Double%20heterozygosity%20for%20BRCA1%20pathogenic%20variant%20and%20BRCA2%20polymorphic%20stop%20codon%20K3326X:%20A%20case%20report%20in%20a%20Southern%20Italian%20family&amp;author=R.%20Palmirotta&amp;author=D.%20Lovero&amp;author=L.S.%20Stucci&amp;author=E.%20Silvestris&amp;author=D.%20Quaresmini&amp;volume=19&amp;publication_year=2018&amp;pages=285&amp;pmid=29346284&amp;doi=10.3390/ijms19010285&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B75-genes-11-00856">
<span class="label">75.</span><cite>Ramus S.J., Friedman L.S., Gayther S.A., Ponder B.A., Bobrow L., van der Looji M., Papp J., Olah E. A breast/ovarian cancer patient with germline mutations in both BRCA1 and BRCA2. Nat. Genet. 1997;15:14–15. doi: 10.1038/ng0197-14.</cite> [<a href="https://doi.org/10.1038/ng0197-14" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8988162/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Genet.&amp;title=A%20breast/ovarian%20cancer%20patient%20with%20germline%20mutations%20in%20both%20BRCA1%20and%20BRCA2&amp;author=S.J.%20Ramus&amp;author=L.S.%20Friedman&amp;author=S.A.%20Gayther&amp;author=B.A.%20Ponder&amp;author=L.%20Bobrow&amp;volume=15&amp;publication_year=1997&amp;pages=14-15&amp;pmid=8988162&amp;doi=10.1038/ng0197-14&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B76-genes-11-00856">
<span class="label">76.</span><cite>Lavie O., Narod S., Lejbkowicz F., Dishon S., Goldberg Y., Gemer O., Rennert G. Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population. Ann. Oncol. 2011;22:964–966. doi: 10.1093/annonc/mdq460.</cite> [<a href="https://doi.org/10.1093/annonc/mdq460" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3065879/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20924075/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Oncol.&amp;title=Double%20heterozygosity%20in%20the%20BRCA1%20and%20BRCA2%20genes%20in%20the%20Jewish%20population&amp;author=O.%20Lavie&amp;author=S.%20Narod&amp;author=F.%20Lejbkowicz&amp;author=S.%20Dishon&amp;author=Y.%20Goldberg&amp;volume=22&amp;publication_year=2011&amp;pages=964-966&amp;pmid=20924075&amp;doi=10.1093/annonc/mdq460&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B77-genes-11-00856">
<span class="label">77.</span><cite>Friedman E., Bar-Sade Bruchim R., Kruglikova A., Risel S., Levy-Lahad E., Halle D., Bar-On E., Gershoni-Baruch R., Dagan E., Kepten I., et al.  Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes. Am. J. Hum. Genet. 1998;63:1224–1227. doi: 10.1086/302040.</cite> [<a href="https://doi.org/10.1086/302040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1377473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9758598/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Double%20heterozygotes%20for%20the%20Ashkenazi%20founder%20mutations%20in%20BRCA1%20and%20BRCA2%20genes&amp;author=E.%20Friedman&amp;author=R.%20Bar-Sade%20Bruchim&amp;author=A.%20Kruglikova&amp;author=S.%20Risel&amp;author=E.%20Levy-Lahad&amp;volume=63&amp;publication_year=1998&amp;pages=1224-1227&amp;pmid=9758598&amp;doi=10.1086/302040&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B78-genes-11-00856">
<span class="label">78.</span><cite>Le Page C., Rahimi K., Rodrigues M., Heinzelmann-Schwarz V., Recio N., Tommasi S., Bataillon G., Portelance L., Golmard L., Meunier L., et al.  Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis. Gynecol. Oncol. 2020;156:377–386. doi: 10.1016/j.ygyno.2019.11.019.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2019.11.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31753525/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol.%20Oncol.&amp;title=Clinicopathological%20features%20of%20women%20with%20epithelial%20ovarian%20cancer%20and%20double%20heterozygosity%20for%20BRCA1%20and%20BRCA2:%20A%20systematic%20review%20and%20case%20report%20analysis&amp;author=C.%20Le%20Page&amp;author=K.%20Rahimi&amp;author=M.%20Rodrigues&amp;author=V.%20Heinzelmann-Schwarz&amp;author=N.%20Recio&amp;volume=156&amp;publication_year=2020&amp;pages=377-386&amp;pmid=31753525&amp;doi=10.1016/j.ygyno.2019.11.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B79-genes-11-00856">
<span class="label">79.</span><cite>Rebbeck T.R., Mitra N., Domchek S.M., Wan F., Chuai S., Friebel T.M., Panossian S., Spurdle A., Chenevix-Trench G., Singer C.F., et al.  Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Cancer Res. 2009;69:5801–5810. doi: 10.1158/0008-5472.CAN-09-0625.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-09-0625" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2751603/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19584272/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=Modification%20of%20ovarian%20cancer%20risk%20by%20BRCA1/2-interacting%20genes%20in%20a%20multicenter%20cohort%20of%20BRCA1/2%20mutation%20carriers&amp;author=T.R.%20Rebbeck&amp;author=N.%20Mitra&amp;author=S.M.%20Domchek&amp;author=F.%20Wan&amp;author=S.%20Chuai&amp;volume=69&amp;publication_year=2009&amp;pages=5801-5810&amp;pmid=19584272&amp;doi=10.1158/0008-5472.CAN-09-0625&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B80-genes-11-00856">
<span class="label">80.</span><cite>Spurdle A.B., Marquart L., McGuffog L., Healey S., Sinilnikova O., Wan F., Chen X., Beesley J., Singer C.F., Dressler A.-C., et al.  Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Cancer Epidemiol. Biomark. Prev. 2011;20:1032–1038. doi: 10.1158/1055-9965.EPI-10-0909.</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-10-0909" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3089675/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21393566/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol.%20Biomark.%20Prev.&amp;title=Common%20genetic%20variation%20at%20BARD1%20is%20not%20associated%20with%20breast%20cancer%20risk%20in%20BRCA1%20or%20BRCA2%20mutation%20carriers&amp;author=A.B.%20Spurdle&amp;author=L.%20Marquart&amp;author=L.%20McGuffog&amp;author=S.%20Healey&amp;author=O.%20Sinilnikova&amp;volume=20&amp;publication_year=2011&amp;pages=1032-1038&amp;pmid=21393566&amp;doi=10.1158/1055-9965.EPI-10-0909&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B81-genes-11-00856">
<span class="label">81.</span><cite>Moore J.H., Williams S.M. Epistasis and its implications for personal genetics. Am. J. Hum. Genet. 2009;85:309–320. doi: 10.1016/j.ajhg.2009.08.006.</cite> [<a href="https://doi.org/10.1016/j.ajhg.2009.08.006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2771593/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19733727/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Epistasis%20and%20its%20implications%20for%20personal%20genetics&amp;author=J.H.%20Moore&amp;author=S.M.%20Williams&amp;volume=85&amp;publication_year=2009&amp;pages=309-320&amp;pmid=19733727&amp;doi=10.1016/j.ajhg.2009.08.006&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B82-genes-11-00856">
<span class="label">82.</span><cite>Gibson G. Rare and common variants: Twenty arguments. Nat. Rev. Genet. 2012;13:135–145. doi: 10.1038/nrg3118.</cite> [<a href="https://doi.org/10.1038/nrg3118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4408201/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22251874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Genet.&amp;title=Rare%20and%20common%20variants:%20Twenty%20arguments&amp;author=G.%20Gibson&amp;volume=13&amp;publication_year=2012&amp;pages=135-145&amp;pmid=22251874&amp;doi=10.1038/nrg3118&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B83-genes-11-00856">
<span class="label">83.</span><cite>Slatkin M. Exchangeable models of complex inherited diseases. Genetics. 2008;179:2253–2261. doi: 10.1534/genetics.107.077719.</cite> [<a href="https://doi.org/10.1534/genetics.107.077719" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2516095/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18689899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Exchangeable%20models%20of%20complex%20inherited%20diseases&amp;author=M.%20Slatkin&amp;volume=179&amp;publication_year=2008&amp;pages=2253-2261&amp;pmid=18689899&amp;doi=10.1534/genetics.107.077719&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B84-genes-11-00856">
<span class="label">84.</span><cite>Belanger M.H., Dolman L., Arcand S.L., Shen Z., Chong G., Mes-Masson A.-M., Provencher D., Tonin P.N. A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population. J. Ovarian Res. 2015;8:1. doi: 10.1186/s13048-015-0124-8.</cite> [<a href="https://doi.org/10.1186/s13048-015-0124-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4376165/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25884701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Ovarian%20Res.&amp;title=A%20targeted%20analysis%20identifies%20a%20high%20frequency%20of%20BRCA1%20and%20BRCA2%20mutation%20carriers%20in%20women%20with%20ovarian%20cancer%20from%20a%20founder%20population&amp;author=M.H.%20Belanger&amp;author=L.%20Dolman&amp;author=S.L.%20Arcand&amp;author=Z.%20Shen&amp;author=G.%20Chong&amp;volume=8&amp;publication_year=2015&amp;pages=1&amp;pmid=25884701&amp;doi=10.1186/s13048-015-0124-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B85-genes-11-00856">
<span class="label">85.</span><cite>Behl S., Hamel N., de Ladurantaye M., Lepage S., Lapointe R., Mes-Masson A.-M., Foulkes W.D. Founder BRCA1/BRCA2/PALB2 pathogenic variants in French-Canadian breast cancer cases and controls. Sci. Rep. 2020;10 doi: 10.1038/s41598-020-63100-w.</cite> [<a href="https://doi.org/10.1038/s41598-020-63100-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7162921/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32300229/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Founder%20BRCA1/BRCA2/PALB2%20pathogenic%20variants%20in%20French-Canadian%20breast%20cancer%20cases%20and%20controls&amp;author=S.%20Behl&amp;author=N.%20Hamel&amp;author=M.%20de%20Ladurantaye&amp;author=S.%20Lepage&amp;author=R.%20Lapointe&amp;volume=10&amp;publication_year=2020&amp;pmid=32300229&amp;doi=10.1038/s41598-020-63100-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B86-genes-11-00856">
<span class="label">86.</span><cite>Tonin P.N., Mes-Masson A.M., Futreal P.A., Morgan K., Mahon M., Foulkes W.D., Cole D.E., Provencher D., Ghadirian P., Narod S.A. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am. J. Hum. Genet. 1998;63:1341–1351. doi: 10.1086/302099.</cite> [<a href="https://doi.org/10.1086/302099" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1377544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9792861/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Founder%20BRCA1%20and%20BRCA2%20mutations%20in%20French%20Canadian%20breast%20and%20ovarian%20cancer%20families&amp;author=P.N.%20Tonin&amp;author=A.M.%20Mes-Masson&amp;author=P.A.%20Futreal&amp;author=K.%20Morgan&amp;author=M.%20Mahon&amp;volume=63&amp;publication_year=1998&amp;pages=1341-1351&amp;pmid=9792861&amp;doi=10.1086/302099&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B87-genes-11-00856">
<span class="label">87.</span><cite>Tonin P.N., Mes-Masson A.-M., Narod S.A., Ghadirian P., Provencher D. Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history. Clin. Genet. 1999;55:318–324. doi: 10.1034/j.1399-0004.1999.550504.x.</cite> [<a href="https://doi.org/10.1034/j.1399-0004.1999.550504.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10422801/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Genet.&amp;title=Founder%20BRCA1%20and%20BRCA2%20mutations%20in%20French%20Canadian%20ovarian%20cancer%20cases%20unselected%20for%20family%20history&amp;author=P.N.%20Tonin&amp;author=A.-M.%20Mes-Masson&amp;author=S.A.%20Narod&amp;author=P.%20Ghadirian&amp;author=D.%20Provencher&amp;volume=55&amp;publication_year=1999&amp;pages=318-324&amp;pmid=10422801&amp;doi=10.1034/j.1399-0004.1999.550504.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B88-genes-11-00856">
<span class="label">88.</span><cite>Tonin P.N., Perret C., Lambert J.A., Paradis A.J., Kantemiroff T., Benoît M.H., Martin G., Foulkes W.D., Ghadirian P. Founder BRCA1 and BRCA2 mutations in early-onset french Canadian breast cancer cases unselected for family history. Int. J. Cancer. 2001;95:189–193. doi: 10.1002/1097-0215(20010520)95:3&amp;#x0003c;189::AID-IJC1032&amp;#x0003e;3.0.CO;2-N.</cite> [<a href="https://doi.org/10.1002/1097-0215(20010520)95:3&amp;#x0003c;189::AID-IJC1032&amp;#x0003e;3.0.CO;2-N" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11307153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cancer&amp;title=Founder%20BRCA1%20and%20BRCA2%20mutations%20in%20early-onset%20french%20Canadian%20breast%20cancer%20cases%20unselected%20for%20family%20history&amp;author=P.N.%20Tonin&amp;author=C.%20Perret&amp;author=J.A.%20Lambert&amp;author=A.J.%20Paradis&amp;author=T.%20Kantemiroff&amp;volume=95&amp;publication_year=2001&amp;pages=189-193&amp;pmid=11307153&amp;doi=10.1002/1097-0215(20010520)95:3&amp;#x0003c;189::AID-IJC1032&amp;#x0003e;3.0.CO;2-N&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B89-genes-11-00856">
<span class="label">89.</span><cite>Oros K.K., Ghadirian P., Greenwood C.M.T., Perret C., Shen Z., Paredes Y., Arcand S.L., Mes-Masson A.M., Narod S.A., Foulkes W.D., et al.  Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations. Int. J. Cancer. 2004;112:411–419. doi: 10.1002/ijc.20406.</cite> [<a href="https://doi.org/10.1002/ijc.20406" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15382066/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Cancer&amp;title=Significant%20proportion%20of%20breast%20and/or%20ovarian%20cancer%20families%20of%20French%20Canadian%20descent%20harbor%201%20of%205%20BRCA1%20and%20BRCA2%20mutations&amp;author=K.K.%20Oros&amp;author=P.%20Ghadirian&amp;author=C.M.T.%20Greenwood&amp;author=C.%20Perret&amp;author=Z.%20Shen&amp;volume=112&amp;publication_year=2004&amp;pages=411-419&amp;pmid=15382066&amp;doi=10.1002/ijc.20406&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B90-genes-11-00856">
<span class="label">90.</span><cite>Tischkowitz M., Sabbaghian N., Hamel N., Pouchet C., Foulkes W.D., Mes-Masson A.-M., Provencher D.M., Tonin P.N. Contribution of the PALB2 c.2323C&gt;T [p. Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent. BMC Med. Genet. 2013;14:5.  doi: 10.1186/1471-2350-14-5.</cite> [<a href="https://doi.org/10.1186/1471-2350-14-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3549741/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23302520/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med.%20Genet.&amp;title=Contribution%20of%20the%20PALB2%20c.2323C&gt;T%20%5Bp.%20Q775X%5D%20Founder%20mutation%20in%20well-defined%20breast%20and/or%20ovarian%20cancer%20families%20and%20unselected%20ovarian%20cancer%20cases%20of%20French%20Canadian%20descent&amp;author=M.%20Tischkowitz&amp;author=N.%20Sabbaghian&amp;author=N.%20Hamel&amp;author=C.%20Pouchet&amp;author=W.D.%20Foulkes&amp;volume=14&amp;publication_year=2013&amp;pages=5&amp;pmid=23302520&amp;doi=10.1186/1471-2350-14-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B91-genes-11-00856">
<span class="label">91.</span><cite>Rivera B., Di Iorio M., Frankum J., Nadaf J., Fahiminiya S., Arcand S.L., Burk D.L., Grapton D., Tomiak E., Hastings V., et al.  Functionally null RAD51D missense mutation associates strongly with ovarian carcinoma. Cancer Res. 2017;77:4517–4529. doi: 10.1158/0008-5472.CAN-17-0190.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-17-0190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28646019/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=Functionally%20null%20RAD51D%20missense%20mutation%20associates%20strongly%20with%20ovarian%20carcinoma&amp;author=B.%20Rivera&amp;author=M.%20Di%20Iorio&amp;author=J.%20Frankum&amp;author=J.%20Nadaf&amp;author=S.%20Fahiminiya&amp;volume=77&amp;publication_year=2017&amp;pages=4517-4529&amp;pmid=28646019&amp;doi=10.1158/0008-5472.CAN-17-0190&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B92-genes-11-00856">
<span class="label">92.</span><cite>Castellsagué E., Liu J., Volenik A., Giroux S., Gagné R., Maranda B., Roussel-Jobin A., Latrielle J., Laframboise R., Palma L., et al.  Characterization of a novel founder MSH6 mutation causing Lynch syndrome in the French Canadian population. Clin. Genet. 2015;87:536–542. doi: 10.1111/cge.12526.</cite> [<a href="https://doi.org/10.1111/cge.12526" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25318681/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Genet.&amp;title=Characterization%20of%20a%20novel%20founder%20MSH6%20mutation%20causing%20Lynch%20syndrome%20in%20the%20French%20Canadian%20population&amp;author=E.%20Castellsagu%C3%A9&amp;author=J.%20Liu&amp;author=A.%20Volenik&amp;author=S.%20Giroux&amp;author=R.%20Gagn%C3%A9&amp;volume=87&amp;publication_year=2015&amp;pages=536-542&amp;pmid=25318681&amp;doi=10.1111/cge.12526&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B93-genes-11-00856">
<span class="label">93.</span><cite>Fierheller C.T., Guitton-Sert L., Alenezi W.M., Revil T., Oros K.K., Bedard K., Arcand S.L., Serruya C., Behl S., Meunier L., et al.  The genetic analysis of a founder Northern American population of European descent identifies FANCI as a candidate familial ovarian cancer risk gene. medRxiv. 2020 doi: 10.1101/2020.05.04.20090407.</cite> [<a href="https://doi.org/10.1101/2020.05.04.20090407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=medRxiv&amp;title=The%20genetic%20analysis%20of%20a%20founder%20Northern%20American%20population%20of%20European%20descent%20identifies%20FANCI%20as%20a%20candidate%20familial%20ovarian%20cancer%20risk%20gene&amp;author=C.T.%20Fierheller&amp;author=L.%20Guitton-Sert&amp;author=W.M.%20Alenezi&amp;author=T.%20Revil&amp;author=K.K.%20Oros&amp;publication_year=2020&amp;doi=10.1101/2020.05.04.20090407&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B94-genes-11-00856">
<span class="label">94.</span><cite>Jin Y., Xu X.L., Yang M.C., Wei F., Ayi T.C., Bowcock A.M., Baer R. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc. Natl. Acad. Sci. USA. 1997;94:12075–12080. doi: 10.1073/pnas.94.22.12075.</cite> [<a href="https://doi.org/10.1073/pnas.94.22.12075" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC23707/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9342365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=Cell%20cycle-dependent%20colocalization%20of%20BARD1%20and%20BRCA1%20proteins%20in%20discrete%20nuclear%20domains&amp;author=Y.%20Jin&amp;author=X.L.%20Xu&amp;author=M.C.%20Yang&amp;author=F.%20Wei&amp;author=T.C.%20Ayi&amp;volume=94&amp;publication_year=1997&amp;pages=12075-12080&amp;pmid=9342365&amp;doi=10.1073/pnas.94.22.12075&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B95-genes-11-00856">
<span class="label">95.</span><cite>Irminger-Finger I., Soriano J.V., Vaudan G., Montesano R., Sappino A.P. In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells. J. Cell Biol. 1998;143:1329–1339. doi: 10.1083/jcb.143.5.1329.</cite> [<a href="https://doi.org/10.1083/jcb.143.5.1329" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2133073/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9832560/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cell%20Biol.&amp;title=In%20vitro%20repression%20of%20Brca1-associated%20RING%20domain%20gene,%20Bard1,%20induces%20phenotypic%20changes%20in%20mammary%20epithelial%20cells&amp;author=I.%20Irminger-Finger&amp;author=J.V.%20Soriano&amp;author=G.%20Vaudan&amp;author=R.%20Montesano&amp;author=A.P.%20Sappino&amp;volume=143&amp;publication_year=1998&amp;pages=1329-1339&amp;pmid=9832560&amp;doi=10.1083/jcb.143.5.1329&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B96-genes-11-00856">
<span class="label">96.</span><cite>Cimmino F., Formicola D., Capasso M. Dualistic role of BARD1 in cancer. Genes (Basel) 2017;8:375.  doi: 10.3390/genes8120375.</cite> [<a href="https://doi.org/10.3390/genes8120375" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5748693/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29292755/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genes%20(Basel)&amp;title=Dualistic%20role%20of%20BARD1%20in%20cancer&amp;author=F.%20Cimmino&amp;author=D.%20Formicola&amp;author=M.%20Capasso&amp;volume=8&amp;publication_year=2017&amp;pages=375&amp;pmid=29292755&amp;doi=10.3390/genes8120375&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B97-genes-11-00856">
<span class="label">97.</span><cite>Bell D., Berchuck A., Birrer M., Chien J., Cramer D.W., Dao F., Dhir R., Disaia P., Gabra H., Glenn P., et al.  Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609–615. doi: 10.1038/nature10166.Integrated.</cite> [<a href="https://doi.org/10.1038/nature10166.Integrated" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3163504/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21720365/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Integrated%20genomic%20analyses%20of%20ovarian%20carcinoma&amp;author=D.%20Bell&amp;author=A.%20Berchuck&amp;author=M.%20Birrer&amp;author=J.%20Chien&amp;author=D.W.%20Cramer&amp;volume=474&amp;publication_year=2011&amp;pages=609-615&amp;pmid=21720365&amp;doi=10.1038/nature10166.Integrated&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B98-genes-11-00856">
<span class="label">98.</span><cite>Koboldt D.C., Fulton R.S., McLellan M.D., Schmidt H., Kalicki-Veizer J., McMichael J.F., Fulton L.L., Dooling D.J., Ding L., Mardis E.R., et al.  Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61–70. doi: 10.1038/nature11412.</cite> [<a href="https://doi.org/10.1038/nature11412" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3465532/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23000897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Comprehensive%20molecular%20portraits%20of%20human%20breast%20tumours&amp;author=D.C.%20Koboldt&amp;author=R.S.%20Fulton&amp;author=M.D.%20McLellan&amp;author=H.%20Schmidt&amp;author=J.%20Kalicki-Veizer&amp;volume=490&amp;publication_year=2012&amp;pages=61-70&amp;pmid=23000897&amp;doi=10.1038/nature11412&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B99-genes-11-00856">
<span class="label">99.</span><cite>Zack T.I., Schumacher S.E., Carter S.L., Cherniack A.D., Saksena G., Tabak B., Lawrence M.S., Zhang C.Z., Wala J., Mermel C.H., et al.  Pan-Cancer patterns of somatic copy number alteration. Nat. Genet. 2013;45:1134–1140. doi: 10.1038/ng.2760.</cite> [<a href="https://doi.org/10.1038/ng.2760" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3966983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24071852/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Genet.&amp;title=Pan-Cancer%20patterns%20of%20somatic%20copy%20number%20alteration&amp;author=T.I.%20Zack&amp;author=S.E.%20Schumacher&amp;author=S.L.%20Carter&amp;author=A.D.%20Cherniack&amp;author=G.%20Saksena&amp;volume=45&amp;publication_year=2013&amp;pages=1134-1140&amp;pmid=24071852&amp;doi=10.1038/ng.2760&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B100-genes-11-00856">
<span class="label">100.</span><cite>Campbell P.J., Getz G., Korbel J.O., Stuart J.M., Jennings J.L., Stein L.D., Perry M.D., Nahal-Bose H.K., Ouellette B.F.F., Li C.H., et al.  Pan-Cancer analysis of whole genomes. Nature. 2020;578:82–93. doi: 10.1038/s41586-020-1969-6.</cite> [<a href="https://doi.org/10.1038/s41586-020-1969-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7025898/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32025007/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Pan-Cancer%20analysis%20of%20whole%20genomes&amp;author=P.J.%20Campbell&amp;author=G.%20Getz&amp;author=J.O.%20Korbel&amp;author=J.M.%20Stuart&amp;author=J.L.%20Jennings&amp;volume=578&amp;publication_year=2020&amp;pages=82-93&amp;pmid=32025007&amp;doi=10.1038/s41586-020-1969-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B101-genes-11-00856">
<span class="label">101.</span><cite>McCarthy E.E., Celebi J.T., Baer R., Ludwig T. Loss of Bard1, the heterodimeric partner of the brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability. Mol. Cell. Biol. 2003;23:5056–5063. doi: 10.1128/MCB.23.14.5056-5063.2003.</cite> [<a href="https://doi.org/10.1128/MCB.23.14.5056-5063.2003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC162231/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12832489/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell.%20Biol.&amp;title=Loss%20of%20Bard1,%20the%20heterodimeric%20partner%20of%20the%20brca1%20tumor%20suppressor,%20results%20in%20early%20embryonic%20lethality%20and%20chromosomal%20instability&amp;author=E.E.%20McCarthy&amp;author=J.T.%20Celebi&amp;author=R.%20Baer&amp;author=T.%20Ludwig&amp;volume=23&amp;publication_year=2003&amp;pages=5056-5063&amp;pmid=12832489&amp;doi=10.1128/MCB.23.14.5056-5063.2003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B102-genes-11-00856">
<span class="label">102.</span><cite>Shakya R., Szabolcs M., McCarthy E., Ospina E., Basso K., Nandula S., Murty V., Baer R., Ludwig T. The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression. Proc. Natl. Acad. Sci. USA. 2008;105:7040–7045. doi: 10.1073/pnas.0711032105.</cite> [<a href="https://doi.org/10.1073/pnas.0711032105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2365565/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18443292/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=The%20basal-like%20mammary%20carcinomas%20induced%20by%20Brca1%20or%20Bard1%20inactivation%20implicate%20the%20BRCA1/BARD1%20heterodimer%20in%20tumor%20suppression&amp;author=R.%20Shakya&amp;author=M.%20Szabolcs&amp;author=E.%20McCarthy&amp;author=E.%20Ospina&amp;author=K.%20Basso&amp;volume=105&amp;publication_year=2008&amp;pages=7040-7045&amp;pmid=18443292&amp;doi=10.1073/pnas.0711032105&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B103-genes-11-00856">
<span class="label">103.</span><cite>Ayi T.C., Tsan J.T., Hwang L.Y., Bowcock A.M., Baer R. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein. Oncogene. 1998;17:2143–2148. doi: 10.1038/sj.onc.1202123.</cite> [<a href="https://doi.org/10.1038/sj.onc.1202123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9798686/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Conservation%20of%20function%20and%20primary%20structure%20in%20the%20BRCA1-associated%20RING%20domain%20(BARD1)%20protein&amp;author=T.C.%20Ayi&amp;author=J.T.%20Tsan&amp;author=L.Y.%20Hwang&amp;author=A.M.%20Bowcock&amp;author=R.%20Baer&amp;volume=17&amp;publication_year=1998&amp;pages=2143-2148&amp;pmid=9798686&amp;doi=10.1038/sj.onc.1202123&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B104-genes-11-00856">
<span class="label">104.</span><cite>Fox D., III, Le Trong I., Rajagopal P., Brzovic P.S., Stenkamp R.E., Klevit R.E. Crystal structure of the BARD1 ankyrin repeat domain and its functional consequences. J. Biol. Chem. 2008;283:21179–21186. doi: 10.1074/jbc.M802333200.</cite> [<a href="https://doi.org/10.1074/jbc.M802333200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2475683/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18480049/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Crystal%20structure%20of%20the%20BARD1%20ankyrin%20repeat%20domain%20and%20its%20functional%20consequences&amp;author=D.%20Fox&amp;author=I.%20Le%20Trong&amp;author=P.%20Rajagopal&amp;author=P.S.%20Brzovic&amp;author=R.E.%20Stenkamp&amp;volume=283&amp;publication_year=2008&amp;pages=21179-21186&amp;pmid=18480049&amp;doi=10.1074/jbc.M802333200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B105-genes-11-00856">
<span class="label">105.</span><cite>Tarsounas M., Sung P. The antitumorigenic roles of BRCA1–BARD1 in DNA repair and replication. Nat. Rev. Mol. Cell Biol. 2020;21:284–299. doi: 10.1038/s41580-020-0218-z.</cite> [<a href="https://doi.org/10.1038/s41580-020-0218-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7204409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32094664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Mol.%20Cell%20Biol.&amp;title=The%20antitumorigenic%20roles%20of%20BRCA1%E2%80%93BARD1%20in%20DNA%20repair%20and%20replication&amp;author=M.%20Tarsounas&amp;author=P.%20Sung&amp;volume=21&amp;publication_year=2020&amp;pages=284-299&amp;pmid=32094664&amp;doi=10.1038/s41580-020-0218-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B106-genes-11-00856">
<span class="label">106.</span><cite>Meza J.E., Brzovic P.S., King M.C., Klevit R.E. Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1. J. Biol. Chem. 1999;274:5659–5665. doi: 10.1074/jbc.274.9.5659.</cite> [<a href="https://doi.org/10.1074/jbc.274.9.5659" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10026184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Mapping%20the%20functional%20domains%20of%20BRCA1.%20Interaction%20of%20the%20ring%20finger%20domains%20of%20BRCA1%20and%20BARD1&amp;author=J.E.%20Meza&amp;author=P.S.%20Brzovic&amp;author=M.C.%20King&amp;author=R.E.%20Klevit&amp;volume=274&amp;publication_year=1999&amp;pages=5659-5665&amp;pmid=10026184&amp;doi=10.1074/jbc.274.9.5659&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B107-genes-11-00856">
<span class="label">107.</span><cite>Brzovic P.S., Rajagopal P., Hoyt D.W., King M.C., Klevit R.E. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat. Struct. Biol. 2001;8:833–837. doi: 10.1038/nsb1001-833.</cite> [<a href="https://doi.org/10.1038/nsb1001-833" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11573085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Struct.%20Biol.&amp;title=Structure%20of%20a%20BRCA1-BARD1%20heterodimeric%20RING-RING%20complex&amp;author=P.S.%20Brzovic&amp;author=P.%20Rajagopal&amp;author=D.W.%20Hoyt&amp;author=M.C.%20King&amp;author=R.E.%20Klevit&amp;volume=8&amp;publication_year=2001&amp;pages=833-837&amp;pmid=11573085&amp;doi=10.1038/nsb1001-833&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B108-genes-11-00856">
<span class="label">108.</span><cite>Joukov V., Chen J., Fox E.A., Green J.B., Livingston D.M. Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development. Proc. Natl. Acad. Sci. USA. 2001;98:12078–12083. doi: 10.1073/pnas.211427098.</cite> [<a href="https://doi.org/10.1073/pnas.211427098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC59770/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11593018/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=Functional%20communication%20between%20endogenous%20BRCA1%20and%20its%20partner,%20BARD1,%20during%20Xenopus%20laevis%20development&amp;author=V.%20Joukov&amp;author=J.%20Chen&amp;author=E.A.%20Fox&amp;author=J.B.%20Green&amp;author=D.M.%20Livingston&amp;volume=98&amp;publication_year=2001&amp;pages=12078-12083&amp;pmid=11593018&amp;doi=10.1073/pnas.211427098&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B109-genes-11-00856">
<span class="label">109.</span><cite>Choudhury A.D., Xu H., Baer R. Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression. J. Biol. Chem. 2004;279:33909–33918. doi: 10.1074/jbc.M403646200.</cite> [<a href="https://doi.org/10.1074/jbc.M403646200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15166217/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Ubiquitination%20and%20proteasomal%20degradation%20of%20the%20BRCA1%20tumor%20suppressor%20is%20regulated%20during%20cell%20cycle%20progression&amp;author=A.D.%20Choudhury&amp;author=H.%20Xu&amp;author=R.%20Baer&amp;volume=279&amp;publication_year=2004&amp;pages=33909-33918&amp;pmid=15166217&amp;doi=10.1074/jbc.M403646200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B110-genes-11-00856">
<span class="label">110.</span><cite>Lorick K.L., Jensen J.P., Fang S., Ong A.M., Hatakeyama S., Weissman A.M. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc. Natl. Acad. Sci. USA. 1999;96:11364–11369. doi: 10.1073/pnas.96.20.11364.</cite> [<a href="https://doi.org/10.1073/pnas.96.20.11364" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC18039/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10500182/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=RING%20fingers%20mediate%20ubiquitin-conjugating%20enzyme%20(E2)-dependent%20ubiquitination&amp;author=K.L.%20Lorick&amp;author=J.P.%20Jensen&amp;author=S.%20Fang&amp;author=A.M.%20Ong&amp;author=S.%20Hatakeyama&amp;volume=96&amp;publication_year=1999&amp;pages=11364-11369&amp;pmid=10500182&amp;doi=10.1073/pnas.96.20.11364&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B111-genes-11-00856">
<span class="label">111.</span><cite>Buetow L., Huang D.T. Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2016;17:626–642. doi: 10.1038/nrm.2016.91.</cite> [<a href="https://doi.org/10.1038/nrm.2016.91" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6211636/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27485899/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Mol.%20Cell%20Biol.&amp;title=Structural%20insights%20into%20the%20catalysis%20and%20regulation%20of%20E3%20ubiquitin%20ligases&amp;author=L.%20Buetow&amp;author=D.T.%20Huang&amp;volume=17&amp;publication_year=2016&amp;pages=626-642&amp;pmid=27485899&amp;doi=10.1038/nrm.2016.91&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B112-genes-11-00856">
<span class="label">112.</span><cite>Senft D., Qi J., Ronai Z.A. Ubiquitin ligases in oncogenic transformation and cancer therapy. Nat. Rev. Cancer. 2018;18:69–88. doi: 10.1038/nrc.2017.105.</cite> [<a href="https://doi.org/10.1038/nrc.2017.105" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6054770/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29242641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Cancer&amp;title=Ubiquitin%20ligases%20in%20oncogenic%20transformation%20and%20cancer%20therapy&amp;author=D.%20Senft&amp;author=J.%20Qi&amp;author=Z.A.%20Ronai&amp;volume=18&amp;publication_year=2018&amp;pages=69-88&amp;pmid=29242641&amp;doi=10.1038/nrc.2017.105&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B113-genes-11-00856">
<span class="label">113.</span><cite>Hashizume R., Fukuda M., Maeda I., Nishikawa H., Oyake D., Yabuki Y., Ogata H., Ohta T. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J. Biol. Chem. 2001;276:14537–14540. doi: 10.1074/jbc.C000881200.</cite> [<a href="https://doi.org/10.1074/jbc.C000881200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11278247/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=The%20RING%20heterodimer%20BRCA1-BARD1%20is%20a%20ubiquitin%20ligase%20inactivated%20by%20a%20breast%20cancer-derived%20mutation&amp;author=R.%20Hashizume&amp;author=M.%20Fukuda&amp;author=I.%20Maeda&amp;author=H.%20Nishikawa&amp;author=D.%20Oyake&amp;volume=276&amp;publication_year=2001&amp;pages=14537-14540&amp;pmid=11278247&amp;doi=10.1074/jbc.C000881200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B114-genes-11-00856">
<span class="label">114.</span><cite>Ruffner H., Joazeiro C.A.P., Hemmati D., Hunter T., Verma I.M. Cancer-Predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc. Natl. Acad. Sci. USA. 2001;98:5134–5139. doi: 10.1073/pnas.081068398.</cite> [<a href="https://doi.org/10.1073/pnas.081068398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC33176/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11320250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA.&amp;title=Cancer-Predisposing%20mutations%20within%20the%20RING%20domain%20of%20BRCA1:%20Loss%20of%20ubiquitin%20protein%20ligase%20activity%20and%20protection%20from%20radiation%20hypersensitivity&amp;author=H.%20Ruffner&amp;author=C.A.P.%20Joazeiro&amp;author=D.%20Hemmati&amp;author=T.%20Hunter&amp;author=I.M.%20Verma&amp;volume=98&amp;publication_year=2001&amp;pages=5134-5139&amp;pmid=11320250&amp;doi=10.1073/pnas.081068398&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B115-genes-11-00856">
<span class="label">115.</span><cite>Brzovic P.S., Keeffe J.R., Nishikawa H., Miyamoto K., Fox D., III, Fukuda M., Ohta T., Klevit R. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc. Natl. Acad. Sci. USA. 2003;100:5646–5651. doi: 10.1073/pnas.0836054100.</cite> [<a href="https://doi.org/10.1073/pnas.0836054100" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC156255/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12732733/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=Binding%20and%20recognition%20in%20the%20assembly%20of%20an%20active%20BRCA1/BARD1%20ubiquitin-ligase%20complex&amp;author=P.S.%20Brzovic&amp;author=J.R.%20Keeffe&amp;author=H.%20Nishikawa&amp;author=K.%20Miyamoto&amp;author=D.%20Fox&amp;volume=100&amp;publication_year=2003&amp;pages=5646-5651&amp;pmid=12732733&amp;doi=10.1073/pnas.0836054100&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B116-genes-11-00856">
<span class="label">116.</span><cite>Brzovic P.S., Meza J.E., King M.C., Klevit R.E. BRCA1 RING domain cancer-predisposing mutations. Structural consequences and effects on protein-protein interactions. J. Biol. Chem. 2001;276:41399–41406. doi: 10.1074/jbc.M106551200.</cite> [<a href="https://doi.org/10.1074/jbc.M106551200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11526114/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=BRCA1%20RING%20domain%20cancer-predisposing%20mutations.%20Structural%20consequences%20and%20effects%20on%20protein-protein%20interactions&amp;author=P.S.%20Brzovic&amp;author=J.E.%20Meza&amp;author=M.C.%20King&amp;author=R.E.%20Klevit&amp;volume=276&amp;publication_year=2001&amp;pages=41399-41406&amp;pmid=11526114&amp;doi=10.1074/jbc.M106551200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B117-genes-11-00856">
<span class="label">117.</span><cite>Stewart M.D., Zelin E., Dhall A., Walsh T., Upadhyay E., Corn J.E., Chatterjee C., King M.-C., Klevit R.E. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes. Proc. Natl. Acad. Sci. USA. 2018;115:1316–1321. doi: 10.1073/pnas.1715467115.</cite> [<a href="https://doi.org/10.1073/pnas.1715467115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5819413/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29367421/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=BARD1%20is%20necessary%20for%20ubiquitylation%20of%20nucleosomal%20histone%20H2A%20and%20for%20transcriptional%20regulation%20of%20estrogen%20metabolism%20genes&amp;author=M.D.%20Stewart&amp;author=E.%20Zelin&amp;author=A.%20Dhall&amp;author=T.%20Walsh&amp;author=E.%20Upadhyay&amp;volume=115&amp;publication_year=2018&amp;pages=1316-1321&amp;pmid=29367421&amp;doi=10.1073/pnas.1715467115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B118-genes-11-00856">
<span class="label">118.</span><cite>Adamovich A.I., Banerjee T., Wingo M., Duncan K., Ning J., Martins Rodrigues F., Huang K.-L., Lee C., Chen F., Ding L., et al.  Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity. PLoS Genet. 2019;15:e1008049.  doi: 10.1371/journal.pgen.1008049.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1008049" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6457558/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30925164/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet.&amp;title=Functional%20analysis%20of%20BARD1%20missense%20variants%20in%20homology-directed%20repair%20and%20damage%20sensitivity&amp;author=A.I.%20Adamovich&amp;author=T.%20Banerjee&amp;author=M.%20Wingo&amp;author=K.%20Duncan&amp;author=J.%20Ning&amp;volume=15&amp;publication_year=2019&amp;pages=e1008049&amp;pmid=30925164&amp;doi=10.1371/journal.pgen.1008049&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B119-genes-11-00856">
<span class="label">119.</span><cite>Irminger-Finger I., Jefford C.E. Is there more to BARD1 than BRCA1? Nat. Rev. Cancer. 2006;6:382–391. doi: 10.1038/nrc1878.</cite> [<a href="https://doi.org/10.1038/nrc1878" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16633366/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Cancer&amp;title=Is%20there%20more%20to%20BARD1%20than%20BRCA1?&amp;author=I.%20Irminger-Finger&amp;author=C.E.%20Jefford&amp;volume=6&amp;publication_year=2006&amp;pages=382-391&amp;pmid=16633366&amp;doi=10.1038/nrc1878&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B120-genes-11-00856">
<span class="label">120.</span><cite>Nakamura K., Saredi G., Becker J.R., Foster B.M., Nguyen N.V., Beyer T.E., Cesa L.C., Faull P.A., Lukauskas S., Frimurer T., et al.  H4K20me0 recognition by BRCA1–BARD1 directs homologous recombination to sister chromatids. Nat. Cell Biol. 2019;21:311–318. doi: 10.1038/s41556-019-0282-9.</cite> [<a href="https://doi.org/10.1038/s41556-019-0282-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6420097/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30804502/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Cell%20Biol.&amp;title=H4K20me0%20recognition%20by%20BRCA1%E2%80%93BARD1%20directs%20homologous%20recombination%20to%20sister%20chromatids&amp;author=K.%20Nakamura&amp;author=G.%20Saredi&amp;author=J.R.%20Becker&amp;author=B.M.%20Foster&amp;author=N.V.%20Nguyen&amp;volume=21&amp;publication_year=2019&amp;pages=311-318&amp;pmid=30804502&amp;doi=10.1038/s41556-019-0282-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B121-genes-11-00856">
<span class="label">121.</span><cite>Tsuzuki M., Wu W., Nishikawa H., Hayami R., Oyake D., Yabuki Y., Fukuda M., Ohta T. A truncated splice variant of human BARD1 that lacks the RING finger and ankyrin repeats. Cancer Lett. 2006;233:108–116. doi: 10.1016/j.canlet.2005.03.012.</cite> [<a href="https://doi.org/10.1016/j.canlet.2005.03.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15878232/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Lett.&amp;title=A%20truncated%20splice%20variant%20of%20human%20BARD1%20that%20lacks%20the%20RING%20finger%20and%20ankyrin%20repeats&amp;author=M.%20Tsuzuki&amp;author=W.%20Wu&amp;author=H.%20Nishikawa&amp;author=R.%20Hayami&amp;author=D.%20Oyake&amp;volume=233&amp;publication_year=2006&amp;pages=108-116&amp;pmid=15878232&amp;doi=10.1016/j.canlet.2005.03.012&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B122-genes-11-00856">
<span class="label">122.</span><cite>Ratajska M., Matusiak M., Kuzniacka A., Wasag B., Brozek I., Biernat W., Koczkowska M., Debniak J., Sniadecki M., Kozlowski P., et al.  Cancer predisposing BARD1 mutations affect exon skipping and are associated with overexpression of specific BARD1 isoforms. Oncol. Rep. 2015;34:2609–2617. doi: 10.3892/or.2015.4235.</cite> [<a href="https://doi.org/10.3892/or.2015.4235" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26329992/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol.%20Rep.&amp;title=Cancer%20predisposing%20BARD1%20mutations%20affect%20exon%20skipping%20and%20are%20associated%20with%20overexpression%20of%20specific%20BARD1%20isoforms&amp;author=M.%20Ratajska&amp;author=M.%20Matusiak&amp;author=A.%20Kuzniacka&amp;author=B.%20Wasag&amp;author=I.%20Brozek&amp;volume=34&amp;publication_year=2015&amp;pages=2609-2617&amp;pmid=26329992&amp;doi=10.3892/or.2015.4235&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B123-genes-11-00856">
<span class="label">123.</span><cite>Billing D., Horiguchi M., Wu-Baer F., Taglialatela A., Leuzzi G., Nanez S.A., Jiang W., Zha S., Szabolcs M., Lin C.-S., et al.  The BRCT domains of the BRCA1 and BARD1 tumor suppressors differentially regulate homology-directed repair and stalled fork protection. Mol. Cell. 2018;72:127–139.e8. doi: 10.1016/j.molcel.2018.08.016.</cite> [<a href="https://doi.org/10.1016/j.molcel.2018.08.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6347115/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30244837/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell&amp;title=The%20BRCT%20domains%20of%20the%20BRCA1%20and%20BARD1%20tumor%20suppressors%20differentially%20regulate%20homology-directed%20repair%20and%20stalled%20fork%20protection&amp;author=D.%20Billing&amp;author=M.%20Horiguchi&amp;author=F.%20Wu-Baer&amp;author=A.%20Taglialatela&amp;author=G.%20Leuzzi&amp;volume=72&amp;publication_year=2018&amp;pages=127-139.e8&amp;pmid=30244837&amp;doi=10.1016/j.molcel.2018.08.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B124-genes-11-00856">
<span class="label">124.</span><cite>Li M., Yu X. Function of BRCA1 in the DNA damage response is mediated by ADP-ribosylation. Cancer Cell. 2013;23:693–704. doi: 10.1016/j.ccr.2013.03.025.</cite> [<a href="https://doi.org/10.1016/j.ccr.2013.03.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3759356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23680151/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Cell&amp;title=Function%20of%20BRCA1%20in%20the%20DNA%20damage%20response%20is%20mediated%20by%20ADP-ribosylation&amp;author=M.%20Li&amp;author=X.%20Yu&amp;volume=23&amp;publication_year=2013&amp;pages=693-704&amp;pmid=23680151&amp;doi=10.1016/j.ccr.2013.03.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B125-genes-11-00856">
<span class="label">125.</span><cite>Choudhary R.K., Siddiqui M.Q., Thapa P.S., Gadewal N., Nachimuthu S.K., Varma A.K. Structural basis to stabilize the domain motion of BARD1-ARD BRCT by CstF50. Sci. Rep. 2017;7:3849. doi: 10.1038/s41598-017-03816-4.</cite> [<a href="https://doi.org/10.1038/s41598-017-03816-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5478621/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28634376/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Structural%20basis%20to%20stabilize%20the%20domain%20motion%20of%20BARD1-ARD%20BRCT%20by%20CstF50&amp;author=R.K.%20Choudhary&amp;author=M.Q.%20Siddiqui&amp;author=P.S.%20Thapa&amp;author=N.%20Gadewal&amp;author=S.K.%20Nachimuthu&amp;volume=7&amp;publication_year=2017&amp;pages=3849&amp;pmid=28634376&amp;doi=10.1038/s41598-017-03816-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B126-genes-11-00856">
<span class="label">126.</span><cite>Laufer M., Nandula S.V., Modi A.P., Wang S., Jasin M., Murty V.V.V.S., Ludwig T., Baer R. Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair. J. Biol. Chem. 2007;282:34325–34333. doi: 10.1074/jbc.M705198200.</cite> [<a href="https://doi.org/10.1074/jbc.M705198200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17848578/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Structural%20requirements%20for%20the%20BARD1%20tumor%20suppressor%20in%20chromosomal%20stability%20and%20homology-directed%20DNA%20repair&amp;author=M.%20Laufer&amp;author=S.V.%20Nandula&amp;author=A.P.%20Modi&amp;author=S.%20Wang&amp;author=M.%20Jasin&amp;volume=282&amp;publication_year=2007&amp;pages=34325-34333&amp;pmid=17848578&amp;doi=10.1074/jbc.M705198200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B127-genes-11-00856">
<span class="label">127.</span><cite>Irminger-Finger I., Leung W.-C., Li J., Dubois-Dauphin M., Harb J., Feki A., Jefford C.E., Soriano J.V., Jaconi M., Montesano R., et al.  Identification of BARD1 as Mediator between proapoptotic stress and p53-Dependent apoptosis. Mol. Cell. 2001;8:1255–1266. doi: 10.1016/S1097-2765(01)00406-3.</cite> [<a href="https://doi.org/10.1016/S1097-2765(01)00406-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11779501/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell&amp;title=Identification%20of%20BARD1%20as%20Mediator%20between%20proapoptotic%20stress%20and%20p53-Dependent%20apoptosis&amp;author=I.%20Irminger-Finger&amp;author=W.-C.%20Leung&amp;author=J.%20Li&amp;author=M.%20Dubois-Dauphin&amp;author=J.%20Harb&amp;volume=8&amp;publication_year=2001&amp;pages=1255-1266&amp;pmid=11779501&amp;doi=10.1016/S1097-2765(01)00406-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B128-genes-11-00856">
<span class="label">128.</span><cite>Kleiman F.E., Manley J.L. The BARD1-CstF-50 interaction links mRNA 3′ end formation to DNA damage and tumor suppression. Cell. 2001;104:743–753. doi: 10.1016/S0092-8674(01)00270-7.</cite> [<a href="https://doi.org/10.1016/S0092-8674(01)00270-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11257228/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=The%20BARD1-CstF-50%20interaction%20links%20mRNA%203%E2%80%B2%20end%20formation%20to%20DNA%20damage%20and%20tumor%20suppression&amp;author=F.E.%20Kleiman&amp;author=J.L.%20Manley&amp;volume=104&amp;publication_year=2001&amp;pages=743-753&amp;pmid=11257228&amp;doi=10.1016/S0092-8674(01)00270-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B129-genes-11-00856">
<span class="label">129.</span><cite>Lee C., Banerjee T., Gillespie J., Ceravolo A., Parvinsmith M.R., Starita L.M., Fields S., Toland A.E., Parvin J.D. Functional analysis of BARD1 missense variants in homology-directed repair of DNA double strand breaks. Hum. Mutat. 2015;36:1205–1214. doi: 10.1002/humu.22902.</cite> [<a href="https://doi.org/10.1002/humu.22902" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6005381/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26350354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Functional%20analysis%20of%20BARD1%20missense%20variants%20in%20homology-directed%20repair%20of%20DNA%20double%20strand%20breaks&amp;author=C.%20Lee&amp;author=T.%20Banerjee&amp;author=J.%20Gillespie&amp;author=A.%20Ceravolo&amp;author=M.R.%20Parvinsmith&amp;volume=36&amp;publication_year=2015&amp;pages=1205-1214&amp;pmid=26350354&amp;doi=10.1002/humu.22902&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B130-genes-11-00856">
<span class="label">130.</span><cite>Casadei S., Gulsuner S., Shirts B.H., Mandell J.B., Kortbawi H.M., Norquist B.S., Swisher E.M., Lee M.K., Goldberg Y., O’Connor R., et al.  Characterization of splice-altering mutations in inherited predisposition to cancer. Proc. Natl. Acad. Sci. USA. 2019;116:26798–26807. doi: 10.1073/pnas.1915608116.</cite> [<a href="https://doi.org/10.1073/pnas.1915608116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6936554/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31843900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=Characterization%20of%20splice-altering%20mutations%20in%20inherited%20predisposition%20to%20cancer&amp;author=S.%20Casadei&amp;author=S.%20Gulsuner&amp;author=B.H.%20Shirts&amp;author=J.B.%20Mandell&amp;author=H.M.%20Kortbawi&amp;volume=116&amp;publication_year=2019&amp;pages=26798-26807&amp;pmid=31843900&amp;doi=10.1073/pnas.1915608116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B131-genes-11-00856">
<span class="label">131.</span><cite>Yoshino Y., Qi H., Fujita H., Shirota M., Abe S., Komiyama Y., Shindo K., Nakayama M., Matsuzawa A., Kobayashi A., et al.  BRCA1-Interacting Protein OLA1 requires interaction with BARD1 to regulate centrosome number. Mol. Cancer Res. 2018;16:1499–1511. doi: 10.1158/1541-7786.MCR-18-0269.</cite> [<a href="https://doi.org/10.1158/1541-7786.MCR-18-0269" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29858377/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cancer%20Res.&amp;title=BRCA1-Interacting%20Protein%20OLA1%20requires%20interaction%20with%20BARD1%20to%20regulate%20centrosome%20number&amp;author=Y.%20Yoshino&amp;author=H.%20Qi&amp;author=H.%20Fujita&amp;author=M.%20Shirota&amp;author=S.%20Abe&amp;volume=16&amp;publication_year=2018&amp;pages=1499-1511&amp;pmid=29858377&amp;doi=10.1158/1541-7786.MCR-18-0269&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B132-genes-11-00856">
<span class="label">132.</span><cite>Chen H., Cohen P., Chen S. How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Commun. Stat. Simul. Comput. 2010;39:860–864. doi: 10.1080/03610911003650383.</cite> [<a href="https://doi.org/10.1080/03610911003650383" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Commun.%20Stat.%20Simul.%20Comput.&amp;title=How%20big%20is%20a%20big%20odds%20ratio?%20Interpreting%20the%20magnitudes%20of%20odds%20ratios%20in%20epidemiological%20studies&amp;author=H.%20Chen&amp;author=P.%20Cohen&amp;author=S.%20Chen&amp;volume=39&amp;publication_year=2010&amp;pages=860-864&amp;doi=10.1080/03610911003650383&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B133-genes-11-00856">
<span class="label">133.</span><cite>Liu J., Cristea M.C., Frankel P., Neuhausen S.L., Steele L., Engelstaedter V., Matulonis U., Sand S., Tung N., Garber J.E., et al.  Clinical characteristics and outcomes of BRCA-associated ovarian cancer: Genotype and survival. Cancer Genet. 2012;205:34–41. doi: 10.1016/j.cancergen.2012.01.008.</cite> [<a href="https://doi.org/10.1016/j.cancergen.2012.01.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3337330/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22429596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Genet.&amp;title=Clinical%20characteristics%20and%20outcomes%20of%20BRCA-associated%20ovarian%20cancer:%20Genotype%20and%20survival&amp;author=J.%20Liu&amp;author=M.C.%20Cristea&amp;author=P.%20Frankel&amp;author=S.L.%20Neuhausen&amp;author=L.%20Steele&amp;volume=205&amp;publication_year=2012&amp;pages=34-41&amp;pmid=22429596&amp;doi=10.1016/j.cancergen.2012.01.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B134-genes-11-00856">
<span class="label">134.</span><cite>Suszynska M., Klonowska K., Jasinska A.J., Kozlowski P. Large-Scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes—Providing evidence of cancer predisposition genes. Gynecol. Oncol. 2019;153:452–462. doi: 10.1016/j.ygyno.2019.01.027.</cite> [<a href="https://doi.org/10.1016/j.ygyno.2019.01.027" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30733081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gynecol.%20Oncol.&amp;title=Large-Scale%20meta-analysis%20of%20mutations%20identified%20in%20panels%20of%20breast/ovarian%20cancer-related%20genes%E2%80%94Providing%20evidence%20of%20cancer%20predisposition%20genes&amp;author=M.%20Suszynska&amp;author=K.%20Klonowska&amp;author=A.J.%20Jasinska&amp;author=P.%20Kozlowski&amp;volume=153&amp;publication_year=2019&amp;pages=452-462&amp;pmid=30733081&amp;doi=10.1016/j.ygyno.2019.01.027&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B135-genes-11-00856">
<span class="label">135.</span><cite>Ding D.-P., Zhang Y., Ma W.-L., He X.-F., Wang W., Yu H.-L., Guo Y.-B., Zheng W.-L. Lack of association between BARD1 Cys557Ser variant and breast cancer risk: A meta-analysis of 11,870 cases and 7,687 controls. J. Cancer Res. Clin. Oncol. 2011;137:1463–1468. doi: 10.1007/s00432-011-1006-0.</cite> [<a href="https://doi.org/10.1007/s00432-011-1006-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11827948/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21809034/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cancer%20Res.%20Clin.%20Oncol.&amp;title=Lack%20of%20association%20between%20BARD1%20Cys557Ser%20variant%20and%20breast%20cancer%20risk:%20A%20meta-analysis%20of%2011,870%20cases%20and%207,687%20controls&amp;author=D.-P.%20Ding&amp;author=Y.%20Zhang&amp;author=W.-L.%20Ma&amp;author=X.-F.%20He&amp;author=W.%20Wang&amp;volume=137&amp;publication_year=2011&amp;pages=1463-1468&amp;pmid=21809034&amp;doi=10.1007/s00432-011-1006-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B136-genes-11-00856">
<span class="label">136.</span><cite>Tung N.M., Boughey J.C., Pierce L.J., Robson M.E., Bedrosian I., Dietz J.R., Dragun A., Gelpi J.B., Hofstatter E.W., Isaacs C.J., et al.  Management of hereditary breast cancer: American society of clinical oncology, American society for radiation oncology, and society of surgical oncology guideline. J. Clin. Oncol. 2020;38:2080–2106. doi: 10.1200/JCO.20.00299.</cite> [<a href="https://doi.org/10.1200/JCO.20.00299" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32243226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=Management%20of%20hereditary%20breast%20cancer:%20American%20society%20of%20clinical%20oncology,%20American%20society%20for%20radiation%20oncology,%20and%20society%20of%20surgical%20oncology%20guideline&amp;author=N.M.%20Tung&amp;author=J.C.%20Boughey&amp;author=L.J.%20Pierce&amp;author=M.E.%20Robson&amp;author=I.%20Bedrosian&amp;volume=38&amp;publication_year=2020&amp;pages=2080-2106&amp;pmid=32243226&amp;doi=10.1200/JCO.20.00299&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B137-genes-11-00856">
<span class="label">137.</span><cite>Pal T., Agnese D., Daly M., La Spada A., Litton J., Wick M., Klugman S., Esplin E.D., Jarvik G.P. Points to consider: Is there evidence to support BRCA1/2 and other inherited breast cancer genetic testing for all breast cancer patients? A statement of the American College of Medical Genetics and Genomics (ACMG) Genet. Med. 2020;22:681–685. doi: 10.1038/s41436-019-0712-x.</cite> [<a href="https://doi.org/10.1038/s41436-019-0712-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31831881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Points%20to%20consider:%20Is%20there%20evidence%20to%20support%20BRCA1/2%20and%20other%20inherited%20breast%20cancer%20genetic%20testing%20for%20all%20breast%20cancer%20patients?%20A%20statement%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20(ACMG)&amp;author=T.%20Pal&amp;author=D.%20Agnese&amp;author=M.%20Daly&amp;author=A.%20La%20Spada&amp;author=J.%20Litton&amp;volume=22&amp;publication_year=2020&amp;pages=681-685&amp;pmid=31831881&amp;doi=10.1038/s41436-019-0712-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B138-genes-11-00856">
<span class="label">138.</span><cite>Plon S.E., Eccles D.M., Easton D., Foulkes W.D., Genuardi M., Greenblatt M.S., Hogervorst F.B.L., Hoogerbrugge N., Spurdle A.B., Tavtigian S.V. Sequence variant classification and reporting: Recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum. Mutat. 2008;29:1282–1291. doi: 10.1002/humu.20880.</cite> [<a href="https://doi.org/10.1002/humu.20880" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3075918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18951446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Sequence%20variant%20classification%20and%20reporting:%20Recommendations%20for%20improving%20the%20interpretation%20of%20cancer%20susceptibility%20genetic%20test%20results&amp;author=S.E.%20Plon&amp;author=D.M.%20Eccles&amp;author=D.%20Easton&amp;author=W.D.%20Foulkes&amp;author=M.%20Genuardi&amp;volume=29&amp;publication_year=2008&amp;pages=1282-1291&amp;pmid=18951446&amp;doi=10.1002/humu.20880&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B139-genes-11-00856">
<span class="label">139.</span><cite>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al.  Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 2015;17:405–424. doi: 10.1038/gim.2015.30.</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Standards%20and%20guidelines%20for%20the%20interpretation%20of%20sequence%20variants:%20A%20joint%20consensus%20recommendation%20of%20the%20American%20college%20of%20medical%20genetics%20and%20genomics%20and%20the%20association%20for%20molecular%20pathology&amp;author=S.%20Richards&amp;author=N.%20Aziz&amp;author=S.%20Bale&amp;author=D.%20Bick&amp;author=S.%20Das&amp;volume=17&amp;publication_year=2015&amp;pages=405-424&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B140-genes-11-00856">
<span class="label">140.</span><cite>Konstantinopoulos P.A., Norquist B., Lacchetti C., Armstrong D., Grisham R.N., Goodfellow P.J., Kohn E.C., Levine D.A., Liu J.F., Lu K.H., et al.  Germline and somatic tumor testing in epithelial ovarian cancer: ASCO guideline. J. Clin. Oncol. 2020;38:1222–1245. doi: 10.1200/JCO.19.02960.</cite> [<a href="https://doi.org/10.1200/JCO.19.02960" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8842911/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31986064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=Germline%20and%20somatic%20tumor%20testing%20in%20epithelial%20ovarian%20cancer:%20ASCO%20guideline&amp;author=P.A.%20Konstantinopoulos&amp;author=B.%20Norquist&amp;author=C.%20Lacchetti&amp;author=D.%20Armstrong&amp;author=R.N.%20Grisham&amp;volume=38&amp;publication_year=2020&amp;pages=1222-1245&amp;pmid=31986064&amp;doi=10.1200/JCO.19.02960&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B141-genes-11-00856">
<span class="label">141.</span><cite>Landrum M.J., Lee J.M., Benson M., Brown G.R., Chao C., Chitipiralla S., Gu B., Hart J., Hoffman D., Jang W., et al.  ClinVar: Improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46:1062–1067. doi: 10.1093/nar/gkx1153.</cite> [<a href="https://doi.org/10.1093/nar/gkx1153" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5753237/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29165669/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=ClinVar:%20Improving%20access%20to%20variant%20interpretations%20and%20supporting%20evidence&amp;author=M.J.%20Landrum&amp;author=J.M.%20Lee&amp;author=M.%20Benson&amp;author=G.R.%20Brown&amp;author=C.%20Chao&amp;volume=46&amp;publication_year=2018&amp;pages=1062-1067&amp;pmid=29165669&amp;doi=10.1093/nar/gkx1153&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B142-genes-11-00856">
<span class="label">142.</span><cite>Cline M.S., Liao R.G., Parsons M.T., Paten B., Alquaddoomi F., Antoniou A., Baxter S., Brody L., Cook-Deegan R., Coffin A., et al.  BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2. PLoS Genet. 2018;14:e1007752.  doi: 10.1371/journal.pgen.1007752.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1007752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6324924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30586411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet.&amp;title=BRCA%20Challenge:%20BRCA%20Exchange%20as%20a%20global%20resource%20for%20variants%20in%20BRCA1%20and%20BRCA2&amp;author=M.S.%20Cline&amp;author=R.G.%20Liao&amp;author=M.T.%20Parsons&amp;author=B.%20Paten&amp;author=F.%20Alquaddoomi&amp;volume=14&amp;publication_year=2018&amp;pages=e1007752&amp;pmid=30586411&amp;doi=10.1371/journal.pgen.1007752&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B143-genes-11-00856">
<span class="label">143.</span><cite>Hart S.N., Polley E.C., Yussuf A., Yadav S., Goldgar D.E., Hu C., LaDuca H., Smith L.P., Fujimoto J., Li S., et al.  Mutation prevalence tables for hereditary cancer derived from multi-gene panel testing. Hum. Mutat. 2020;92:220–225. doi: 10.1002/humu.24053.</cite> [<a href="https://doi.org/10.1002/humu.24053" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7418063/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32442341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Mutation%20prevalence%20tables%20for%20hereditary%20cancer%20derived%20from%20multi-gene%20panel%20testing&amp;author=S.N.%20Hart&amp;author=E.C.%20Polley&amp;author=A.%20Yussuf&amp;author=S.%20Yadav&amp;author=D.E.%20Goldgar&amp;volume=92&amp;publication_year=2020&amp;pages=220-225&amp;pmid=32442341&amp;doi=10.1002/humu.24053&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B144-genes-11-00856">
<span class="label">144.</span><cite>PDQ Cancer Genetics Editorial Board  . Genetics of Breast and Gynecologic Cancers (PDQ®): Health Professional Version. National Cancer Institute (US); Bethesda, MD, USA: 2020. </cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/26389210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Genetics%20of%20Breast%20and%20Gynecologic%20Cancers%20(PDQ%C2%AE):%20Health%20Professional%20Version&amp;publication_year=2020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B145-genes-11-00856">
<span class="label">145.</span><cite>Yang X., Song H., Leslie G., Engel C., Hahnen E., Auber B., Horváth J., Kast K., Niederacher D., Turnbull C., et al.  Ovarian and breast cancer risks associated with pathogenic variants in RAD51C and RAD51D. J. Natl. Cancer Inst. 2020:djaa030. doi: 10.1093/jnci/djaa030.</cite> [<a href="https://doi.org/10.1093/jnci/djaa030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7735771/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32107557/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=Ovarian%20and%20breast%20cancer%20risks%20associated%20with%20pathogenic%20variants%20in%20RAD51C%20and%20RAD51D&amp;author=X.%20Yang&amp;author=H.%20Song&amp;author=G.%20Leslie&amp;author=C.%20Engel&amp;author=E.%20Hahnen&amp;publication_year=2020&amp;pages=djaa030&amp;pmid=32107557&amp;doi=10.1093/jnci/djaa030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B146-genes-11-00856">
<span class="label">146.</span><cite>Yang X., Leslie G., Doroszuk A., Schneider S., Allen J., Decker B., Dunning A.M., Redman J., Scarth J., Plaskocinska I., et al.  Cancer risks associated with germline PALB2 pathogenic variants: An international study of 524 families. J. Clin. Oncol. 2020;38:674–685. doi: 10.1200/JCO.19.01907.</cite> [<a href="https://doi.org/10.1200/JCO.19.01907" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7049229/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31841383/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=Cancer%20risks%20associated%20with%20germline%20PALB2%20pathogenic%20variants:%20An%20international%20study%20of%20524%20families&amp;author=X.%20Yang&amp;author=G.%20Leslie&amp;author=A.%20Doroszuk&amp;author=S.%20Schneider&amp;author=J.%20Allen&amp;volume=38&amp;publication_year=2020&amp;pages=674-685&amp;pmid=31841383&amp;doi=10.1200/JCO.19.01907&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B147-genes-11-00856">
<span class="label">147.</span><cite>Meeks H.D., Song H., Michailidou K., Bolla M.K., Dennis J., Wang Q., Barrowdale D., Frost D., McGuffog L., Ellis S., et al.  BRCA2 Polymorphic Stop Codon K3326X and the risk of breast, prostate, and ovarian cancers. J. Natl. Cancer Inst. 2016;108 doi: 10.1093/jnci/djv315.</cite> [<a href="https://doi.org/10.1093/jnci/djv315" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4907358/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26586665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=BRCA2%20Polymorphic%20Stop%20Codon%20K3326X%20and%20the%20risk%20of%20breast,%20prostate,%20and%20ovarian%20cancers&amp;author=H.D.%20Meeks&amp;author=H.%20Song&amp;author=K.%20Michailidou&amp;author=M.K.%20Bolla&amp;author=J.%20Dennis&amp;volume=108&amp;publication_year=2016&amp;pmid=26586665&amp;doi=10.1093/jnci/djv315&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B148-genes-11-00856">
<span class="label">148.</span><cite>Peterlongo P., Catucci I., Colombo M., Caleca L., Mucaki E., Bogliolo M., Marin M., Damiola F., Bernard L., Pensotti V., et al.  FANCM c.5791C&gt;T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor. Hum. Mol. Genet. 2015;24:5345–5355. doi: 10.1093/hmg/ddv251.</cite> [<a href="https://doi.org/10.1093/hmg/ddv251" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4550823/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26130695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mol.%20Genet.&amp;title=FANCM%20c.5791C&gt;T%20nonsense%20mutation%20(rs144567652)%20induces%20exon%20skipping,%20affects%20DNA%20repair%20activity%20and%20is%20a%20familial%20breast%20cancer%20risk%20factor&amp;author=P.%20Peterlongo&amp;author=I.%20Catucci&amp;author=M.%20Colombo&amp;author=L.%20Caleca&amp;author=E.%20Mucaki&amp;volume=24&amp;publication_year=2015&amp;pages=5345-5355&amp;pmid=26130695&amp;doi=10.1093/hmg/ddv251&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B149-genes-11-00856">
<span class="label">149.</span><cite>Arem H., Loftfield E. Cancer epidemiology: A survey of modifiable risk factors for prevention and survivorship. Am. J. Lifestyle Med. 2018;12:200–210. doi: 10.1177/1559827617700600.</cite> [<a href="https://doi.org/10.1177/1559827617700600" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6124966/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30202392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Lifestyle%20Med.&amp;title=Cancer%20epidemiology:%20A%20survey%20of%20modifiable%20risk%20factors%20for%20prevention%20and%20survivorship&amp;author=H.%20Arem&amp;author=E.%20Loftfield&amp;volume=12&amp;publication_year=2018&amp;pages=200-210&amp;pmid=30202392&amp;doi=10.1177/1559827617700600&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B150-genes-11-00856">
<span class="label">150.</span><cite>Moorman P.G., Havrilesky L.J., Gierisch J.M., Coeytaux R.R., Lowery W.J., Urrutia R.P., Dinan M., Mcbroom A.J., Hasselblad V., Sanders G.D., et al.  Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: A systematic review and meta-analysis. J. Clin. Oncol. 2013;31:4188–4198. doi: 10.1200/JCO.2013.48.9021.</cite> [<a href="https://doi.org/10.1200/JCO.2013.48.9021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24145348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=Oral%20contraceptives%20and%20risk%20of%20ovarian%20cancer%20and%20breast%20cancer%20among%20high-risk%20women:%20A%20systematic%20review%20and%20meta-analysis&amp;author=P.G.%20Moorman&amp;author=L.J.%20Havrilesky&amp;author=J.M.%20Gierisch&amp;author=R.R.%20Coeytaux&amp;author=W.J.%20Lowery&amp;volume=31&amp;publication_year=2013&amp;pages=4188-4198&amp;pmid=24145348&amp;doi=10.1200/JCO.2013.48.9021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B151-genes-11-00856">
<span class="label">151.</span><cite>Milne R.L., Osorio A., Ramón y Cajal T., Baiget M., Lasa A., Diaz-Rubio E., de la Hoya M., Caldés T., Teulé A., Lázaro C., et al.  Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. Treat. 2010;119:221–232. doi: 10.1007/s10549-009-0394-1.</cite> [<a href="https://doi.org/10.1007/s10549-009-0394-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19370414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Parity%20and%20the%20risk%20of%20breast%20and%20ovarian%20cancer%20in%20BRCA1%20and%20BRCA2%20mutation%20carriers&amp;author=R.L.%20Milne&amp;author=A.%20Osorio&amp;author=T.%20Ram%C3%B3n%20y%20Cajal&amp;author=M.%20Baiget&amp;author=A.%20Lasa&amp;volume=119&amp;publication_year=2010&amp;pages=221-232&amp;pmid=19370414&amp;doi=10.1007/s10549-009-0394-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B152-genes-11-00856">
<span class="label">152.</span><cite>Hartmann L.C., Sellers T.A., Schaid D.J., Frank T.S., Soderberg C.L., Sitta D.L., Frost M.H., Grant C.S., Donohue J.H., Woods J.E., et al.  Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J. Natl. Cancer Inst. 2001;93:1633–1637. doi: 10.1093/jnci/93.21.1633.</cite> [<a href="https://doi.org/10.1093/jnci/93.21.1633" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11698567/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=Efficacy%20of%20bilateral%20prophylactic%20mastectomy%20in%20BRCA1%20and%20BRCA2%20gene%20mutation%20carriers&amp;author=L.C.%20Hartmann&amp;author=T.A.%20Sellers&amp;author=D.J.%20Schaid&amp;author=T.S.%20Frank&amp;author=C.L.%20Soderberg&amp;volume=93&amp;publication_year=2001&amp;pages=1633-1637&amp;pmid=11698567&amp;doi=10.1093/jnci/93.21.1633&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B153-genes-11-00856">
<span class="label">153.</span><cite>Rebbeck T.R., Lynch H.T., Neuhausen S.L., Narod S.A., van’t Veer L., Garber J.E., Evans G., Isaacs C., Daly M.B., Matloff E., et al.  Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N. Engl. J. Med. 2002;346:1616–1622. doi: 10.1056/NEJMoa012158.</cite> [<a href="https://doi.org/10.1056/NEJMoa012158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12023993/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Prophylactic%20oophorectomy%20in%20carriers%20of%20BRCA1%20or%20BRCA2%20mutations&amp;author=T.R.%20Rebbeck&amp;author=H.T.%20Lynch&amp;author=S.L.%20Neuhausen&amp;author=S.A.%20Narod&amp;author=L.%20van%E2%80%99t%20Veer&amp;volume=346&amp;publication_year=2002&amp;pages=1616-1622&amp;pmid=12023993&amp;doi=10.1056/NEJMoa012158&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B154-genes-11-00856">
<span class="label">154.</span><cite>Meijers-Heijboer H., van Geel B., van Putten W.L., Henzen-Logmans S.C., Seynaeve C., Menke-Pluymers M.B., Bartels C.C., Verhoog L.C., van den Ouweland A.M., Niermeijer M.F., et al.  Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. 2001;345:159–164. doi: 10.1056/NEJM200107193450301.</cite> [<a href="https://doi.org/10.1056/NEJM200107193450301" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11463009/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Breast%20cancer%20after%20prophylactic%20bilateral%20mastectomy%20in%20women%20with%20a%20BRCA1%20or%20BRCA2%20mutation&amp;author=H.%20Meijers-Heijboer&amp;author=B.%20van%20Geel&amp;author=W.L.%20van%20Putten&amp;author=S.C.%20Henzen-Logmans&amp;author=C.%20Seynaeve&amp;volume=345&amp;publication_year=2001&amp;pages=159-164&amp;pmid=11463009&amp;doi=10.1056/NEJM200107193450301&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B155-genes-11-00856">
<span class="label">155.</span><cite>Bolton K.L., Chenevix-Trench G., Goh C., Sadetzki S., Ramus S.J., Karlan B.Y., Lambrechts D., Despierre E., Barrowdale D., McGuffog L., et al.  Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. JAMA. 2012;307:382–390. doi: 10.1001/jama.2012.20.</cite> [<a href="https://doi.org/10.1001/jama.2012.20" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3727895/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22274685/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Association%20between%20BRCA1%20and%20BRCA2%20mutations%20and%20survival%20in%20women%20with%20invasive%20epithelial%20ovarian%20cancer&amp;author=K.L.%20Bolton&amp;author=G.%20Chenevix-Trench&amp;author=C.%20Goh&amp;author=S.%20Sadetzki&amp;author=S.J.%20Ramus&amp;volume=307&amp;publication_year=2012&amp;pages=382-390&amp;pmid=22274685&amp;doi=10.1001/jama.2012.20&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B156-genes-11-00856">
<span class="label">156.</span><cite>Mylavarapu S., Das A., Roy M. Role of BRCA mutations in the modulation of response to platinum therapy. Front. Oncol. 2018;8:16. doi: 10.3389/fonc.2018.00016.</cite> [<a href="https://doi.org/10.3389/fonc.2018.00016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5807680/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29459887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Oncol.&amp;title=Role%20of%20BRCA%20mutations%20in%20the%20modulation%20of%20response%20to%20platinum%20therapy&amp;author=S.%20Mylavarapu&amp;author=A.%20Das&amp;author=M.%20Roy&amp;volume=8&amp;publication_year=2018&amp;pages=16&amp;pmid=29459887&amp;doi=10.3389/fonc.2018.00016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B157-genes-11-00856">
<span class="label">157.</span><cite>Fong P.C., Yap T.A., Boss D.S., Carden C.P., Mergui-Roelvink M., Gourley C., De Greve J., Lubinski J., Shanley S., Messiou C., et al.  Poly (ADP)-Ribose polymerase inhibition: Frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval. J. Clin. Oncol. 2010;28:2512–2519. doi: 10.1200/JCO.2009.26.9589.</cite> [<a href="https://doi.org/10.1200/JCO.2009.26.9589" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20406929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=Poly%20(ADP)-Ribose%20polymerase%20inhibition:%20Frequent%20durable%20responses%20in%20BRCA%20carrier%20ovarian%20cancer%20correlating%20with%20platinum-free%20interval&amp;author=P.C.%20Fong&amp;author=T.A.%20Yap&amp;author=D.S.%20Boss&amp;author=C.P.%20Carden&amp;author=M.%20Mergui-Roelvink&amp;volume=28&amp;publication_year=2010&amp;pages=2512-2519&amp;pmid=20406929&amp;doi=10.1200/JCO.2009.26.9589&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B158-genes-11-00856">
<span class="label">158.</span><cite>Audeh M.W., Carmichael J., Penson R.T., Friedlander M., Powell B., Bell-Mcguinn K.M., Scott C., Weitzel J.N., Oaknin A., Loman N., et al.  Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: A proof-of-concept trial. Lancet Oncol. 2010;376:245–251. doi: 10.1016/S0140-6736(10)60893-8.</cite> [<a href="https://doi.org/10.1016/S0140-6736(10)60893-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20609468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol.&amp;title=Oral%20poly%20(ADP-ribose)%20polymerase%20inhibitor%20olaparib%20in%20patients%20with%20BRCA1%20or%20BRCA2%20mutations%20and%20recurrent%20ovarian%20cancer:%20A%20proof-of-concept%20trial&amp;author=M.W.%20Audeh&amp;author=J.%20Carmichael&amp;author=R.T.%20Penson&amp;author=M.%20Friedlander&amp;author=B.%20Powell&amp;volume=376&amp;publication_year=2010&amp;pages=245-251&amp;pmid=20609468&amp;doi=10.1016/S0140-6736(10)60893-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B159-genes-11-00856">
<span class="label">159.</span><cite>Gelmon K.A., Tischkowitz M., Mackay H., Swenerton K., Robidoux A., Tonkin K., Hirte H., Huntsman D., Clemons M., Gilks B., et al.  Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: A phase 2, multicentre, open-label, non-randomised study. Lancet Oncol. 2011;12:852–861. doi: 10.1016/S1470-2045(11)70214-5.</cite> [<a href="https://doi.org/10.1016/S1470-2045(11)70214-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21862407/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol.&amp;title=Olaparib%20in%20patients%20with%20recurrent%20high-grade%20serous%20or%20poorly%20differentiated%20ovarian%20carcinoma%20or%20triple-negative%20breast%20cancer:%20A%20phase%202,%20multicentre,%20open-label,%20non-randomised%20study&amp;author=K.A.%20Gelmon&amp;author=M.%20Tischkowitz&amp;author=H.%20Mackay&amp;author=K.%20Swenerton&amp;author=A.%20Robidoux&amp;volume=12&amp;publication_year=2011&amp;pages=852-861&amp;pmid=21862407&amp;doi=10.1016/S1470-2045(11)70214-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B160-genes-11-00856">
<span class="label">160.</span><cite>Kaufman B., Shapira-Frommer R., Schmutzler R.K., Audeh M.W., Friedlander M., Balmana J., Mitchell G., Fried G., Stemmer S.M., Hubert A., et al.  Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation. J. Clin. Oncol. 2015;33:244–250. doi: 10.1200/JCO.2014.56.2728.</cite> [<a href="https://doi.org/10.1200/JCO.2014.56.2728" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6057749/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25366685/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=Olaparib%20monotherapy%20in%20patients%20with%20advanced%20cancer%20and%20a%20germline%20BRCA1/2%20mutation&amp;author=B.%20Kaufman&amp;author=R.%20Shapira-Frommer&amp;author=R.K.%20Schmutzler&amp;author=M.W.%20Audeh&amp;author=M.%20Friedlander&amp;volume=33&amp;publication_year=2015&amp;pages=244-250&amp;pmid=25366685&amp;doi=10.1200/JCO.2014.56.2728&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B161-genes-11-00856">
<span class="label">161.</span><cite>Pujade-Lauraine E., Ledermann J.A., Selle F., Gebski V., Penson R.T., Oza A.M., Korach J., Huzarski T., Poveda A., Pignata S., et al.  Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2017;18:1274–1284. doi: 10.1016/S1470-2045(17)30469-2.</cite> [<a href="https://doi.org/10.1016/S1470-2045(17)30469-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28754483/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol.&amp;title=Olaparib%20tablets%20as%20maintenance%20therapy%20in%20patients%20with%20platinum-sensitive,%20relapsed%20ovarian%20cancer%20and%20a%20BRCA1/2%20randomised,%20placebo-controlled,%20phase%203%20trial&amp;author=E.%20Pujade-Lauraine&amp;author=J.A.%20Ledermann&amp;author=F.%20Selle&amp;author=V.%20Gebski&amp;author=R.T.%20Penson&amp;volume=18&amp;publication_year=2017&amp;pages=1274-1284&amp;pmid=28754483&amp;doi=10.1016/S1470-2045(17)30469-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B162-genes-11-00856">
<span class="label">162.</span><cite>Ledermann J., Harter P., Gourley C., Friedlander M., Vergote I., Rustin G., Scott C.L., Meier W., Shapira-Frommer R., Safra T., et al.  Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: A preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial. Lancet Oncol. 2014;15:852–861. doi: 10.1016/S1470-2045(14)70228-1.</cite> [<a href="https://doi.org/10.1016/S1470-2045(14)70228-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24882434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol.&amp;title=Olaparib%20maintenance%20therapy%20in%20patients%20with%20platinum-sensitive%20relapsed%20serous%20ovarian%20cancer:%20A%20preplanned%20retrospective%20analysis%20of%20outcomes%20by%20BRCA%20status%20in%20a%20randomised%20phase%202%20trial&amp;author=J.%20Ledermann&amp;author=P.%20Harter&amp;author=C.%20Gourley&amp;author=M.%20Friedlander&amp;author=I.%20Vergote&amp;volume=15&amp;publication_year=2014&amp;pages=852-861&amp;pmid=24882434&amp;doi=10.1016/S1470-2045(14)70228-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7464855/bin/genes-11-00856-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (81.5KB, zip) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Genes are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/genes11080856"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/genes-11-00856.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/7464855/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/7464855/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7464855%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7464855/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC7464855/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC7464855/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/32726901/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC7464855/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/32726901/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC7464855/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/7464855/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="gjRhxiPhs2wmfri63gmPLY2SMcP19HEDSthujaiPJK0GqxN7jfKpi6VyT4eecs98">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
